Structure of Sorafenib
CAS No.: 284461-73-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Sorafenib is a multi-kinase inhibitor that inhibits Raf-1 and B-RAF (IC50s = 6 and 22 µM, respectively), as well as the receptor tyrosine kinases VEGFR2, VEGFR3, PDGFRβ, FLT3, and c-Kit (IC50s = 90, 15, 20, 57, and 58 nM, respectively).
Synonyms: Bay 43-9006
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Marlhoux, Léna ; Arnaud, Alexandre ; Hervieu, Céline ; Makulyte, Gabriela ; Martinasso, Charlotte ; Mularoni, Angélique , et al.
Abstract: Casein kinase 2 (CK2) has emerged as a promising therapeutic target across a broad spectrum of malignancies, including pediatric and orphan cancers. The identification of a ligandable allosteric αD pocket on the CK2α subunit has enabled the development of bivalent inhibitors, which bind simultaneously to both the adenosine triphosphate (ATP) site and the allosteric pocket. Here, we report the discovery and pharmacological characterization of KDX1381, a structure-guided bivalent CK2α inhibitor with low-nanomolar potency and high selectivity, confirmed by cocrystal structures. In mice, KDX1381 suppressed CK2-driven tumor growth as a monotherapy and enhanced therapeutic efficacy when combined with vascular endothelial growth factor receptor (VEGFR) inhibitors or DNA-damaging agents in hepatocellular carcinoma and glioma models. These findings support bivalent CK2α inhibition as a differentiated therapeutic strategy with broad applicability in CK2-dependent cancers.
Show More >
Purchased from AmBeed: 61825-94-3 ; 1009820-21-6 ; 444731-52-6 ; 85622-93-1 ; 557795-19-4 ; 755037-03-7 ; 849217-68-1 ; 15663-27-1 ; 284461-73-0 ; 417716-92-8 ; 51-21-8
Show More >
| CAS No. : | 284461-73-0 |
| Formula : | C21H16ClF3N4O3 |
| M.W : | 464.83 |
| SMILES Code : | O=C(NC)C1=NC=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C=C2)=C1 |
| Synonyms : |
Bay 43-9006
|
| MDL No. : | MFCD06411450 |
| InChI Key : | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
| Pubchem ID : | 216239 |
| GHS Pictogram: |
|
| Signal Word: | Danger |
| Hazard Statements: | H360-H362-H372-H410 |
| Precautionary Statements: | P201-P202-P260-P263-P264-P270-P273-P280-P308+P313-P391-P405-P501 |
| Class: | 9 |
| UN#: | 3077 |
| Packing Group: | Ⅲ |
| Target |
|
In Vitro:
| Concentration | Treated Time | Description | References |
| AML12 and BNLCL.2 cells | 2 μM | 5 days | Evaluation of toxicity in untransformed liver cells, showing that compound 40 combined with sorafenib had low toxicity in normal liver cells | J Med Chem. 2025 Apr 10;68(7):7180-7196 |
| Hep3B cells | 1.7 μM | 5 days | Assessment of cell viability, showing that compound 40 combined with sorafenib significantly reduced Hep3B cell viability | J Med Chem. 2025 Apr 10;68(7):7180-7196 |
| L02 hepatocytes | 10 μM | 18 h | To investigate the effects of Sorafenib on lipid accumulation and inflammation, the results showed that Sorafenib significantly reduced lipid accumulation in L02 hepatocytes and suppressed the expression of inflammatory factors. | Cell Metab. 2020 May 5;31(5):892-908.e11. |
| Huh7 | 10 μM | 24 h | To investigate Sorafenib-induced macropinocytosis and its effect on ferroptosis. Results showed that Sorafenib induced macropinocytosis through activation of PI3K-RAC1-PAK1 signaling, replenishing intracellular cysteine and conferring resistance to Sorafenib. | J Exp Clin Cancer Res. 2022 Mar 14;41(1):98. |
| SK-Hep1 | 10 μM | 24 h | To investigate Sorafenib-induced macropinocytosis and its effect on ferroptosis. Results showed that Sorafenib induced macropinocytosis through activation of PI3K-RAC1-PAK1 signaling, replenishing intracellular cysteine and conferring resistance to Sorafenib. | J Exp Clin Cancer Res. 2022 Mar 14;41(1):98. |
| MHCC97L | 10 µM | 24 h | To assess the effect of Sorafenib on cell viability, the results showed that Sorafenib significantly reduced cell viability. | J Exp Clin Cancer Res. 2024 May 14;43(1):143. |
| MHCC97H | 10 µM | 24 h | To assess the effect of Sorafenib on cell viability, the results showed that Sorafenib significantly reduced cell viability. | J Exp Clin Cancer Res. 2024 May 14;43(1):143. |
| MOLM-13 cells | 0.1 μM | 24 h | Sorafenib increased IL-15 production by inhibiting ATF4 expression, thereby activating the IRF7/IL-15 axis. | Nat Med. 2018 Mar;24(3):282-291. |
| MV4-11 cells | 0.1 μM | 24 h | Sorafenib increased IL-15 production by inhibiting ATF4 expression, thereby activating the IRF7/IL-15 axis. | Nat Med. 2018 Mar;24(3):282-291. |
| Ba/F3-ITD cells | 10 nM | 24 h | Sorafenib increased IL-15 production by inhibiting ATF4 expression, thereby activating the IRF7/IL-15 axis. | Nat Med. 2018 Mar;24(3):282-291. |
| HSC-T6 cells | 10 μM | 24 h | To investigate the effect of Sorafenib on ferroptosis in HSC-T6 cells, results showed that Sorafenib significantly inhibited cell growth and induced ferroptosis. | Autophagy. 2020 Aug;16(8):1482-1505. |
| HSC-LX2 cells | 10 μM | 24 h | To investigate the effect of Sorafenib on ferroptosis in HSC-LX2 cells, results showed that Sorafenib significantly inhibited cell growth and induced ferroptosis. | Autophagy. 2020 Aug;16(8):1482-1505. |
| HSC-T6 | 5 μM | 24 h | To evaluate the effect of Sorafenib on HSC-T6 cells, the results showed that Sorafenib induced ferroptosis, which was validated by the inhibition of the ferroptosis inhibitor ferrostatin-1. | Autophagy. 2018;14(12):2083-2103. |
| HSC-LX2 | 5 μM | 24 h | To evaluate the effect of Sorafenib on HSC-LX2 cells, the results showed that Sorafenib induced ferroptosis, which was validated by the inhibition of the ferroptosis inhibitor ferrostatin-1. | Autophagy. 2018;14(12):2083-2103. |
| HT-29 colorectal cancer cells | 6 μM | 24 h | To study the effect of sorafenib on ERK1/2 and CSE1L phosphorylation in HT-29 cells. Results showed that sorafenib treatment inhibited ERK1/2 and CSE1L phosphorylation. | J Transl Med. 2015 Jun 13;13:191. |
In Vivo:
| Administration | Dosage | Frequency | Description | References |
| Mice | Akt1Myr;MycOE HCC organoids | In vitro culture | 4 μM | 5 days | Assessment of therapeutic efficacy, showing that compound 40 combined with sorafenib exhibited significant therapeutic effects in HCC organoids | J Med Chem. 2025 Apr 10;68(7):7180-7196 |
| Mice | NASH-HCC model | Oral | 15 mg/kg/2 days | Every 2 days for 8 weeks | To evaluate the therapeutic effects of low-dose Sorafenib on the NASH-HCC model, the results showed that Sorafenib significantly reduced tumor incidence and size, and improved major pathological features of NASH, including steatosis, inflammation, and fibrosis. | Cell Metab. 2020 May 5;31(5):892-908.e11. |
| Mice | SK-Hep1 and Huh7 xenograft models | Intraperitoneal injection | 5 mg/kg | Daily for 3 days | To investigate the effect of combined Sorafenib and Amiloride treatment on tumor growth. Results showed that Amiloride enhanced the antitumor effect of Sorafenib by inhibiting macropinocytosis, significantly suppressing tumor growth. | J Exp Clin Cancer Res. 2022 Mar 14;41(1):98. |
| BALB/c nude mice | Subcutaneous tumor model and orthotopic tumor model | Oral | 10 mg/kg | Once daily for two weeks | To evaluate the efficacy of Sorafenib in inhibiting tumor growth, the results showed that Sorafenib significantly inhibited tumor growth. | J Exp Clin Cancer Res. 2024 May 14;43(1):143. |
| Mice | Bile duct ligation-induced liver fibrosis model | Intraperitoneal injection | 10 mg/kg | Once every other day for 2 weeks | To investigate the effect of Sorafenib on liver fibrosis in mice, results showed that Sorafenib significantly alleviated liver fibrosis and induced HSC ferroptosis. | Autophagy. 2020 Aug;16(8):1482-1505. |
| Mice | Bile duct ligation (BDL)-induced liver fibrosis model | Intraperitoneal injection | 10 mg/kg | Once every other day for 2 weeks | To evaluate the effect of Sorafenib on murine liver fibrosis, the results showed that Sorafenib alleviated liver fibrosis by inducing HSC ferroptosis. | Autophagy. 2018;14(12):2083-2103. |
| C57BL/6 mice | Subcutaneous Hepa1-6 liver cancer model | Oral gavage | 10 mg/kg | Daily for 12 days | To evaluate the antitumor effects of low-dose Sorafenib alone or in combination with R848 in a liver cancer model. The results showed that the combination of low-dose Sorafenib with R848 significantly enhanced antitumor activity with no obvious toxic side effects. | Adv Sci (Weinh). 2023 Jun;10(18):e2207650 |
| Nude Balb/c mice | HepG2/SOR tumor model | Intravenous injection | 5 mg/kg | Every two days for a total of four injections, lasting 14 days | To evaluate the anti-tumor effect of CTNP-PMS/SOR in the HepG2/SOR tumor model. Results showed that CTNP-PMS/SOR significantly inhibited tumor growth and prolonged the survival time of mice. | Drug Deliv. 2019 Dec;26(1):1080-1091 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT03565536 | Thyroid Cancer, Anaplastic | Phase 2 | Recruiting | October 30, 2019 | China, Fujian ... More >> Fujian Medical University Union Hospital Recruiting FuZhou, Fujian, China, 350001 Contact: bo wang, md 13705947900 wangbo@fjmu.edu.cn Less << |
| NCT00984425 | Solid Tumors | Phase 1 | Completed | - | Italy ... More >> Istituto Clinco Humanitas Rozzano, Milano, Italy, 20089 Less << |
| NCT01259193 | Hepatocellular Carcinoma | Phase 2 | Unknown | July 2012 | China, Shanghai ... More >> Liver Cancer Institute Recruiting Shanghai, Shanghai, China, 200032 Contact: Zheng-Gang Ren, Ph.D 0086-021-64041990 ext 2137 ren.zhenggang@zs-hospital.sh.cn Contact: Lan Zhang, Master 0086-021-64041990 ext 2171 zhang.lan@zs-hospital.sh.cn Principal Investigator: Zheng-Gang Ren, Ph.D Sub-Investigator: Jubo Zhang, PhD Less << |
| NCT01640665 | Metastatic Breast Cancer ... More >> Gastrointestinal Tumors Less << | Phase 1 | Completed | - | United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06519 Less << |
| NCT01901692 | Hepatocellular Carcinoma | Phase 2 Phase 3 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 05505 Less << |
| NCT02716766 | Carcinoma, Hepatocellular ... More >> Secondary Less << | Phase 2 | Active, not recruiting | December 2020 | Hong Kong ... More >> Queen Mary Hospital Hong Kong, Hong Kong Less << |
| NCT02227914 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 1 Phase 2 | Withdrawn(Study stopped due to... More >> administrative reasons) Less << | - | United States, California ... More >> Lahey Hospital & Medical Center Burlington, California, United States United States, Colorado Rocky Mountain Cancer Centers Denver, Colorado, United States United States, Florida University of Miami Hospital & Clinics Miami, Florida, United States United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States United States, Ohio The Ohio State University, Martha Morehouse Medical Plaza Columbus, Ohio, United States United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States Less << |
| NCT00572078 | SOLID TUMORS | PHASE1 | COMPLETED | 2014-09-14 | Indiana University Cancer Cent... More >>er, Indianapolis, Indiana, 46202, United States Less << |
| NCT01075113 | Liver Cancer | Phase 1 | Active, not recruiting | January 31, 2023 | United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less << |
| NCT01851408 | Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << | Phase 2 | Withdrawn(No progression of Ph... More >>ase 1 trial to Phase 2.) Less << | - | - |
| NCT00893373 | Acute Myeloid Leukemia (AML) | Phase 2 | Completed | - | Germany ... More >> Sozialstiftung Bamberg Klinikum am Bruderwald Bamberg, Germany, 96049 Klinikum Bayreuth Bayreuth, Germany, 95445 Charite Campus Benjamin Franklin Berlin, Germany Ev. Diakonie-Krankenhaus gGmbH Bremen Bremen, Germany, 28239 University Hospital Dresden Dresden, Germany, 01307 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Westpfalz-Klinikum GmbH Kaiserslautern, Germany, 67655 Agaplesion Diakoniekrankenhaus Rotenburg Rotenburg, Germany, 27356 Robert-Bosch-Krankenhaus Stuttgart, Germany, 70376 Less << |
| NCT00884416 | Glioblastoma ... More >>Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Less << | Phase 1 | Completed | - | Switzerland ... More >> Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology Geneva, GE, Switzerland, 1211 Less << |
| NCT00964743 | Neoplastic Meningitis | Not Applicable | Terminated(Low Accrual) | - | United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less << |
| NCT00862082 | - | Terminated(PR104 plus sorafeni... More >>b was poorly tolerated in patients with advanced HCC) Less << | - | - | |
| NCT00813293 | Hepatocellular Cancer | Phase 2 | Active, not recruiting | December 2017 | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less << |
| NCT01613846 | Renal Cell Carcinoma | Phase 3 | Completed | - | - |
| NCT00565370 | Advanced Gastric Cancer | Phase 1 Phase 2 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less << |
| NCT00964743 | - | Terminated(Low Accrual) | - | - | |
| NCT01005875 | Hepatocellular Carcinoma ... More >> Liver Cancer Less << | Not Applicable | Terminated(Sponsor(Bayer)did n... More >>ot wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes.) Less << | - | United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less << |
| NCT00565370 | - | Completed | - | - | |
| NCT02072486 | Advanced Adult Hepatocellular ... More >>Carcinoma Localized Non-Resectable Adult Hepatocellular Carcinoma Stage III Childhood Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IV Childhood Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << | Not Applicable | Active, not recruiting | December 3, 2018 | United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less << |
| NCT00862082 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Terminated(PR104 plus sorafeni... More >>b was poorly tolerated in patients with advanced HCC) Less << | - | United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85724 United States, California Moores UCSD Cancer Center La Jolla, California, United States, 92093 University of California, Irvine Orange, California, United States, 92868 Sharp Clinical Oncology Research San Diego, California, United States, 92123 Pacific Oncology/Hematology San Francisco, California, United States, 94115 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21231 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Hong Kong Prince of Wales Hospital Shatin, New Territories, Hong Kong Singapore Singapore General Hospital Singapore, Singapore Taiwan Chang Gung Memorial Hospital Kaohsiung, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan Chi Mei Medical Center, Liouying T'ai-nan, Taiwan China Medical University Hospital Taichung City, Taiwan Cathay General Hospital Taipei City, Taiwan, 10630 National Taiwan University Hospital Taipei, Taiwan Less << |
| NCT01005875 | - | Terminated(Sponsor(Bayer)did n... More >>ot wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes.) Less << | - | - | |
| NCT02323906 | Carcinoma, Hepatocellular | Phase 1 | Terminated(Slow enrollment and... More >> business decision. No safety concerns were identified for the study drugs.) Less << | - | United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94115 United States, Florida University of Florida College of Med Gainesville, Florida, United States, 32610-0277 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-528 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 United States, Utah University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less << |
| NCT01804374 | Metastatic Osteosarcoma ... More >> Relapsed Osteosarcoma Less << | Phase 2 | Completed | - | Italy ... More >> Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo, Torino, Italy, 10060 Less << |
| NCT01041482 | Renal Cell Carcinoma | Phase 2 | Unknown | November 2013 | China, Beijing ... More >> Jianhui Ma Recruiting Beijing, Beijing, China, 100730 Contact: Jianhui Ma Jianhui Ma Jianhui Ma, Doctor 01086108878 Less << |
| NCT02971696 | HCC | Phase 3 | Completed | - | Egypt ... More >> El Kahraba Hosital Cairo, N/A = Not Applicable, Egypt, 1234 Ain Shams University Hospital Cairo, Egypt Nasser Institute Cairo, Egypt Less << |
| NCT00887107 | Thyroid Cancer | Phase 2 | Completed | - | Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less << |
| NCT00892658 | Hepatocellular Carcinoma | PHASE1 | COMPLETED | 2020-12-16 | University Health Network, Tor... More >>onto, Ontario, M5G 2M9, Canada Less << |
| NCT00942682 | Neuroendocrine Tumor ... More >> Carcinoid Tumor Pancreatic Neuroendocrine Tumor Less << | Phase 1 | Completed | - | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
| NCT00917462 | Esophageal Cancer ... More >> Gastroesophageal Junction Cancer Less << | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT00880542 | - | Terminated(The study lost fund... More >>ing.) Less << | - | - | |
| NCT00880542 | Sarcoma | Phase 2 | Terminated(The study lost fund... More >>ing.) Less << | - | United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less << |
| NCT00703365 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | Thailand ... More >> Department of Medicine, Siriraj Hospital Bangkoknoi, Bangkok, Thailand, 10700 Medical Oncology Unit, Chulalongkorn Hospital Patumwan, Bangkok, Thailand, 10330 Horizon Regional Cancer Center, Bamrungrad Hospital Sukhumvit 3, Bangkok, Thailand, 10110 Less << |
| NCT01539018 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 2 | Terminated(After interim resul... More >>ts data showed no evidence of a difference between both groups) Less << | - | Egypt ... More >> Ain shams university Cairo, Egypt Cairo University Hospitals Cairo, Egypt National cancer institute Cairo, Egypt NHTMRI Cairo, Egypt National Liver Institute Monofeiya, Egypt Less << |
| NCT02672488 | Hepatocellular Carcinoma | Phase 2 | Unknown | December 2018 | China ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, China, 300060 Contact: TI ZHANG, MD +862223340123 ext 3092 zhangti@tjmuch.com Contact: Huikai Li, MD +862223340123 ext 3091 lihuikai@tjmuch.com Less << |
| NCT00854620 | Carcinoma, Renal Cell|Kidney D... More >>isease|Kidney Cancer Less << | PHASE2 | COMPLETED | 2025-01-11 | Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less << |
| NCT00854620 | Carcinoma, Renal Cell|Kidney D... More >>isease|Kidney Cancer Less << | PHASE2 | COMPLETED | 2025-01-11 | Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States Less << |
| NCT01025453 | Thyroid Cancer | Phase 2 | Completed | - | United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less << |
| NCT02185560 | - | Recruiting | June 30, 2021 | Japan ... More >> Recruiting Multiple Locations, Japan Less << | |
| NCT01025453 | - | Completed | - | - | |
| NCT00480389 | Renal Cell Carcinoma|Metastati... More >>c Disease Less << | PHASE2 | COMPLETED | 2025-03-13 | Princess Margaret Hospital, Un... More >>iversity Health Network, Toronto, Ontario, M5G 2M9, Canada Less << |
| NCT00956436 | Hepatocellular Carcinoma | Phase 1 | Completed | - | United States, Colorado ... More >> Resesarch Site Denver, Colorado, United States United States, Florida Resesarch Site Ocoee, Florida, United States United States, Indiana Resesarch Site Indianapolis, Indiana, United States United States, Massachusetts Resesarch Site Boston, Massachusetts, United States United States, New York Resesarch Site New York, New York, United States United States, Virginia Resesarch Site Norfolk, Virginia, United States Singapore Resesarch Site Singapore, Singapore Taiwan Resesarch Site Tainan, Taiwan Resesarch Site Taipei, Taiwan Resesarch Site Tao-Yuan, Taiwan United Kingdom Resesarch Site Edgbaston, Birmingham, United Kingdom Less << |
| NCT00810394 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | PHASE2 | COMPLETED | 2025-03-12 | University of California Davis... More >> Cancer Center, Sacramento, California, 95817, United States Less << |
| NCT00810394 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | PHASE2 | COMPLETED | 2025-03-12 | University of California Davis... More >> Cancer Center, Sacramento, California, 95817, United States Less << |
| NCT01319942 | - | Unknown | June 2013 | Taiwan ... More >> Chi-Mei Hospital Recruiting Tainan, Taiwan, 600 Contact: Li-Ching Lin, MD 886-6-2812811 ext 53501 liching51@yahoo.com.tw Principal Investigator: Li-Ching Lin, MD Taipei Medical University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jeng-Fong Chiou, MD;PhD 886-2-27372181 ext 2130 sjfchiou@xuite.net Principal Investigator: Jen-Fong Chiou, MD;PhD Less << | |
| NCT01230697 | Kidney Cancer|Liver Cancer | UNKNOWN | 2025-09-11 | Alfredo Berruti, Orbassano (To... More >>), Turin, 10043, Italy Less << | |
| NCT03037437 | Hepatocellular Cancer | Phase 2 | Recruiting | December 2018 | United States, Texas ... More >> University of Texas Health Cancer Center Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin 210-450-5798 goodwine@uthscsa.edu Less << |
| NCT03170895 | AML FLT3-ITD ... More >>Mutation Less << | Phase 2 | Recruiting | October 1, 2021 | Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC 852-22554361 chunxiao@hku.hk Less << |
| NCT00924807 | - | Terminated(Sponsor closed the ... More >>trial) Less << | - | - | |
| NCT01306058 | Hepatoma Live... More >>r Neoplasms Adenoma, Liver Cell Carcinoma, Hepatocellular Liver Neoplasms, Experimental Less << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT02562755 | Hepatocellular Carcinoma (HCC) | Phase 3 | Recruiting | October 2019 | - |
| NCT00808145 | Hepatocellular Carcinoma | Phase 2 | Withdrawn(Lack of enrollment, ... More >>many screen failures and non eligible study participants) Less << | - | United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less << |
| NCT01306058 | - | Completed | - | - | |
| NCT00801801 | Non Squamous Cell Lung Cancer ... More >> Non Small Cell Lung Cancer Less << | Phase 2 | Terminated(Sponsors withdrew f... More >>unding; preliminary efficacy data was not encouraging.) Less << | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 Less << |
| NCT00544609 | Bladder Cancer | Phase 1 | Completed | - | Spain ... More >> Hospital Clínic i Provincial de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Institut Català d' Oncología Barcelona, Spain Less << |
| NCT00924807 | Prostate Cancer | Phase 1 Phase 2 | Terminated(Sponsor closed the ... More >>trial) Less << | - | United States, New York ... More >> St.Luke's-Roosevelt Hospital Center New York, New York, United States, 10019 Less << |
| NCT00801801 | - | Terminated(Sponsors withdrew f... More >>unding; preliminary efficacy data was not encouraging.) Less << | - | - | |
| NCT02961998 | Hepatocellular Carcinoma | Phase 4 | Completed | - | - |
| NCT02538393 | Biological Availability | Phase 1 | Completed | - | Germany ... More >> Berlin, Germany, 13353 Less << |
| NCT01141309 | Thyroid Cancer | Phase 2 | Active, not recruiting | June 2019 | United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT00954278 | Carcinoma, Non Small Cell Lung | Phase 1 | Active, not recruiting | December 2018 | United States, Wisconsin ... More >> University of Wisconsin - Madison Madison, Wisconsin, United States, 53792 Less << |
| NCT02529761 | Hepatocellular Carcinoma | Not Applicable | Unknown | October 2018 | China, Shaanxi ... More >> Xijing Hospital of digestive disease, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Han hangh@fmmu.edu.cn Principal Investigator: Guohong Han, MD,Ph.D Less << |
| NCT01328223 | - | Unknown | December 2012 | Taiwan ... More >> Shang-Wen Chen Recruiting Taichung, Taiwan, 404 Contact: Shang-Wen Chen, MD 886-4-22052121 ext 7450 vincent1680616@yahoo.com.tw Sub-Investigator: Yu-Cheng Kuo Sub-Investigator: Ji-An Liang, MD Li-Ching Lin Recruiting Tainan, Taiwan, 700 Contact: Li-Ching Lin, MD liching51@yahoo.com.tw Jeng-Fong Chiou Recruiting Taipei, Taiwan, 100 Contact: Jeng-Fong Chiou, MD;PhD sjfchiou@xuite.net Less << | |
| NCT01029418 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Terminated(The phase II portio... More >>n was not conducted due to funding issue.) Less << | - | Singapore ... More >> National University Hospital Singapore Singapore, Singapore, 119074 National Cancer Centre Singapore Singapore, Singapore, 169610 Less << |
| NCT01736878 | Medullary Thyroid Carcinoma | PHASE2 | WITHDRAWN | 2025-04-13 | University Hospital Ulm, Clini... More >>c for Nuclear Medicine, Ulm, Baden-Wuerttemberg, D-89081, Germany Less << |
| NCT02150317 | Advanced Hepatocellular Carcin... More >>oma Less << | Not Applicable | Unknown | December 2016 | China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Ai-jun Li, M.D. 0086-021-81875531 yinlei409@hotmail.com Contact: Lei Yin, M.D. 0086-021-81875532 dermatology2008@126.com Less << |
| NCT01334710 | - | Terminated(safety issue observ... More >>ed on another hepatocellular study using OSI906) Less << | - | - | |
| NCT00933777 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Non-Small Cell Lung Cancer Less << | Phase 1 | Completed | - | Germany ... More >> Center for Integrated Oncology, Dep.I of Internal Medicine, University Hospital Cologne Cologne, Germany Less << |
| NCT01398501 | Acute Myeloid Leukemia | PHASE1 | COMPLETED | 2025-08-16 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02214, United States Less << |
| NCT03606590 | Hepatocellular Carcinoma | Phase 2 | Recruiting | December 2020 | Spain ... More >> Vall d'Hebron Institute of Oncology (VHIO) Recruiting Barcelona, Spain Contact: Teresa Macarulla, Dr. +34-932748855 tmacarulla@vhio.net Contact: Raquel García Pelaez +34-934893000 rgarcia@vhio.net Principal Investigator: Teresa Macarulla Mercade, Dr. HM Hospitales - Centro Integral Oncológico Clara Campal Recruiting Madrid, Spain, 28050 Contact: Antonio Cubillo, Dr. acubillo@hmhospitales.com Principal Investigator: acubillo@hmhospitales.com acubillo@hmhospitales.com, Dr. Less << |
| NCT00478114 | Renal Cell Carcinoma | Phase 3 | Completed | - | Thailand ... More >> Siriraj Hospital, Department of Medicine Bangkoknoi, Bangkok, Thailand, 10700 Less << |
| NCT01334710 | Liver Cancer | Phase 2 | Terminated(safety issue observ... More >>ed on another hepatocellular study using OSI906) Less << | - | United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less << |
| NCT02691780 | Refractory Solid Tumors | WITHDRAWN | 2019-11-19 | Samsung Medical Center, Seoul,... More >> Seoul, Korea, Republic Of, 135-710, Korea, Republic of Less << | |
| NCT01833299 | Hepatocellular Carcinoma ... More >> Face Cancer Less << | Phase 4 | Unknown | December 2014 | China ... More >> Cancer Centre of Sun Yat-Sen University Recruiting Guangzhou, China, 510060 Contact: min-shan chen, M.D.,Ph.D. 87343117 Chminsh@mail.sysu.edu.cn Principal Investigator: min-shan chen, M.D.,Ph.D. Less << |
| NCT01342627 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | TERMINATED | 2025-09-15 | Centro di Riferimento Oncologi... More >>co, Aviano, Pordenone, 33081, Italy Less << |
| NCT00997022 | Hepatocellular Cancer | PHASE1 | COMPLETED | 2025-05-15 | University of Southern Califor... More >>nia, Los Angeles, California, 90089, United States|University of California, Los Angeles, Los Angeles, California, 90095, United States|Columbia University Medical Center, New York, New York, 10032, United States Less << |
| NCT00846131 | Hepatocellular Carcinoma | Phase 1 | Completed | - | United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less << |
| NCT02834546 | - | Recruiting | October 2019 | France ... More >> Institut Bergonié Not yet recruiting Bordeaux, France Principal Investigator: Dominique BECHADE, MD CHU de Limoges Not yet recruiting Limoges, France Principal Investigator: Véronique LOUSTAUD-RATTI, MD CHU de Montpellier Not yet recruiting Montpellier, France Principal Investigator: Eric ASSENAT, MD CHU de Bordeaux Recruiting Pessac, France Contact: Clémence FRON, MD 05 57 65 64 39 ext +33 clemence.fron@chu-bordeaux.fr Contact: Nathalie TERRAS 05 57 62 34 60 ext +33 nathalie.terras@chu-bordeaux.fr Principal Investigator: Clémence FRON, MD Sub-Investigator: Jean-Frédéric BLANC, MD-PhD CHU de Toulouse Not yet recruiting Toulouse, France Principal Investigator: Jean-Marie PERON, MD Less << | |
| NCT00780169 | Metastatic Colorectal Cancer | Phase 1 | Completed | - | Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less << |
| NCT01338857 | - | Terminated(Sorafenib ineffecti... More >>ve for tx of recurrent or progressive PLGA) Less << | - | - | |
| NCT00875745 | Leukemia, Myeloid, Acute ... More >> Leukemia, Promyelocytic, Acute Myelodysplastic Syndromes Less << | Phase 1 | Completed | - | United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less << |
| NCT01444807 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 2 | Recruiting | September 2019 | Italy ... More >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD +390223902557 Giuseppe.Procopio@istitutotumori.mi.it Contact: Elena Verzoni, MD +390223902557 elena.verzoni@istitutotumori.mi.it Principal Investigator: Giuseppe Procopio, MD Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella Franco Morelli Recruiting San Giovanni Rotondo, Italy Less << |
| NCT02332031 | Drug Interactions | Phase 1 | Completed | - | Germany ... More >> Berlin, Germany, 13353 Less << |
| NCT01254890 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02311205 | Hepatocellular Carcinoma ... More >> Metastasis Less << | Phase 2 | Active, not recruiting | June 2018 | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less << |
| NCT01338857 | neurofibromatosis1 (NF1) ... More >> Recurrent or Progressive Optic Pathway Gliomas (OPG) Recurrent or Progressive Low-grade Glioma Less << | Phase 2 | Terminated(Sorafenib ineffecti... More >>ve for tx of recurrent or progressive PLGA) Less << | - | United States, New York ... More >> New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders New York, New York, United States, 10016 Less << |
| NCT02530476 | Leukemia Acut... More >>e Myeloid Leukemia Less << | Phase 1 Phase 2 | Active, not recruiting | December 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01507064 | Hepatocellular Carcinoma | Phase 2 | Completed | - | Italy ... More >> UOSC Epatologia - Cardarelli Hospital Napoli, Italy, 80131 Less << |
| NCT01254890 | - | Completed | - | - | |
| NCT01510756 | Chronic Lymphocytic Leukemia | PHASE2 | TERMINATED | 2025-12-14 | UCSD Medical Center, La Jolla,... More >> California, 92093, United States Less << |
| NCT01510756 | Chronic Lymphocytic Leukemia | PHASE2 | TERMINATED | 2025-12-14 | UCSD Medical Center, La Jolla,... More >> California, 92093, United States Less << |
| NCT02474290 | Acute Myeloid Leukemia|Hematop... More >>oietic Stem Cell Transplantation Less << | PHASE2|PHASE3 | COMPLETED | 2019-08-10 | Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less << |
| NCT01561833 | T Cell Lymphoma | PHASE1 | COMPLETED | 2025-06-13 | Yale Cancer Center, New Haven,... More >> Connecticut, 06510, United States Less << |
| NCT01203787 | Hepatocellular Carcinoma | Phase 4 | Completed | - | United States, Florida ... More >> University of Florida Hepatology Gainesville, Florida, United States, 32610-0277 Mayo Clinic Jacksonville, Florida, United States, 32224 Florida Hospital Transplant Center Orlando, Florida, United States, 32804 Tampa General Hospital Tampa, Florida, United States, 33606 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19107 United States, Texas University of Texas Health Science Center Houston Houston, Texas, United States, 77030 Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less << |
| NCT01471353 | Colorectal Cancer Metastatic | Phase 2 | Completed | - | United States, Florida ... More >> UF Health Cancer Center Gainesville, Florida, United States, 32610 Less << |
| NCT01203787 | - | Completed | - | - | |
| NCT01556815 | PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Liver Neoplasms Carcinoma, Hepatocellular Digestive System Neoplasms Neoplasms by Site Liver Diseases Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction] HBV Less << | Phase 2 | Unknown | May 2015 | China, Shandong ... More >> Shandong Cancer Hospital and Institute Not yet recruiting Jinan, Shandong, China, 250117 Contact: Wenbo Shao, MD, Ph D +8653167626412 shaowenbomd@gmail.com Principal Investigator: Jinlong Song, MD Sub-Investigator: Wenbo Shao, MD, Ph D Less << |
| NCT02069145 | Hepatocellular Cancer ... More >> Liver Cancer Less << | Phase 1 | Completed | - | United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Massachussetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less << |
| NCT01906216 | Hepatocellular Carcinoma | Phase 2 Phase 3 | Recruiting | December 2018 | China, Shaanxi ... More >> Xijing Hospital of Digestive Disease Recruiting Xi`an, Shaanxi, China, 710032 Contact: Wei Bai, MD +8615991771343 Contact: Yan Zhao, MD +8613571884093 Less << |
| NCT01471353 | - | Completed | - | - | |
| NCT02196857 | Leukemia | Phase 2 | Active, not recruiting | February 2021 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02298348 | Neuroblastoma | Phase 1 | Active, not recruiting | May 2019 | United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago, Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Cook Children's Healthcare System Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less << |
| NCT01900002 | Liver Cancer | Phase 2 | Active, not recruiting | September 2020 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02599337 | Fasting | Phase 1 | Completed | - | Canada, Quebec ... More >> Inventiv Health Clinique Inc. Québec, Quebec, Canada, G1P 0A2 Less << |
| NCT02021929 | Hepatopulmonary Syndrome | Phase 2 | Terminated | - | United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Columbia University-NewYork-Presbyterian Hospital New York, New York, United States, 10032 United States, Pennsylvania University of Pennsylvania - Perelman Center Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29424 United States, Texas University of Texas Health Science Center at Houston Medical School Houston, Texas, United States, 77030 Less << |
| NCT02560779 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Recruiting | November 2020 | United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294-3300 United States, California City of Hope Withdrawn Duarte, California, United States, 91010 United States, Maryland National Cancer Institute Withdrawn Bethesda, Maryland, United States, 20892 United States, Ohio University Hospitals Recruiting Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Less << |
| NCT03582618 | Hepatocellular Carcinoma ... More >> Advanced Cancer Less << | Phase 2 | Recruiting | June 2021 | United States, California ... More >> Innovative Clinical Research Institute Recruiting Whittier, California, United States, 90603 United States, South Carolina Charleston Hematology Oncology Associates Recruiting Charleston, South Carolina, United States, 29403 Taiwan National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Less << |
| NCT02867280 | Hepatocellular Carcinoma|Recur... More >>rence Less << | PHASE3 | TERMINATED | 2020-01-31 | Sun Yat-sen University Cancer ... More >>Center, Guangzhou, Guangdong, 510060, China Less << |
| NCT02084732 | Thyroid Cancer | PHASE2 | COMPLETED | 2019-11-01 | Instituto Nacional de Cancerol... More >>ogía, Bogotá, Cundinamarca, 00000, Colombia Less << |
| NCT03535259 | Hepatocellular Carcinoma, Radi... More >>otherapy, Sorafenib Less << | Phase 2 | Recruiting | April 1, 2021 | China, Beijing ... More >> Bo Chen Recruiting Beijing, Beijing, China, 100021 Contact: Bo Chen, MD 008613240000876 chenboo@outlook.com Contact: Yexiong Li, MD 00861087788860 yexiong12@163.com Principal Investigator: Yexiong Li, MD Principal Investigator: Bo Chen, MD Sub-Investigator: Huiying Zeng, MD Sub-Investigator: Liming Wang, MD Less << |
| NCT03722498 | Hepatocellular Carcinoma | Phase 2 | Recruiting | November 1, 2018 | China, Guangdong ... More >> Ming Shi Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD (8620)-87343938 shiming@sysu.edu.cn Principal Investigator: Ming Shi, MD Less << |
| NCT02733809 | Hepatocellular Carcinoma | PHASE4 | UNKNOWN | 2025-12-24 | King Saud University Medical C... More >>ity, Riyadh, 7805, Saudi Arabia Less << |
| NCT02288507 | Hepatocellular Cancer | Phase 1 | Withdrawn(Closed due to no acc... More >>rual) Less << | - | United States, Hawaii ... More >> University of Hawaii Honolulu, Hawaii, United States, 96813 Less << |
| NCT02122003 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | TERMINATED | 2017-11-08 | Istituto Tumori, Milan, Mi, 20... More >>156, Italy Less << |
| NCT01425216 | Keloids | PHASE2 | TERMINATED | 2025-03-13 | Michael H. Tirgan, MD, New Yor... More >>k, New York, 10023, United States Less << |
| NCT02636426 | Neoplasms | Phase 1 | Completed | - | Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less << |
| NCT01223027 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 3 | Completed | - | - |
| NCT03622541 | FLT3-ITD Mutation ... More >> AML Less << | Phase 2 | Recruiting | November 2019 | Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC 852-22554361 chunxiao@hku.hk Less << |
| NCT01223027 | - | Completed | - | - | |
| NCT00971126 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Terminated(Two patients in the... More >> first dose level be counted as reaching DLT. DSMB recommend terminated early this trial.) Less << | - | Taiwan ... More >> Ghang-Gung Memorial Hospital at Chia-Yi Chia-Yi, Taiwan, 613 Less << |
| NCT00634634 | Metastatic Breast Cancer | Phase 1 Phase 2 | Active, not recruiting | May 2019 | United States, District of Col... More >>umbia Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Cooper Hospital/University Medical Center Voorhees, New Jersey, United States, 08690 Less << |
| NCT00779311 | - | Terminated(Dose limiting toxic... More >>ity at the lowest planned dose level.) Less << | - | - | |
| NCT01482442 | Liver Carcinoma | Phase 3 | Completed | - | France ... More >> CHU Amiens #2 Amiens, France, 80054 CHU Angers #3 Angers, France, 49933 CHRU Besançon Hôpital Jean Minjoz #21 Besançon, France, 25030 Hôpital Jean Verdier #25 Bondy, France, 93140 Hôpital Côte de Nacre #4 Caen, France, 14033 Hôpital Antoine Béclère #29 Clamart, France, 92140 Hopital beaujon #1 Clichy, France, 92110 Henri Mondor #24 Créteil, France, 94000 CHU Dijon Hôpital Bocage #22 Dijon, France, 21000 CHU Grenoble #5 Grenoble, France, 38043 Hôpital Edouard Herriot #6 Lyon, France, 69003 Lyon La croix Rousse #27 Lyon, France, 69004 Institut Paoli Calmettes #7 Marseille, France, 13009 CHU Marseille Hôpital La Timone #23 Marseille, France, 13385 Hôpital Saint Eloi #8 Montpellier, France, 34295 Hôpital de Brabois #9 Nancy, France, 54511 Hotel Dieu #10 Nantes, France, 44093 Hôpital de L'Archet #11 Nice, France, 06002 Hôpital Européen Georges Pompidou #13 Paris, France, 75908 Hôpital Haut Leveque #14 Pessac, France, 33604 CHU Poitiers La Milétrie Poitiers, France, 86021 CHU Robert Debré #28 Reims, France, 51100 CHU Saint Etienne Hôpital Nord #17 Saint-Priest en Jarez, France, 42270 Hôpital de Hautepierre #18 Strasbourg, France, 67098 Paul Brousse #19 Villejuif, France, 94275 Institut Gustave Roussy #20 Villejuif, France, 94805 Less << |
| NCT00779311 | Metastatic Colorectal Cancer | Phase 1 | Terminated(Dose limiting toxic... More >>ity at the lowest planned dose level.) Less << | - | United States, Georgia ... More >> Central Georgia Cancer Care Macon, Georgia, United States, 31201 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less << |
| NCT01903694 | Child-Pugh A Hepatocellular Ca... More >>rcinoma Less << | Phase 3 | Completed | - | France ... More >> CHU de Dijon Dijon, France, 21079 Less << |
| NCT01258608 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
| NCT00131937 | - | Completed | - | - | |
| NCT03247088 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Recruiting | July 2022 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations CR_Study_Registration@mdanderson.org Less << |
| NCT00466232 | Small Cell Carcinoma ... More >> Lung Cancer Less << | Phase 1 | Completed | - | United States, Minnesota ... More >> Park Nicollet Institute St. Louis Park, Minnesota, United States, 55416 Less << |
| NCT00844168 | Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Resectable Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << | Phase 1 | Completed | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
| NCT01093222 | Extrahepatic Bile Duct Adenoca... More >>rcinoma Gallbladder Adenocarcinoma Gallbladder Adenocarcinoma With Squamous Metaplasia Hilar Cholangiocarcinoma Recurrent Extrahepatic Bile Duct Carcinoma Recurrent Gallbladder Carcinoma Undifferentiated Gallbladder Carcinoma Unresectable Extrahepatic Bile Duct Carcinoma Unresectable Gallbladder Carcinoma Less << | Phase 2 | Completed | - | - |
| NCT00131937 | Anaplastic Large Cell Lymphoma... More >> Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less << |
| NCT01093222 | - | Completed | - | - | |
| NCT00734526 | Glioblastoma ... More >>Gliosarcoma Less << | Phase 1 | Terminated | - | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01335074 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Withdrawn | - | Germany ... More >> University Hospital Giessen and Marburg Marburg, Germany, 35043 Less << |
| NCT00678288 | - | Terminated | - | - | |
| NCT00300885 | - | Terminated(Based on the result... More >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) Less << | - | - | |
| NCT00300885 | Carcinoma, Non-Small Cell Lung | Phase 3 | Terminated(Based on the result... More >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) Less << | - | - |
| NCT00678288 | Carcinoma, Renal Cell | Phase 2 | Terminated | - | Austria ... More >> Salzburg, Austria, 5020 Wien, Austria, 1090 France Avignon, France, 84000 Bayonne, France, 64100 Bordeaux, France, 33000 Marseille, France, 13015 Marseille, France, 13385 Nantes, France, 44020 Paris, France, 75014 Paris, France, 75651 Reims, France, 51100 Strasbourg, France, 67000 Toulouse, France, 31052 Vandoeuvre Les Nancy, France, 54000 Ireland Cork, Ireland Dublin, Ireland, 24 Italy Aviano, Pordenone, Italy, 33081 Legnago, Verona, Italy, 37045 Napoli, Italy, 80131 Pavia, Italy, 27100 Perugia, Italy, 06156 Reggio Emilia, Italy, 42100 Poland Gdansk, Poland, 80-219 Lublin, Poland, 20-090 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 Spain Barcelona, Spain, 08035 Madrid, Spain, 28041 Madrid, Spain, 28046 Oviedo, Spain, 33006 Pamplona, Spain, 31008 Valencia, Spain, 46009 United Kingdom Northwood, Middlesex, United Kingdom, HA6 2RN Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE London, United Kingdom, SW3 6JJ Less << |
| NCT01126645 | Hepatocellular Carcinoma | Phase 2 | Unknown | March 2018 | Germany ... More >> University of Magdeburg Magdeburg, Germany, 39120 Less << |
| NCT00619242 | Esophageal Cancer | Not Applicable | Terminated(Low accrual) | - | United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less << |
| NCT00542971 | - | Completed | - | - | |
| NCT00510250 | Cancer of the Cervix | Phase 1 Phase 2 | Completed | - | Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less << |
| NCT00619242 | - | Terminated(Low accrual) | - | - | |
| NCT01557127 | - | Completed | - | Poland ... More >> Many Locations, Poland Less << | |
| NCT01578109 | Acute Myeloid Leukemia in Remi... More >>ssion Acute Myeloid Leukemia With FLT3/ITD Mutation Less << | Not Applicable | Active, not recruiting | - | United States, Maryland ... More >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less << |
| NCT00542971 | AML Acute Mye... More >>loid Leukemia Myelodysplastic Disorders Less << | Phase 1 Phase 2 | Completed | - | United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01033240 | Advanced Hepatocellular Carcin... More >>oma Liver Cancer Hepatic Cancer Liver Neoplasms Less << | Phase 2 | Completed | - | United States, California ... More >> Kenmar Research Group Los Angeles, California, United States, 90057 United States, District of Columbia Georgetown-Lombardi Cancer Center Washington DC, District of Columbia, United States, 20007 United States, New York The Mount Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Japan Kurume University Hospital Kurume-shi, Fukuoka, Japan, 830-0011 Hiroshima University Hiroshima-city, Hiroshima, Japan Kanazawa University Kanazawa, Ishikawa, Japan Kinki University Hospital Osaka, Osaka-sayama, Japan, 589-8511 Osaka Med Center Cancer and Cardiovascular Disease Higashinari-ku, Osaka, Japan, 537-8511 Yamaguchi University Hospital Ube, Yamaguchi, Japan Chiba University Hospital Chiba, Japan, 260-8677 Okayama University Hospital Okayama, Japan, 700-8558 Musashino Red-Cross Hospital Tokyo, Japan, 180-8610 Korea, Republic of Samsung Medical Center Gangnam-gu, Seoul, Korea, Republic of, 135-710 Keimyung University Dongsan Hospital Daegu, Korea, Republic of, 700-712 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Severance Hospital Seoul, Korea, Republic of, 120-752 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Catholic Univ. of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Taiwan Chang Gung Memorial Hospital Putz, Chiayi, Taiwan Kaohiung Chang Gung Hospital Kaohsiung, Niaosung Hsiang, Taiwan Chi-Mei Medical Center Liouying, Tainan County, Taiwan, 736 Changhua Christian Hospital Changhua, Taiwan, 500 Kaohslung Medical University Hospital Kaohsiung, Taiwan, 807 National Cheng-Kung University Hospital Tainan city, Taiwan, 704 National Taiwan University Hospital Taipei, Taiwan Chang Gung Medical Foundation-Linkuo Taoyuan, Taiwan, 33305 Less << |
| NCT01194869 | Breast Cancer | Phase 2 | Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << | - | United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less << |
| NCT01194869 | - | Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << | - | - | |
| NCT01450384 | Unspecified Adult Solid Tumor | Phase 1 | Completed | - | United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less << |
| NCT01715441 | Metastatic Colorectal Cancer P... More >>atients With KRAS Mutated Tumors Less << | Phase 2 | Unknown | September 2015 | France ... More >> Hôpital AVICENNE Recruiting Bobigny, France, 93009 Contact: Thomas APARICIO, MD Thomas.aparicio@avc.aphp.fr Principal Investigator: Thomas APARICIO, MD Centre François Baclesse Recruiting Caen, France, 14076 Contact: Marie-Pierre GALAIS, MD Principal Investigator: Marie-Pierre GALAIS, MD Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD a-adenis@o-lambret.fr Principal Investigator: Antoine ADENIS, MD Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Françoise DESSEIGNE, MD Principal Investigator: Françoise DESSEIGNE, MD Hôpital LA TIMONE Recruiting Marseille, France, 13365 Contact: Jean-François SEITZ, MD Jean-françois.seitz@ap-hm.fr Principal Investigator: Jean-François SEITZ, MD CRLC Val d'Aurelle-Paul Lamarque Recruiting Montpellier, France, 34298 Contact: Emmanuelle SAMALIN, MD Principal Investigator: Emmanuelle SAMALIN, MD C.H.U. de REIMS Recruiting Reims, France, 51092 Contact: Olivier BOUCHE, MD Obouche@chu-reims.fr Principal Investigator: Olivier BOUCHE, MD CHU Charles Nicolle Recruiting Rouen, France, 76038 Contact: Frédéric Di FIORE, MD 33 2.32.88.81.01 Frederic.Di-Fiore@chu-rouen.fr Principal Investigator: Frédéric Di FIORE, MD Institut de Cancérologie de l'Ouest - René Gauducheau Recruiting St. Herblain, France, 44805 Contact: Jaafa BENNOUNA, MD Jaafa.bennouna@ico.unicancer.fr Principal Investigator: Jaafa BENNOUNA, MD Less << |
| NCT00064350 | Lung Cancer | Phase 2 | Completed | - | - |
| NCT00722072 | Breast Cancer | Phase 2 | Terminated(Sponsor pulled fund... More >>ing and low accrual) Less << | - | United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less << |
| NCT00064350 | - | Completed | - | - | |
| NCT00722072 | - | Terminated(Sponsor pulled fund... More >>ing and low accrual) Less << | - | - | |
| NCT00418496 | Renal Cancer ... More >>Melanoma Less << | Phase 1 | Completed | - | United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less << |
| NCT01411436 | - | Completed | - | Japan ... More >> Many locations, Japan Less << | |
| NCT01585870 | Neoplasms | Phase 1 | Completed | - | France ... More >> Toulouse, France, 31052 Germany Freiburg, Baden-Württemberg, Germany, 79106 Heidelberg, Baden-Württemberg, Germany, 69120 Berlin, Germany, 10117 Less << |
| NCT01933945 | - | Completed | - | - | |
| NCT00373373 | Acute Myeloid Leukemia | Phase 2 | Completed | - | Germany ... More >> Charité Campus Benjamin Franklin, Med. Klinik III Berlin, Germany, 12203 Klinikum Chemnitz GmbH, Klinik für Innere Medizin III Chemnitz, Germany, 09113 Universitätsklinikum Carl Gustav Carus der TU Dresden, Medizinische Klinik I Dresden, Germany, 01307 St. Johannes Hospital, Medizinische Klinik II Duisburg, Germany, 47166 Universitätsklinikum Essen, Zentrum für Innere Medizin, Medizinische Klinik und Poliklinik für Hämatologie Essen, Germany, 45147 Klinikum der J. W. Goethe-Universität Frankfurt am Main, Medizinische Klinik II Frankfurt / Main, Germany, 60590 Allgemeines Krankenhaus St. Georg, Hämatologische Abteilung Hamburg, Germany, 20099 Universitätsklinikum Heidelberg, Med. Klinik V Heidelberg, Germany, D-69120 Klinikum der Universität zu Köln, Klinik I für Innere Medizin Köln, Germany, 50937 Klinikum der Johannes Gutenberg Universität, 3. Medizinische Klinik und Poliklinik Mainz, Germany, 55101 Philipps Universität, Abteilung für Hämatologie, Onkologie und Immunologie Marburg, Germany, 35043 Klinik für Hämatologie und Onkologie Klinikum Minden Minden, Germany, 32423 TU München, Medizinische Klinik III München, Germany, 81675 Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany, 48149 Klinikum Nürnberg, 5. Medizinische Klinik Einheit für Knochenmarktransplantation Nürnberg, Germany, 90419 Universität Regensburg, Abteilung für Hämatologie und Internistische Onkologie Regensburg, Germany, 93042 Robert-Bosch Krankenhaus Stuttgart Stuttgart, Germany, 70376 Julius-Maximilians-Universität Würzburg, Medizinische Klinik und Poliklinik II Würzburg, Germany, 97979 Less << |
| NCT00889057 | Osteosarcoma | Phase 2 | Completed | - | Italy ... More >> I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy, 10060 Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Istituto Nazionale Tumori - Unit of Medical Oncology Milano, Italy, 20133 Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Torino, Italy, 10126 Less << |
| NCT00722969 | Non-Small Cell Lung Cancer | Phase 2 | Unknown | April 2009 | Netherlands ... More >> VU university medical center Amsterdam, Netherlands, 1007 MB Netherlands Cancer Institute Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands University Hospital Maastricht Maastricht, Netherlands Less << |
| NCT02024087 | Advanced Adult Hepatocellular ... More >>Carcinoma Less << | Phase 1 Phase 2 | Completed | - | United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States United States, Kansas University of Kansas Medical Center (KUMC) Westwood, Kansas, United States United States, Massachusetts Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States University of Rochester Rochester, New York, United States United States, Ohio University of Cincinnati Cancer Institute Cincinnati, Ohio, United States Less << |
| NCT00610246 | Cancer | PHASE1 | COMPLETED | 2025-05-11 | Princess Margaret Hospital, To... More >>ronto, Ontario, M5G 2M9, Canada Less << |
| NCT00405366 | Kidney Cancer | Early Phase 1 | Completed | - | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less << |
| NCT00602862 | Clear Cell Renal Cell Carcinom... More >>a Less << | Not Applicable | Completed | - | Netherlands ... More >> Radboud University Nijmegen Medical Center Nijmegen, Gelderland, Netherlands, 6500 HB Less << |
| NCT01272557 | Liver Carcinoma | Phase 2 | Unknown | December 2014 | Germany ... More >> Medizinische Klinik und Poliklinik, Heinrich-Heine-Universität Düsseldorf, Germany, 40225 Martin-Luther-University Halle-Wittenberg Halle (Saale), Germany, D-06099 Universitätsklinikum des Saarlande Homburg/Saar, Germany, 66421 Ortenau Klinikum Lahr-Ettenheim Lahr, Germany, 77933 Universitätsklinikum Leipzig Leipzig, Germany, 04013 Klinikum Ludwigsburg Ludwigsburg, Germany, 71640 Less << |
| NCT01047891 | Ovarian Cancer | PHASE2 | COMPLETED | 2025-02-15 | Charité Campus Virchow-Kliniku... More >>m, Berlin, 13355, Germany Less << |
| NCT01839630 | - | Completed | - | China ... More >> Multiple Locations, China Less << | |
| NCT01518413 | Rhabdomyosarcoma and Other Sof... More >>t Tissue Sarcomas Ewing's Sarcoma Family of Tumors Osteosarcoma Neuroblastoma Brain Tumors Less << | Phase 1 | Completed | - | United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Children's Hospital Boston/Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT00712790 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Completed | - | Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul, Korea, Republic of Malaysia Selayang Hospital Selangor, Malaysia Myanmar Yangon GI & Liver Centre Yangon, Myanmar Singapore Singapore General Hospital Singapore, Singapore, 169608 National Cancer Centre Singapore, Singapore, 169610 Less << |
| NCT01141478 | Carcinoma, Hepatocellular | Not Applicable | Unknown | June 2018 | United States, California ... More >> Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92354 Less << |
| NCT01497444 | Kidney Cancer ... More >> Liver Cancer Less << | Phase 1 | Active, not recruiting | - | United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less << |
| NCT00093613 | Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << | Phase 1 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT01412671 | - | Completed | - | Japan ... More >> Multiple Locations, Japan Less << | |
| NCT01411423 | - | Completed | - | Japan ... More >> Multiple Locations, Japan Less << | |
| NCT01861314 | Acute Myeloid Leukemia ... More >> Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << | Phase 1 | Active, not recruiting | - | United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less << |
| NCT01840592 | Hepatocellular Carcinoma | Phase 2 | Active, not recruiting | April 2019 | United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less << |
| NCT02988440 | Hepatocellular Carcinoma | Phase 1 | Recruiting | August 16, 2019 | United States, Michigan ... More >> Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Colette Zack zackc@karmanos.org Principal Investigator: Philip A. Philip Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Terminated Clichy, France, 92110 Germany Novartis Investigative Site Completed Essen, Germany, 45147 Hong Kong Novartis Investigative Site Active, not recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Active, not recruiting Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Active, not recruiting Yokohama city, Kanagawa, Japan, 232 0024 Spain Novartis Investigative Site Completed Pamplona, Navarra, Spain, 31008 Taiwan Novartis Investigative Site Active, not recruiting Taipei, Taiwan, 10002 Less << |
| NCT01135056 | Hepatocellular Carcinoma | Phase 3 | Active, not recruiting | July 31, 2018 | - |
| NCT00461851 | Bladder Cancer | Phase 2 | Completed | - | United States, Connecticut ... More >> Yale University, Comprehensive Cancer Center New Haven, Connecticut, United States, 06520 Less << |
| NCT00461851 | - | Completed | - | - | |
| NCT03644511 | - | Not yet recruiting | December 31, 2021 | Germany ... More >> Many Locations Not yet recruiting Multiple Locations, Germany Less << | |
| NCT00411671 | Lung Cancer | PHASE2 | COMPLETED | 2025-11-12 | UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less << |
| NCT00411671 | Lung Cancer | PHASE2 | COMPLETED | 2025-11-12 | UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less << |
| NCT00848640 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | COMPLETED | 2025-03-10 | Egyptian Foundation For Cancer... More >> Research, Cairo, 11553, Egypt Less << |
| NCT00090545 | Prostate Cancer | Phase 2 | Completed | - | United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less << |
| NCT00090545 | - | Completed | - | - | |
| NCT00126568 | - | Terminated | - | - | |
| NCT02114658 | Thyroid Carcinoma | Phase 2 | Completed | - | Japan ... More >> Kobe, Hyogo, Japan, 650-0011 Matsumoto, Nagano, Japan, 390-8621 Bunkyo-ku, Tokyo, Japan, 113-8603 Koto-ku, Tokyo, Japan, 135-8550 Osaka, Japan, 545-8586 Less << |
| NCT00557830 | - | Terminated(The study was close... More >>d to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.) Less << | - | - | |
| NCT00557830 | Renal Cell Carcinoma | Phase 2 | Terminated(The study was close... More >>d to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.) Less << | - | United States, Arkansas ... More >> Clopton Clinic Jonesboro, Arkansas, United States, 72401 United States, California Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Florida Advanced Medical Specialties Miami, Florida, United States, 33176 United States, Georgia Northeast Georgia Cancer Care Athens, Georgia, United States, 30607 Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Illinois Mid-Illinois Hematology and Oncology Associates, Ltd. Normal, Illinois, United States, 61761 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, North Carolina Gaston Hematology and Oncology Gastonia, North Carolina, United States, 28054 United States, Oregon Pacific Oncology, PC Beaverton, Oregon, United States, 97006 United States, Pennsylvania The Lancaster Cancer Center, Ltd Lancaster, Pennsylvania, United States, 17605 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less << |
| NCT00496756 | Kidney Cancer | PHASE2 | TERMINATED | 2014-04-25 | University of Nebraska Medical... More >> Center, Omaha, Nebraska, 68198, United States Less << |
| NCT01290926 | Colorectal Cancer | Phase 2 | Completed | - | Belgium ... More >> Cliniques Universitaires Saint Luc Woluwe Saint Lambert, Bruxelles, Belgium, 1200 Universiteit Ziekenhuis Antwerpen Antwerpen, Belgium Institut Jules Bordet Brussels, Belgium, 1000 Hopital Erasme Brussels, Belgium, 1070 Entité Jolimontoise La Louviere, Belgium Hopitaux St Joseph Liege, Belgium, 4000 CHU Ambroise Paré Mons, Belgium, 7000 Less << |
| NCT01982097 | - | Completed | - | Russian Federation ... More >> Multiple Locations, Russian Federation Less << | |
| NCT00126568 | Anaplastic Thyroid Cancer ... More >> Recurrent Thyroid Cancer Less << | Phase 2 | Terminated | - | United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less << |
| NCT01730937 | Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << | Phase 3 | Recruiting | June 2025 | - |
| NCT00943449 | Hepatocellular Carcinoma | Phase 2 | Completed | - | Germany ... More >> ONKOPLUS Beratung und Hilfe für Menschen mit Krebs Berlin, Germany, 14195 Universitätsklinikum Essen (Innere Klinik/Tumorforschung und Zentrum für Innere Medizin) Essen, Germany, 45147 Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg (Klinik und Poliklinik für Innere Medizin I) Halle, Germany, 06120 Universitätsklinikum Hamburg-Eppendorf (I. Medizinische Klinik und Poliklinik) Hamburg, Germany, 20246 Universitätsklinikum Heidelberg (Medizinische Universitätsklinik/Innere Medizin IV/Nationales Centrum für Tumorerkrankungen) Heidelberg, Germany, 69120 Johannes Gutenberg-Universität Mainz (I. Medizinische Klinik und Poliklinik) Mainz, Germany, 55131 Klinikum rechts der Isar der Technischen Universität München (Medizinische Klinik und Poliklinik II/Gastroenterologie) Munich, Germany, 81675 Universitätsklinikum Tübingen (Medizinische Klinik/Innere Medizin I) Tübingen, Germany, 72076 Italy l'Azienda Ospedaliero-Universitaria di Bologna-Policlinico S. Orsola Malpighi Bologna, Italy, 40138 l'Università degli Studi di Genova (Dipartimento di Medicina Interna e Specialità Mediche) Genova, Italy, 16132 Istituto Europea di Oncologia EIO Milano, Italy, 20141 A.O.R.N. Monaldi-Cotugno-CTO Napoli, Italy, 80131 l'Azienda Ospedaliera di Padova and l'Istituto Oncologico Veneto IOV Padova, Italy l'Ente "Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone" Palermo, Italy, 12990127 L'Istituto Clinico Humanitas-Humanitas Mirasole S.p.A. Rozzano-Milano, Italy, 20089 Less << |
| NCT03009461 | HepatoCellular Carcinoma ... More >> Portal Vein Thrombosis Less << | Phase 2 | Recruiting | December 2019 | China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xiaodong Wang, MD 008610-88196476 wangxde@gmail.com Sub-Investigator: Guang Cao, MD Sub-Investigator: Hui Chen, MD Sub-Investigator: Jianhai Guo, MD Sub-Investigator: Haifeng Xu, MD Sub-Investigator: Peng Liu, MD Sub-Investigator: Jungang Hu, MD Less << |
| NCT00436215 | Ovarian Neoplasm ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << | Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT00436215 | - | Completed | - | - | |
| NCT00863746 | Carcinoma Non... More >>-Small-Cell Lung Less << | Phase 3 | Completed | - | - |
| NCT00825734 | Metastatic Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/ Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70806 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63044 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07962 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less << |
| NCT00714948 | Bladder Cancer ... More >> URINARY BLADDER Less << | Phase 2 | Terminated(Lack of accrual) | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT00863746 | - | Completed | - | - | |
| NCT01844947 | Urothelial Carcinoma ... More >> Bladder Cancer Renal Pelvis Cancer Ureter Cancer Urethra Cancer Less << | Phase 1 | Completed | - | Denmark ... More >> Department of Oncology, Aarhus University Hospital Aarhus, Denmark, DK-8200 Department of Oncology, Rigshospitalet Copenhagen, Denmark, DK-2100 Sweden Department of Oncology, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Less << |
| NCT00825734 | - | Completed | - | - | |
| NCT00392821 | - | Completed | - | - | |
| NCT00714948 | - | Terminated(Lack of accrual) | - | - | |
| NCT00839111 | Colorectal Neoplasms | Phase 2 | Unknown | November 2010 | China, Shanghai ... More >> Cancer Hospital,Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Yanfei Liu, Master +862164175590 ext 1107 Less << |
| NCT00613145 | Refractory Malignancy | Phase 1 | Completed | - | United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less << |
| NCT00392821 | Kidney Cancer | Phase 1 Phase 2 | Completed | - | United States, Florida ... More >> Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less << |
| NCT00595985 | Gastric Cancer | Phase 2 | Terminated(low response rate, ... More >>no evidence of PFS or OS improved.) Less << | January 2009 | China, Shanghai ... More >> Fudan University Cancer Hospital ShangHai, Shanghai, China, 200032 Less << |
| NCT02989870 | HepatoCellular Carcinoma ... More >> Unresectable HepatoCellular Carcinoma Liver Cancer Less << | Phase 1 | Withdrawn(No Interest. Investi... More >>gator was unable to enroll any participants on study.) Less << | - | United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less << |
| NCT01076010 | Advanced Renal Cell Carcinoma | Phase 3 | Completed | - | - |
| NCT01445080 | Leukemia With... More >> AML and FLT3-ITD Mutations Less << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT02187081 | HCC | Not Applicable | Recruiting | December 2018 | China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: Xiaobin Feng Principal Investigator: Kuansheng Ma, Ph.D Less << |
| NCT00562913 | Cancer | Phase 1 | Completed | - | Canada, Alberta ... More >> Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 Less << |
| NCT03211416 | Advanced Adult Hepatocellular ... More >>Carcinoma Child-Pugh Class A Stage III Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IV Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << | Phase 1 Phase 2 | Recruiting | October 11, 2019 | United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park 877-275-7724 ASKRPCI@roswellpark.org Principal Investigator: Renuka V. Iyer Less << |
| NCT03097848 | HCC | Not Applicable | Recruiting | December 31, 2018 | China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: kuansheng Ma, MD Less << |
| NCT00606125 | Neoplasms | Phase 1 | Completed | - | United States, Connecticut ... More >> New Haven, Connecticut, United States, 06511-5991 United States, Texas San Antonio, Texas, United States, 78229-3307 Less << |
| NCT00390325 | Multiple Endocrine Neoplasia ... More >> Recurrent Thyroid Gland Carcinoma Thyroid Gland Medullary Carcinoma Less << | Phase 2 | Active, not recruiting | - | United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less << |
| NCT00586105 | Carcinoma, Renal Cell | Phase 3 | Completed | - | China, Jiangsu ... More >> Nanjing, Jiangsu, China, 210003 China Beijing, China, 100021 Shanghai, China, 200032 Shanghai, China, 200127 Taiwan Tainan, Taiwan, 70428 Taipei, Taiwan, 10002 Taipei, Taiwan, 112 Taoyuan, Taiwan, 333 Less << |
| NCT00866320 | Kidney Cancer | Phase 2 | Completed | - | United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 Less << |
| NCT01915602 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
| NCT00866320 | - | Completed | - | - | |
| NCT01187212 | Malignant Neoplasm of Stomach ... More >> Effects of Chemotherapy Less << | Phase 2 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Songpa-gu, Seoul, Korea, Republic of, 138-736 Less << |
| NCT00759928 | Refractory Solid Tumors | Phase 1 | Completed | - | United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less << |
| NCT00414388 | Prostate Cancer | PHASE1|PHASE2 | COMPLETED | 2025-03-12 | Onocology Specialists, S.C, Ni... More >>les, Illinois, 60714, United States|Oncology Specialists, S.C, Park Ridge, Illinois, 60068, United States Less << |
| NCT00586105 | - | Completed | - | - | |
| NCT00414388 | Prostate Cancer | PHASE1|PHASE2 | COMPLETED | 2025-03-12 | Onocology Specialists, S.C, Ni... More >>les, Illinois, 60714, United States|Oncology Specialists, S.C, Park Ridge, Illinois, 60068, United States Less << |
| NCT02575339 | Hepatocellular Carcinoma ... More >> Liver Cancer HCC Less << | Phase 1 Phase 2 | Active, not recruiting | June 2020 | United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 University of Illinois Cancer Center Chicago, Illinois, United States, 60612 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, North Carolina University of Noth Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53705 Less << |
| NCT02450149 | Refractory Solid Tumors | Not Applicable | Completed | - | Korea, Republic of ... More >> Samsung Medical Center Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Less << |
| NCT00635791 | Malignant Solid Tumour ... More >> Renal Cell Carcinoma Non Small Cell Lung Carcinoma Less << | Phase 1 | Completed | - | United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less << |
| NCT00609934 | Renal Cell Carcinoma | Phase 1 Phase 2 | Completed | - | Canada, Ontario ... More >> Princess Margaret Hosptial Toronto, Ontario, Canada, M5G2M9 Less << |
| NCT00844688 | Hepatocellular Carcinoma | Phase 2 | Unknown | December 2009 | Pakistan ... More >> Combined Military Hospital Recruiting Rawalpindi, Punjab, Pakistan, 46000 Principal Investigator: Naeem Naqi, MBBS,FCPS Less << |
| NCT03439891 | Stage III Hepatocellular Carci... More >>noma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 Less << | Phase 2 | Recruiting | December 31, 2020 | United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Robin K. Kelley 877-827-3222 cancertrials@ucsf.edu Principal Investigator: Robin K. Kelley Less << |
| NCT02627963 | Carcinoma, Renal Cell | Phase 3 | Active, not recruiting | December 2019 | - |
| NCT02354898 | Advanced Solid Tumors ... More >> Hepatocellular Carcinoma Less << | Phase 1 | Completed | - | Japan ... More >> 5 Sites Chiba, Etc., Japan Less << |
| NCT02400788 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Completed | - | Japan ... More >> Chiba, Japan Ishikawa, Japan Kanagawa, Japan Kochi, Japan Kyoto, Japan Osaka, Japan Saga, Japan Shizuoka, Japan Tokyo, Japan Korea, Republic of Busan, Korea, Republic of Daegu, Korea, Republic of Seoul, Korea, Republic of Less << |
| NCT02599090 | Glioblastoma ... More >>Gliosarcoma Less << | Phase 2 | Withdrawn(Multi phase study di... More >>d not progress to Phase II. Phase I registered as NCT00734526.) Less << | - | - |
| NCT01687673 | Hepatocellular Carcinoma | Phase 2 | Active, not recruiting | September 2017 | United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Illinois Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 Less << |
| NCT00245102 | Adult Angiosarcoma ... More >> Adult Epithelioid Sarcoma Adult Leiomyosarcoma Adult Malignant Fibrous Histiocytoma Adult Neurofibrosarcoma Adult Synovial Sarcoma Ovarian Sarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Uterine Sarcoma Stage III Adult Soft Tissue Sarcoma Stage III Uterine Sarcoma Stage IV Adult Soft Tissue Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma Uterine Leiomyosarcoma Less << | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT00473486 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Terminated(Sorafenib administe... More >>red in the combination with pemetrexed-carboplatin appears to enhance thrombocytopenia compared to historical data.) Less << | - | Germany ... More >> University of Muenster, Dept. of Medicine, Hematology / Oncology Muenster, Germany, 48145 Less << |
| NCT00494182 | Metastatic Head and Neck Squam... More >>ous Cell Carcinoma Metastatic Squamous Cell Carcinoma of the Hypopharynx Metastatic Squamous Cell Carcinoma of the Larynx Metastatic Squamous Cell Carcinoma of the Oral Cavity Metastatic Squamous Cell Carcinoma of the Oropharynx Recurrent Head and Neck Squamous Cell Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Less << | Phase 2 | Active, not recruiting | April 30, 2019 | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01320111 | Metastatic Breast Cancer | Phase 2 | Completed | - | Germany ... More >> Germany Multiple Sites All Over Germany Recruiting Multiple Sites, Germany Contact: iOMEDICO AG Freiburg, Germany, 79108 Less << |
| NCT01078311 | - | Unknown | February 2014 | Australia, New South Wales ... More >> Westmead Hospital Recruiting Westmead, New South Wales, Australia, 2145 Less << | |
| NCT00245102 | - | Completed | - | - | |
| NCT03775395 | Hepatocellular Carcinoma | Phase 3 | Recruiting | December 1, 2021 | China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD 8620-87343115 shiming@mail.sysu.edu.cn Less << |
| NCT00278382 | Anaplastic Large Cell Lymphoma... More >> Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Less << | Phase 2 | Completed | - | United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 Less << |
| NCT00533585 | Lung Cancer | Phase 1 | Completed | - | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00823290 | Hepatocellular Carcinoma | Phase 1 | Unknown | December 2010 | Germany ... More >> Department of Medicine 1, University Hospital Erlangen Recruiting Erlangen, Germany, 91054 Contact: Matthias Ocker, MD +49-6421-58 ext 68931 Matthias.Ocker@staff.uni-marburg.de Contact: Susanne Gahr, MD +49-9131-85 ext 35000 susanne.gahr@uk-erlangen.de Principal Investigator: Deike Strobel, MD Less << |
| NCT01276210 | Tumors Metastatic to Brain | Phase 1 | Completed | - | United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less << |
| NCT00984282 | Thyroid Neoplasms | Phase 3 | Completed | - | - |
| NCT00984282 | - | Completed | - | - | |
| NCT03456401 | Renal Cancer Cell | Phase 2 | Terminated(availability of new... More >> and more promising therapeutic agents than expected in the experimentation in question) Less << | - | Italy ... More >> Istituto Tumori Milan, Mi, Italy, 20156 Less << |
| NCT01897038 | Carcinoma, Hepatocellular | Phase 1 | Completed | - | United States, Florida ... More >> Sarasota, Florida, United States, 34232 United States, Maryland Baltimore, Maryland, United States, 21231 United States, New York New York, New York, United States, 10065 United States, Tennessee Nashville, Tennessee, United States, 37203 United States, Texas Houston, Texas, United States, 77030 Hong Kong Pokfulam, Hong Kong Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Taiwan Tainan, Taiwan, 00704 Taipei, Taiwan, 100 Less << |
| NCT03164382 | Liver Cancer ... More >>Hepatic Carcinoma Less << | Phase 3 | Recruiting | December 31, 2022 | China, Guangdong ... More >> Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, MD 86-20-87343272 zhaoming@sysucc.org.cn Less << |
| NCT00627835 | Locally Advanced Squamous Cell... More >> Carcinomas of the Head and Neck (SCCHN) Less << | Phase 1 | Withdrawn(Site decided not to ... More >>open this study) Less << | - | Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less << |
| NCT00619996 | Prostate Cancer | Phase 2 | Completed | - | Italy ... More >> Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina ... Indirizzo: via Roma, 55 - 56100 Pisa Tel. 050-2218690 - Fax. 050-2218685 Pisa, Italy, 56100 Less << |
| NCT01159301 | Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Recurrent Adult Acute Myeloid Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Terminated | - | United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less << |
| NCT01171482 | Carcinoma, Hepatocellular | Phase 2 | Terminated(There were problems... More >> with national reimbursement policies.) Less << | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less << |
| NCT01666756 | Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Advanced Adult Hepatocellular Carcinoma BCLC Stage B Adult Hepatocellular Carcinoma BCLC Stage C Adult Hepatocellular Carcinoma Less << | Phase 1 | Active, not recruiting | January 2020 | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less << |
| NCT01624285 | Adult Primary Hepatocellular C... More >>arcinoma Localized Resectable Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << | Phase 2 | Active, not recruiting | July 2020 | - |
| NCT01204177 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | Hong Kong ... More >> Shatin, New Territories, Hong Kong Hong Kong, Hong Kong Korea, Republic of Jung-gu, Daegu Gwang''yeogsi, Korea, Republic of, 700-721 Goyang-si, Gyeonggido, Korea, Republic of, 410-769 Busan, Korea, Republic of, 602-739 Seoul, Korea, Republic of, 110-744 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 135-710 Seoul, Korea, Republic of, 138-736 Singapore Singapore, Singapore, 228510 Singapore, Singapore, 258499 Taiwan Kaohsiung, Taiwan, 833 Tainan, Taiwan, 736 Tainan, Taiwan Taipei, Taiwan, 100 Less << |
| NCT01008566 | Adult Hepatocellular Carcinoma... More >> Advanced Adult Hepatocellular Carcinoma Localized Non-Resectable Adult Liver Carcinoma Recurrent Adult Liver Carcinoma Less << | Phase 1 | Completed | - | United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Pennsylvania Penn State Hershey Cancer Institute-Clinical Trials Office Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less << |
| NCT00398814 | Renal Cancer ... More >>Tumors Less << | Phase 1 | Completed | - | - |
| NCT03113604 | - | Withdrawn(The study has been s... More >>topped because no one is) Less << | - | France ... More >> CHU Amiens Picardie Amiens, Picardie, France, 80054 Less << | |
| NCT00044512 | - | Completed | - | - | |
| NCT00044512 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | United States, California ... More >> Los Angeles, California, United States, 90057 United States, New York New York, New York, United States, 10021-6007 Belgium Bruxelles - Brussel, Belgium, 1000 Bruxelles - Brussel, Belgium, 1070 Bruxelles - Brussel, Belgium, 1090 Gent, Belgium, 9000 Leuven, Belgium, 3000 France Lille Cedex, France, 59020 Marseille, France, 13005 Paris, France, 75020 Rennes Cedex, France, 35062 Saint Herblain, France, 44805 Israel Haifa, Israel, 31096 Jerusalem, Israel, 91120 Petach Tikva, Israel, 49100 Rehovot, Israel, 76100 Tel Aviv, Israel, 64239 Tel Hashomer, Israel, 52621 Italy Rozzano, Milano, Italy, 20089 Forlì, Italy, 47100 Milano, Italy, 20122 Pisa, Italy, 56126 Verona, Italy, 37126 Less << |
| NCT01405573 | Advanced Adult Hepatocellular ... More >>Carcinoma Less << | Phase 3 | Terminated(lack of enrolment) | - | Italy ... More >> Azienda Ospedaliera G. Rummo Benevento, BN, Italy Policlinico Giaccone Palermo, PA, Italy, 90127 S. Orsola-Malpighi Bologna, Italy Ospedale Ramazzini di Carpi Carpi, Italy Osp. Civile Infermi Faenza, Italy Azienda Ospedaliera Careggi Firenze, Italy IRCCS-Azienda Ospedaliera Universitaria San Martino-IST Genova, Italy AO C. Poma Mantova, Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola, Italy A.O.U. G.Martino- Policlinico Universita di Messina Messina, Italy Istituto Nazionale Tumori Milano, Italy A.O.U. Federico II Napoli, Italy AOU II Università di Napoli Napoli, Italy Istituto Nazionale dei Tumori Napoli, Italy Ospedale Cardarelli Napoli, Italy Azienda Ospedaliera Universitaria di Padova Padova, Italy Istituto Oncologico Veneto Padova, Italy A.O. Ospedali Riuniti Villa Sofia-Cervello Palermo, Italy Azienda Ospedaliero Universitaria di Parma Parma, Italy Ospedale Guglielmo da Saliceto Piacenza, Italy, Italy AO S. Carlo Potenza, Italy Policlinico Universitario Tor Vergata Roma, Italy Oncologia IRCCS - Casa Sollilevo Sofferenza S. Giovanni Rotondo, Italy Azienda Ospedaliera Universitaria Arcispedal, U.O. di Oncologia Clinica Sant'Anna di Ferrara, Italy A.O. Trevigilio - Caravaggio Trevigilio, Italy Less << |
| NCT00828074 | Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 South Pasadena Cancer Center Pasadena, California, United States, 91030 Less << |
| NCT02129322 | Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | December 2019 | China ... More >> First affiliated hospital, Zhejiang University Not yet recruiting Hangzhou, China Contact: Weijiafang fang Principal Investigator: Weijia fang, MD Less << |
| NCT00303797 | Refractory Chronic Lymphocytic... More >> Leukemia Refractory Multiple Myeloma Stage III Multiple Myeloma Stage IV Chronic Lymphocytic Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT00869570 | Colorectal Cancer | Phase 1 Phase 2 | Completed | - | Hungary ... More >> Szent Laszlo Korhaz Budapest, Hungary, 1097 Switzerland Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital, Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneva HUG Geneva, Switzerland, CH-1211 Kantonsspital Luzern Luzern, Switzerland, 6000 OnkoZentrum Luzern at Klinik St. Anna Luzern, Switzerland, 6006 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 Onkozentrum - Klinik im Park Zurich, Switzerland, 8002 Onkozentrum Hirslanden Zurich, Switzerland, CH-8008 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Stadtspital Triemli Zürich, Switzerland, 8063 Less << |
| NCT00712855 | Hepatocellular Carcinoma | Phase 1 | Completed | - | United States, California ... More >> Cedars-Sinai Health System Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Florida University of Florida Gainesville, Florida, United States, 32610 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania University of Pennsylvania- Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT01348503 | Hepatocellular Carcinoma | Phase 1 | Terminated(Treatment was ineff... More >>ective) Less << | - | United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less << |
| NCT00828074 | - | Completed | - | - | |
| NCT02035527 | Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Oral Cavity Squamous Cell Carcinoma Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << | Phase 1 | Completed | - | United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
| NCT01751763 | - | Completed | - | China ... More >> Many Locations, China Less << | |
| NCT02576509 | Hepatocellular Carcinoma | Phase 3 | Active, not recruiting | July 14, 2020 | - |
| NCT00826540 | - | Completed | - | - | |
| NCT00105443 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | - |
| NCT00826540 | Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << | Phase 2 | Completed | - | - |
| NCT00855218 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
| NCT00326898 | Stage I Renal Cell Cancer ... More >> Stage II Renal Cell Cancer Stage III Renal Cell Cancer Less << | Phase 3 | Completed | - | - |
| NCT01265576 | HCC | Phase 2 | Unknown | April 2016 | United States, California ... More >> Vicus Clinical Site Berkeley, California, United States, 94704 United States, Georgia Vicus Clinical Site Atlanta, Georgia, United States, 30318 United States, New Jersey Vicus Clinical Site New Brunswick, New Jersey, United States Vicus Clinical Site Newark, New Jersey, United States, 07103 Vicus Clinical Site Paterson, New Jersey, United States, 07503 United States, New York Vicus Clinical Site Buffalo, New York, United States, 14263 Vicus Clinical Site New York, New York, United States, 10016 United States, Pennsylvania Vicus Clinical Site Philadelphia, Pennsylvania, United States United States, Texas Vicus Clinical Site Houston, Texas, United States, 77024 Vicus Clinical Site Houston, Texas, United States, 77030 Less << |
| NCT00326898 | - | Completed | - | - | |
| NCT00105443 | - | Completed | - | - | |
| NCT01377025 | Uveal Melanoma | Phase 2 | Unknown | June 2017 | Germany ... More >> Universitätsmedizin Berlin, Charité Campus Benjamin Franklin Berlin, Germany, 12203 Universitätsklinikum Erlangen Erlangen, Germany, 91052 Univesitätsklinikum Essen Essen, Germany, 45147 Less << |
| NCT00452218 | Pulmonary Arterial Hypertensio... More >>n Less << | PHASE1 | COMPLETED | 2025-05-12 | The University of Chicago, Chi... More >>cago, Illinois, 60637, United States Less << |
| NCT00855218 | - | Completed | - | - | |
| NCT01616186 | Locally Metastatic Malignant N... More >>eoplasm Less << | Phase 2 | Withdrawn | April 2016 | - |
| NCT03434379 | Carcinoma, Hepatocellular | Phase 3 | Recruiting | June 29, 2022 | - |
| NCT00244972 | Advanced Malignant Neoplasm | Phase 1 | Completed | - | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00828594 | Hepatocellular Carcinoma | Phase 1 | Terminated | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 UCLA Department of Medicine Los Angeles, California, United States, 90005 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Netherlands Novartis Investigative Site Amsterdam, Netherlands Spain Novartis Investigative Site Barcelona, Spain Novartis Invstigative Site Madrid, Spain Taiwan Novartis Investigative Site Tainan, Taiwan Less << |
| NCT02908165 | Hepatocellular Carcinoma | Phase 2 | Withdrawn(A future study will ... More >>be taking place using the same patient population.) Less << | June 2020 | United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less << |
| NCT00112905 | Adenocarcinoma of the Bladder ... More >> Distal Urethral Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Proximal Urethral Cancer Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Urethral Cancer Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Squamous Cell Carcinoma of the Bladder Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Urethral Cancer Associated With Invasive Bladder Cancer Less << | Phase 2 | Terminated | - | United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less << |
| NCT00752063 | Advanced Hepatocellular Carcin... More >>oma Metastatic Hepatocellular Carcinoma Less << | Phase 2 | Unknown | December 2008 | China ... More >> Queen Mary Hospital Recruiting Hong Kong, China Contact: Ida Choi, MPhil (852)28553635 cychoia@hkucc.hku.hk Principal Investigator: Ronnie Poon, MD Less << |
| NCT00747799 | Nasopharyngeal Neoplasms | Phase 2 | Completed | - | China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China, 510000 Less << |
| NCT00536575 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, Maryland ... More >> Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less << |
| NCT00112905 | - | Terminated | - | - | |
| NCT01829035 | Advanced Adult Hepatocellular ... More >>Carcinoma Less << | Phase 3 | Completed | - | Korea, Republic of ... More >> National Cancer Center, Korea Seoul, Korea, Republic of Less << |
| NCT00536575 | - | Completed | - | - | |
| NCT00349206 | Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << | Phase 1 | Completed | - | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02066181 | Desmoid-Type Fibromatosis | Phase 3 | Active, not recruiting | - | - |
| NCT01418729 | Advanced Hepatocarcinoma | Phase 2 | Completed | - | Spain ... More >> Hospital Donostia, Instituto Biodonostia San Sebastian, Gipuzkoa, Spain, 20014 Less << |
| NCT00182689 | Extensive Stage Small Cell Lun... More >>g Cancer Recurrent Small Cell Lung Cancer Less << | Phase 2 | Completed | - | United States, Oregon ... More >> SWOG Portland, Oregon, United States, 97239 Less << |
| NCT00788099 | Advanced Solid Tumors ... More >> Lymphomas Less << | Phase 1 | Completed | - | United States, New Jersey ... More >> The Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States, 08901 France Institut Gustave Roussy Villejuif, France, 94800 Less << |
| NCT00456716 | Lung Cancer | Phase 2 | Completed | - | United States, Washington ... More >> Swedish Cancer Institute Seattle, Washington, United States, 98104 Less << |
| NCT00101400 | Breast Neoplasms ... More >> Breast Cancer Less << | Phase 2 | Completed | - | Germany ... More >> Stuttgart, Baden-Württemberg, Germany, 70199 München, Bayern, Germany, 80637 Frankfurt, Hessen, Germany, 60590 Italy Bologna, Italy, 40138 Milano, Italy, 20133 Milano, Italy, 20162 Parma, Italy, 43100 Less << |
| NCT00101400 | - | Completed | - | - | |
| NCT00758381 | Locally Advanced Pancreatic Ca... More >>ncer Less << | Phase 2 | Unknown | August 2009 | Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Recruiting Treviglio, Bergamo, Italy, 24047 Sub-Investigator: sandro Barni, MD Ospedale S.Orsola Fatebenefratelli Active, not recruiting Brescia, BS, Italy, 15100 A.O. Ospedale S.Martino Recruiting Genova, GE, Italy, 16132 Sub-Investigator: Alberto Sobrero, MD A.O. san Paolo Recruiting Milano, MI, Italy, 20100 Sub-Investigator: Paolo Foa, MD Casa di Cura Igea Not yet recruiting Milano, MI, Italy, 20100 Sub-Investigator: Gianfranco Pancera, MD Ospedale S.Carlo Borromeo Not yet recruiting Milano, MI, Italy, 20123 Sub-Investigator: Donata Tabiadon, MD A.O. S.Gerardo Recruiting Monza, MI, Italy, 20052 Sub-Investigator: Paolo Bidoli, MD A.O. Universitaria Ospedali Riuniti Umberto I Recruiting Ancona, Italy, 60020 Principal Investigator: Stefano Cascinu, M.Pr Ospedali Riuniti, Largo Barozzi, 1 Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD A.O.Policlinico S.Orsola Malpighi Active, not recruiting Bologna, Italy, 40138 A.O. Careggi-Università, Viale Pieraccini, 17 Recruiting Firenze, Italy, 50139 Sub-Investigator: Francesco Di Costanzo, MD Ospedale Galliera Active, not recruiting Genova, Italy, 16132 A.O. Carlo Poma - Via Albertoni, 1 Recruiting Mantova, Italy, 46100 Sub-Investigator: Enrico Aitini, MD A.O. Cà Granda, Piazza Ospedale Maggiore, 3 Recruiting Milano, Italy, 20162 Sub-Investigator: Salvatore Siena, MPr Policlinico di modena Active, not recruiting Modena, Italy, 41100 Università Campus Biomedico, Via Emilio Longoni, 83 Active, not recruiting Roma, Italy, 00155 A.O. S.Giovanni Calabita Fatebenefratelli Active, not recruiting Roma, Italy, 00186 Less << |
| NCT00699374 | - | Terminated(See termination rea... More >>son in detailed description.) Less << | - | - | |
| NCT00217620 | Sarcoma | Phase 2 | Completed | - | - |
| NCT00253578 | Refractory Multiple Myeloma | Phase 2 | Completed | - | United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less << |
| NCT00217620 | - | Completed | - | - | |
| NCT00182689 | - | Completed | - | - | |
| NCT01775501 | Hepatocellular Cancer | Phase 2 | Active, not recruiting | December 2019 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02125 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less << |
| NCT00949182 | Liver Cancer | Phase 2 | Completed | - | United States, New Jersey ... More >> Rutgers University Hospital Newark, New Jersey, United States, 07101 Less << |
| NCT00118170 | Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Multiple Myeloma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << | Phase 1 | Completed | - | United States, Illinois ... More >> Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States, 60604-1104 Less << |
| NCT00126503 | - | Completed | - | - | |
| NCT00126503 | Chromophobe Renal Cell Carcino... More >>ma Clear Cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << | Phase 1 Phase 2 | Completed | - | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less << |
| NCT02981498 | Hepatocellular Carcinoma | Phase 2 | Recruiting | April 2017 | China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD Shiming@sysu.edu.cn Less << |
| NCT00259129 | Neoplasms | Phase 1 | Completed | - | United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115 United States, Texas San Antonio, Texas, United States, 78229 Less << |
| NCT00390611 | Ovarian Cancer | Phase 2 | Completed | - | United States, Arkansas ... More >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Holy Cross Hospital Ft. Lauderdale, Florida, United States, 33308 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical College of Georgia Cancer Specialists Augusta, Georgia, United States, 30912 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Michigan St. Joseph Mercy Hospital Ann Arbor, Michigan, United States, 48106 Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Valley Clinical Research Chattanooga, Tennessee, United States, 37411 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Center Newport News, Virginia, United States, 23601 Less << |
| NCT00390611 | - | Completed | - | - | |
| NCT00989469 | Metastatic Colorectal Cancer | Phase 1 Phase 2 | Completed | - | France ... More >> Centre Oscar Lambret Lille, France Hopital Saint Eloi Montpellier, France Centre Rene Gauducheau Nantes, France Centre Antoine Lacassagne Nice, France CHU Robert Debre Reims, France Less << |
| NCT00265798 | Gastrointestinal Stromal Tumor | Phase 2 | Active, not recruiting | - | United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT00699374 | Carcinoma, Hepatocellular | Phase 3 | Terminated(See termination rea... More >>son in detailed description.) Less << | - | - |
| NCT01131689 | Hepatocellular Carcinoma | Phase 1 | Completed | - | Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less << |
| NCT00265798 | - | Active, not recruiting | - | - | |
| NCT00954135 | Breast Cancer | Phase 2 | Unknown | December 2010 | Italy ... More >> Breast Unit Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy Azienda Ospedaliera S.Luigi Orbassano Orbassano, Italy Less << |
| NCT00600015 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kansas Kansas City Cancer Centers Overland Park, Kansas, United States, 66210 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus, Ohio, United States, 43219 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Coastal Bend Cancer Center Corpus Christi, Texas, United States, 78463 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less << |
| NCT00405210 | Primary Disease ... More >> Prostate Cancer Less << | Phase 1 | Completed | - | Belgium ... More >> St Pierre Ottignies, Brabant Wallon, Belgium, 1340 Cliniques Universitaires St Luc Brussels, Brussels Capital, Belgium, 1200 Notre Dame et Reine Fabiola Charleroi, Hainaut, Belgium, 6000 Clinique Universiataire de Mont Godinne Yvoir, Namur, Belgium, 5030 Sainte Elisabeth Namur, Belgium, 5000 France Hôpital Européen Georges Pompidou Paris, France, 75015 Less << |
| NCT00600015 | - | Completed | - | - | |
| NCT00303966 | - | Terminated(Slow accrual) | - | - | |
| NCT00692770 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | - |
| NCT02143401 | Cirrhosis Hep... More >>atitis B Infection Hepatitis C Infection Metastatic Malignant Solid Neoplasm Recurrent Hepatocellular Carcinoma Recurrent Malignant Solid Neoplasm Refractory Malignant Neoplasm Stage IV Hepatocellular Carcinoma AJCC v7 Unresectable Solid Neoplasm Less << | Phase 1 | Recruiting | - | United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Site Public Contact 855-776-0015 Principal Investigator: Brian A. Costello United States, California University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Edward J. Kim United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact 720-848-0650 Principal Investigator: Sarah L. Davis United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Site Public Contact 855-776-0015 Principal Investigator: Brian A. Costello United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Site Public Contact 800-237-1225 Principal Investigator: Mohammed M. Milhem United States, Maryland University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact 800-888-8823 Principal Investigator: Edward A. Sausville United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact 855-776-0015 Principal Investigator: Brian A. Costello United States, New York Columbia University/Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Site Public Contact 212-305-6361 nr2616@cumc.columbia.edu Principal Investigator: Gulam A. Manji United States, Pennsylvania Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Site Public Contact 215-955-6084 Principal Investigator: James A. Posey United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact 877-312-3961 Principal Investigator: Ahmed O. Kaseb Less << |
| NCT00692770 | - | Completed | - | - | |
| NCT00303966 | Refractory Chronic Lymphocytic... More >> Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << | Phase 2 | Terminated(Slow accrual) | - | United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less << |
| NCT00093626 | Primary Peritoneal Carcinoma ... More >> Recurrent Ovarian Carcinoma Less << | Phase 2 | Completed | - | United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less << |
| NCT00098254 | Non-Small-Cell Lung Carcinoma | Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT01531361 | Advanced Malignant Neoplasm ... More >> BRAF Gene Mutation Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Less << | Phase 1 | Active, not recruiting | February 28, 2020 | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00492752 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | China, Anhui ... More >> Hefei, Anhui, China, 230022 China, Guangdong Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510515 China, Hubei Wuhan, Hubei, China, 430030 China, Jiangsu Nanjing, Jiangsu, China, 210003 Nanjing, Jiangsu, China, 210009 China, Liaoning Dalian, Liaoning, China, 116011 Dalian, Liaoning, China, 116027 China, Zhejiang Hangzhou, Zhejiang, China, 310016 China Beijing, China, 100021 Beijing, China, 100039 Chongqing, China, 400038 Shanghai, China, 200003 Shanghai, China, 200032 Tianjin, China Korea, Republic of Seoul, Seoul Teugbyeolsi, Korea, Republic of, 152-703 Daegu, Korea, Republic of, 702-701 Seoul, Korea, Republic of, 138-736 Taiwan Changhua, Taiwan, 500 Tainan, Taiwan, 736 Taipei, Taiwan, 10016 Taipei, Taiwan, 251 Taoyuan, Taiwan, 333 Less << |
| NCT01075555 | Liver Cancer | Phase 3 | Completed | - | France ... More >> Hopital Du Bocage Dijon, France, 21000 Less << |
| NCT00632541 | Metastatic Breast Cancer | Phase 2 | Terminated(Significant Toxicit... More >>ies Experienced) Less << | - | United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Ireland Cancer Center - University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Less << |
| NCT00492752 | - | Completed | - | - | |
| NCT00632541 | - | Terminated(Significant Toxicit... More >>ies Experienced) Less << | - | - | |
| NCT01264705 | Hepatocellular Carcinoma ... More >> Liver Cancer Less << | Phase 1 Phase 2 | Completed | - | United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less << |
| NCT00622466 | Breast Cancer | Phase 2 | Unknown | December 2015 | United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less << |
| NCT00098254 | - | Completed | - | - | |
| NCT00474929 | Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << | Phase 1 Phase 2 | Active, not recruiting | January 2019 | United States, Iowa ... More >> Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less << |
| NCT00474929 | - | Active, not recruiting | - | - | |
| NCT00786110 | Adrenocortical Carcinoma | Phase 2 | Unknown | October 2010 | Italy ... More >> Department of Clinical and Biological Sciences, University of Turin Recruiting Orbassano, Italy Contact: Paola Perotti : +390119026 ext Ext. 017 Principal Investigator: Alfredo Berruti Azienda Ospedaliera di Padova Not yet recruiting Padova, Italy Contact: Franco Mantero Sub-Investigator: Franco Mantero Azienda Ospedaliera Università di Palermo Not yet recruiting Palermo, Italy Sub-Investigator: Vittorio Gebbia Policlinico Universitario Campus Biomedico- Roma Not yet recruiting Roma, Italy Contact: Daniele Santini Sub-Investigator: Daniele Santini Ist. Clin.Humanitas Not yet recruiting Rozzano, Italy Contact: Carlo Carnaghi Sub-Investigator: Carlo Carnaghi Less << |
| NCT00908167 | Acute Myeloid Leukemia ... More >> Infantile Leukemia (Both AML and ALL) Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasms Biphenotypic Leukemia Less << | Phase 1 | Completed | - | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
| NCT00665990 | Refractory Solid Tumors ... More >> Leukemia Less << | Phase 1 | Completed | - | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
| NCT00384969 | Renal Cell Carcinoma | Phase 1 | Completed | - | United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less << |
| NCT00126659 | - | Terminated | - | - | |
| NCT00126659 | Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer Less << | Phase 2 | Terminated | - | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01817751 | Glioblastoma ... More >>Recurrent Adult Brain Neoplasm Malignant Glioma WHO Grade III Glioma Less << | Phase 2 | Recruiting | March 31, 2019 | United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison A Ryan, NP 804-628-1936 masseysiit@vcu.edu Principal Investigator: Mark G Malkin, MD Less << |
| NCT02564666 | Hepatocellular Carcinoma | Not Applicable | Unknown | December 2017 | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less << |
| NCT00589550 | - | Terminated(low accrual) | - | - | |
| NCT00589550 | Kidney Cancer | Phase 1 | Terminated(low accrual) | - | United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less << |
| NCT01078961 | Melanoma | Phase 1 | Completed | - | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less << |
| NCT00872014 | Advanced Hepatocellular Carcin... More >>oma Inoperable Hepatocellular Carcinoma Less << | Phase 2 | Completed | - | - |
| NCT00657254 | Neoplasm Meta... More >>stasis Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115-6084 Belgium Bruxelles - Brussel, Belgium, 1000 Canada, Ontario Hamilton, Ontario, Canada, L8V 5C2 Toronto, Ontario, Canada, M5G 2M9 Germany Essen, Nordrhein-Westfalen, Germany, 45147 Herne, Nordrhein-Westfalen, Germany, 44625 Less << |
| NCT00101114 | Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << | Phase 2 | Completed | - | United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less << |
| NCT00726986 | Lung Cancer | Phase 2 | Terminated(Extreme toxicity) | - | United States, New York ... More >> Columbia Presbyterian New York, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 CCF-Fairview Hospital Cleveland, Ohio, United States, 44111 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Less << |
| NCT00098618 | Clear Cell Renal Cell Carcinom... More >>a Papillary Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << | Phase 2 | Terminated | - | United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less << |
| NCT00726986 | - | Terminated(Extreme toxicity) | - | - | |
| NCT01754987 | Metastatic Hepatocellular Carc... More >>inoma Advanced Liver Cancer Less << | Phase 1 Phase 2 | Completed | - | United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
| NCT01004003 | - | Completed | - | - | |
| NCT01004003 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | Austria ... More >> 1199.37.43001 Boehringer Ingelheim Investigational Site Wien, Austria 1199.37.43002 Boehringer Ingelheim Investigational Site Wien, Austria France 1199.37.33001 Boehringer Ingelheim Investigational Site Paris, France 1199.37.33002 Boehringer Ingelheim Investigational Site Paris, France Germany 1199.37.49008 Boehringer Ingelheim Investigational Site Berlin, Germany 1199.37.49009 Boehringer Ingelheim Investigational Site Erlangen, Germany 1199.37.49002 Boehringer Ingelheim Investigational Site Freiburg, Germany 1199.37.49001 Boehringer Ingelheim Investigational Site Hannover, Germany 1199.37.49010 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1199.37.49005 Boehringer Ingelheim Investigational Site Jena, Germany 1199.37.49004 Boehringer Ingelheim Investigational Site Magdeburg, Germany 1199.37.49003 Boehringer Ingelheim Investigational Site München, Germany 1199.37.49006 Boehringer Ingelheim Investigational Site Tübingen, Germany Hungary 1199.37.36001 Boehringer Ingelheim Investigational Site Debrecen, Hungary Netherlands 1199.37.31002 Boehringer Ingelheim Investigational Site Leiden, Netherlands 1199.37.31001 Boehringer Ingelheim Investigational Site Utrecht, Netherlands Poland 1199.37.48002 Boehringer Ingelheim Investigational Site Olsztyn, Poland 1199.37.48003 Boehringer Ingelheim Investigational Site Warsaw, Poland 1199.37.48001 Boehringer Ingelheim Investigational Site Warszawa, Poland Romania 1199.37.40002 Boehringer Ingelheim Investigational Site Bucharest, Romania 1199.37.40003 Boehringer Ingelheim Investigational Site Cluj-Napoca, Romania United Kingdom 1199.37.44001 Boehringer Ingelheim Investigational Site Edgbaston, Birmingham, United Kingdom 1199.37.44005 Boehringer Ingelheim Investigational Site Glasgow, United Kingdom 1199.37.44008 Boehringer Ingelheim Investigational Site Liverpool, United Kingdom 1199.37.44002 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.37.44003 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.37.44006 Boehringer Ingelheim Investigational Site Manchester, United Kingdom 1199.37.44004 Boehringer Ingelheim Investigational Site Nottingham, United Kingdom Less << |
| NCT00981162 | Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Completed | - | United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less << |
| NCT02856126 | Hepatocellular Carcinoma | Phase 3 | Recruiting | August 2018 | China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD 13827285010 yuwusheng1998@126.com Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD 8620-87343115 shiming@mail.sysu.edu.cn The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD 13725254145 tgs1976@163.com Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD 15521278919 13430288977@139.com Principal Investigator: Jinghua Chen, MD Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD 13717287622 Shijie_9262511@163.com China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD 13975486015 wxp19730806@sina.com China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD 13649265446 183421344@qq.com Less << |
| NCT01754987 | - | Completed | - | - | |
| NCT00387751 | Recurrent Melanoma ... More >> Stage III Skin Melanoma Stage IV Skin Melanoma Less << | Phase 2 | Completed | - | United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less << |
| NCT00387751 | - | Completed | - | - | |
| NCT00111020 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
| NCT00522301 | Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << | Phase 2 | Terminated | - | United States, New York ... More >> Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 Less << |
| NCT00522301 | - | Terminated | - | - | |
| NCT00663741 | Gastric Cancer | Phase 1 | Completed | - | Japan ... More >> Kashiwa, Chiba, Japan, 277-8577 Kobe, Hyogo, Japan, 650-0017 Chuo-ku, Tokyo, Japan, 104-0045 Less << |
| NCT00096395 | Recurrent Ovarian Epithelial C... More >>ancer Recurrent Primary Peritoneal Cavity Cancer Less << | Phase 2 | Completed | - | Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less << |
| NCT01232296 | Hepatocellular Carcinoma | Phase 2 | Completed | - | China, Jiangsu ... More >> Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310016 China Novartis Investigative Site Beijing, China, 100039 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site Shatin, New Territories, Hong Kong Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 232-0024 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Singapore Novartis Investigative Site Singapore, Singapore, 308433 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10048 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Novartis Investigative Site Khon Kaen, Thailand, 40002 Novartis Investigative Site Songkla, Thailand, 90110 Less << |
| NCT00794859 | Mesothelioma | PHASE2 | UNKNOWN | - | Guy's and St Thomas' NHS Found... More >>ation Trust, London, SE1 9RT, United Kingdom Less << |
| NCT01253070 | Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia (Megakaryoblastic) With t(1;22)(p13.3;q13.1); RBM15-MKL1 Acute Myeloid Leukemia With a Variant RARA Translocation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A Acute Myeloid Leukemia With Variant MLL Translocations Untreated Adult Acute Myeloid Leukemia Less << | Phase 2 | Active, not recruiting | - | - |
| NCT01253070 | - | Active, not recruiting | - | - | |
| NCT01009593 | Hepatocellular Carcinoma Non-r... More >>esectable Hepatocellular Carcinoma Recurrent Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma Neoplasms, Glandular and Epithelial Less << | Phase 3 | Terminated(See termination rea... More >>son in detailed description) Less << | - | - |
| NCT00976170 | Hepatocellular Carcinoma | Phase 1 | Completed | - | United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Taiwan National Cheng Kung University Hospital Tainan, Taiwan National Taiwan Univercity Hospital Taipei, Taiwan Less << |
| NCT00114244 | Stage IV Pancreatic Cancer | Phase 2 | Completed | - | United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less << |
| NCT00990860 | Hepatocellular Carcinoma | Phase 2 | Unknown | - | Taiwan ... More >> E-Da hospital Kaohsiung, Taiwan Veterans General Hospital- Kaochiung Kaoshiung, Taiwan Veterans General Hospital- Taichung Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Mackay Memorial Hospital Taipei, Taiwan Tri- Service General Hospital Taipei, Taiwan Veterans General Hospital- Taipei Taipei, Taiwan Chang-Gung Memorial Hospital- LinKou TaoYuan Hsien, Taiwan Less << |
| NCT01232296 | - | Completed | - | - | |
| NCT00329641 | Ciliary Body and Choroid Melan... More >>oma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Less << | Phase 2 | Completed | - | United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less << |
| NCT00329641 | - | Completed | - | - | |
| NCT00114244 | - | Completed | - | - | |
| NCT00812175 | - | Completed | - | - | |
| NCT00791778 | - | Completed | - | - | |
| NCT00791778 | Ovarian Neoplasms | Phase 2 | Completed | - | - |
| NCT00573690 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | Phase 1 | Completed | - | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less << |
| NCT00126594 | Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << | Phase 2 | Completed | - | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00558636 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Terminated(Terminated early wh... More >>en the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.) Less << | - | China, Guangdong ... More >> Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510515 China, Hong Kong Shatin, Hong Kong, China China, Jiangsu Nanjing, Jiangsu, China, 210003 China, Zhejiang Hangzhou, Zhejiang, China, (310022), Hangzhou, Zhejiang, China, 310016 China Beijing, China, 100021 Beijing, China, 100142 Beijing, China, 100730 Chongqing, China, 400038 Shanghai, China, 200032 Shanghai, China, 200433 India Mumbai, Maharashtra, India, 400012 New- Delhi, India, 110008 Korea, Republic of Gyeonggi-do, Korea, Republic of, 410-769 Seoul, Korea, Republic of, 136-705 Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Taiwan Changhua, Taiwan, 500 Taipei, Taiwan, 100 Thailand Bangkok, Thailand, 10330 Bangkok, Thailand Less << |
| NCT00126594 | - | Completed | - | - | |
| NCT00558636 | - | Terminated(Terminated early wh... More >>en the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.) Less << | - | - | |
| NCT03674060 | Healthy, Male | Phase 1 | Not yet recruiting | February 2019 | - |
| NCT00837876 | Pancreatic Cancer | Phase 2 | Completed | - | United States, Kentucky ... More >> Purchase Cancer Group - Paducah Paducah, Kentucky, United States, 42002 United States, Tennessee Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States, 37403 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less << |
| NCT01157013 | Hepatocellular Carcinoma | Not Applicable | Completed | - | Spain ... More >> Miguel Servet University Hospital Zaragoza, Aragon, Spain, 50009 Less << |
| NCT00586495 | Carcinoma, Renal Cell | Phase 2 | Completed | - | Japan ... More >> Asahi, Chiba, Japan, 289-2511 Matsuyama, Ehime, Japan, 791-0280 Kurume, Fukuoka, Japan, 830-0011 Isesaki, Gunma, Japan, 372-0817 Maebashi, Gunma, Japan, 371-8511 Sapporo, Hokkaido, Japan, 003-0804 Sapporo, Hokkaido, Japan, 060-8543 Sapporo, Hokkaido, Japan, 060-8648 Sunagawa, Hokkaido, Japan, 073-0196 Tsukuba, Ibaraki, Japan, 305-8576 Morioka, Iwate, Japan, 020-8505 Tsu, Mie, Japan, 514-8507 Natori, Miyagi, Japan, 981-1293 Kashihara, Nara, Japan, 634-8522 Kurashiki, Okayama, Japan, 710-8602 Osakasayama, Osaka, Japan, 589-8511 Suita, Osaka, Japan, 565-0871 Hidaka, Saitama, Japan, 350-1298 Irima-gun, Saitama, Japan, 350-0495 Tokorozawa, Saitama, Japan, 359-8513 Hamamatsu, Shizuoka, Japan, 431-3192 Sunto, Shizuoka, Japan, 411-8777 Utsunomiya, Tochigi, Japan, 320-0834 Arakawa-ku, Tokyo, Japan, 116-8567 Bunkyo-ku, Tokyo, Japan, 113-8655 Chuo-ku, Tokyo, Japan, 104-0045 Itabashi-ku, Tokyo, Japan, 173-0003 Shinjuku-ku, Tokyo, Japan, 162-8666 Ube, Yamaguchi, Japan, 755-8505 Akita, Japan, 010-8543 Chiba, Japan, 260-8677 Chiba, Japan, 260-8717 Fukuoka, Japan, 812-0033 Fukuoka, Japan, 812-8582 Kagoshima, Japan, 890-8520 Kyoto, Japan, 602-8566 Kyoto, Japan, 606-8507 Okayama, Japan, 700-8558 Osaka, Japan, 537-8511 Tokushima, Japan, 770-8503 Yamagata, Japan, 990-9585 Less << |
| NCT00837876 | - | Completed | - | - | |
| NCT00586495 | - | Completed | - | - | |
| NCT00134069 | Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << | Phase 1 | Completed | - | United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less << |
| NCT01215266 | Bladder Cancer | Phase 2 | Terminated(Slow recruitment) | - | - |
| NCT01466504 | - | Terminated(Accrual did not mee... More >>t expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable.) Less << | - | United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, Vermont White River Junction VA Medical Center White River Junction, Vermont, United States, 05009 Less << | |
| NCT00544817 | Glioblastoma Multiforme | Phase 2 | Completed | - | United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less << |
| NCT02050919 | Pleomorphic Rhabdomyosarcoma ... More >> Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage IV Adult Soft Tissue Sarcoma AJCC v7 Less << | Phase 2 | Active, not recruiting | December 31, 2018 | United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less << |
| NCT00329719 | - | Completed | - | - | |
| NCT00329719 | Adult Glioblastoma ... More >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << | Phase 1 Phase 2 | Completed | - | - |
| NCT01728948 | - | Completed | - | China ... More >> Many Locations, China Less << | |
| NCT00544817 | - | Completed | - | - | |
| NCT00516828 | Leukemia Myel... More >>odysplastic Syndromes Less << | Phase 1 Phase 2 | Completed | - | Canada, Nova Scotia ... More >> QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Less << |
| NCT00281957 | Recurrent Melanoma ... More >> Stage IV Melanoma Less << | Phase 2 | Completed | - | - |
| NCT01703455 | Salivary Gland Cancer | PHASE2 | COMPLETED | 2025-01-13 | IRCCS Istituto Nazionale Tumor... More >>i, Milano, 20133, Italy Less << |
| NCT00281957 | - | Completed | - | - | |
| NCT01245582 | Hepatic Neoplasm Malignant | Phase 3 | Withdrawn | August 2015 | - |
| NCT02240433 | Hepatocellular Carcinoma | Phase 1 | Active, not recruiting | February 11, 2019 | Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 241-8515 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan, 565-0871 Less << |
| NCT00253370 | Adenocarcinoma of the Gastroes... More >>ophageal Junction Metastatic Gastric Cancer Advanced Unresectable Gastric Cancer Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less << |
| NCT00919009 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | Korea, Republic of ... More >> National Cancer Center Seoul, Korea, Republic of Less << |
| NCT02517736 | Uveal Melanoma | Phase 2 | Completed | - | France ... More >> Service d'ophtalmologie, CHU de Caen Caen, France, 14000 Less << |
| NCT00253370 | - | Completed | - | - | |
| NCT00464919 | Hepatocellular Carcinoma | Phase 2 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less << |
| NCT00301847 | Kidney Cancer ... More >> Metastatic Cancer Less << | Phase 2 | Completed | - | United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States, 60201-1781 Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria, Illinois, United States, 61615-7828 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States, 46885-5099 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, Michigan Oncology Care Associates, PLLC Saint Joseph, Michigan, United States, 49085 United States, Missouri David C. Pratt Cancer Center at St. John's Mercy Saint Louis, Missouri, United States, 63141 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less << |
| NCT00131911 | - | Completed | - | - | |
| NCT02460991 | Hepatocellular Carcinoma ... More >> Hepatoma Liver Cell Carcinoma Less << | Phase 3 | Terminated(Slow enrollment) | - | United States, Alabama ... More >> University of Alabama Hospital Birmingham, Alabama, United States, 35233 United States, California University of Southern California Los Angeles, California, United States, 90033 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02460991 | - | Terminated(Slow enrollment) | - | - | |
| NCT00238121 | - | Completed | - | - | |
| NCT01158287 | Esophageal Cancer ... More >> Gastric Cancer Less << | Phase 2 | Completed | - | Ireland ... More >> Bon Secours Hospital Cork, Ireland Cork University Hospital Cork, Ireland Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland, 24 Mater Misericordiae University Hospital Dublin, Ireland, 7 St. James's Hospital Dublin, Ireland, 8 Beaumont Hospital Dublin, Ireland, 9 University College Hospital Galway, Ireland Waterford Regional Hospital Waterford, Ireland Less << |
| NCT00389285 | Carcinoma, Renal Cell | Phase 1 Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Arizona Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less << |
| NCT00131911 | Gastrinoma Gl... More >>ucagonoma Insulinoma Metastatic Gastrointestinal Carcinoid Tumor Neuroendocrine Tumor Pancreatic Polypeptide Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Somatostatinoma WDHA Syndrome Less << | Phase 2 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT01262482 | Advanced or Metastatic Gastric... More >> or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Less << | Phase 2 | Completed | - | Spain ... More >> Hospital Clinic de Barcelona Barcelona, Spain Hospital Sant Pau Barcelona, Spain H. Josep Trueta Girona, Spain Centro Oncológico M.D. Anderson Spain Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital La Paz Madrid, Spain Hospital Althaia Manresa, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital General de Valencia Valencia, Spain Less << |
| NCT00498836 | Malignant Melanoma | Phase 2 | Completed | - | United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States, 78229 Norway The Norwegian Radium Hospital Oslo, Norway, NO-0310 Sweden Lund University Hospital Lund, Sweden, SE-221 85 Umeå University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less << |
| NCT01383343 | Recurrent Colon Carcinoma ... More >> Recurrent Rectal Carcinoma Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << | Phase 1 | Completed | - | United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT00101413 | Cancer Carcin... More >>oma, Non-Small Cell Lung Less << | Phase 2 | Completed | - | United States, Texas ... More >> Houston, Texas, United States, 77030 Germany Großhansdorf, Schleswig-Holstein, Germany, 22927 Less << |
| NCT00101413 | - | Completed | - | - | |
| NCT00941863 | Carcinoma | Phase 1 | Completed | - | United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, Wisconsin Madison, Wisconsin, United States, 53792 Less << |
| NCT00941863 | - | Completed | - | - | |
| NCT00448149 | Carcinoma, Renal Cell | Phase 1 Phase 2 | Completed | - | United States, Texas ... More >> The Methodist Hospital Research Institute Houston, Texas, United States, 77030 Less << |
| NCT00119639 | Kidney Diseases | Phase 1 | Completed | - | - |
| NCT00126620 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | Phase 1 | Completed | - | Canada, Ontario ... More >> Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less << |
| NCT00238121 | Recurrent Uterine Sarcoma ... More >> Stage III Uterine Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma Less << | Phase 2 | Completed | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 University of Southern California Los Angeles, California, United States, 90033-0804 United States, Illinois Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston, Ontario, Canada, K7L 5P9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less << |
| NCT00095966 | Adenocarcinoma of the Pancreas... More >> Recurrent Pancreatic Cancer Stage II Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << | Phase 2 | Completed | - | United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less << |
| NCT00255658 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | Phase 1 | Completed | - | United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less << |
| NCT00865709 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | - |
| NCT02977754 | - | Recruiting | March 2019 | Italy ... More >> Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Egesta Lopci, MD +39 0282247542 Less << | |
| NCT00326495 | - | Completed | - | - | |
| NCT00789763 | Pancreatic Cancer | Phase 1 | Completed | - | Spain ... More >> Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clinic I Provincial Barcelona, Spain, 08036 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario La Fe Valencia, Spain, 46009 Less << |
| NCT00865709 | - | Completed | - | - | |
| NCT00436579 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | Phase 1 | Terminated | - | United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less << |
| NCT01502410 | - | Completed | - | - | |
| NCT00326495 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT00609401 | Metastatic Disease ... More >> Renal Cell Carcinoma Less << | Phase 2 | Completed | - | Italy ... More >> Istituto Tumori Milano, Italy Less << |
| NCT01015833 | Advanced Adult Hepatocellular ... More >>Carcinoma Recurrent Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v7 Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVB Hepatocellular Carcinoma AJCC v7 Unresectable Hepatocellular Carcinoma Less << | Phase 3 | Active, not recruiting | - | - |
| NCT00919061 | Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Less << | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT01015833 | - | Active, not recruiting | - | - | |
| NCT02270788 | Acute Myeloid Leukemia | Phase 1 | Completed | - | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
| NCT00919061 | - | Completed | - | - | |
| NCT01502410 | Childhood Hepatocellular Carci... More >>noma Papillary Thyroid Cancer Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Liver Cancer Recurrent Childhood Rhabdomyosarcoma Recurrent Thyroid Cancer Recurrent Wilms Tumor and Other Childhood Kidney Tumors Less << | Phase 2 | Completed | - | - |
| NCT00619541 | Hepatocellular Carcinoma | Phase 2 | Completed | - | Italy ... More >> Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina ... Indirizzo: via Roma, 55 - 56100 Pisa Tel. 050-2218690 - Fax. 050-2218685 Pisa, Italy, 56100 Less << |
| NCT01234337 | Breast Cancer | Phase 3 | Completed | - | - |
| NCT01481805 | - | Completed | - | Korea, Republic of ... More >> Samsung medical Center Seoul, Korea, Republic of Less << | |
| NCT00217646 | Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Blastic Phase de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Less << | Phase 1 | Completed | - | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00873002 | Liver Cancer | Phase 1 | Terminated(Dose Limiting Toxic... More >>ity) Less << | - | United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less << |
| NCT00727532 | Hereditary Clear Cell Renal Ce... More >>ll Carcinoma|Kidney Cancer Less << | TERMINATED | 2025-09-13 | Robert H. Lurie Comprehensive ... More >>Cancer Center at Northwestern University, Chicago, Illinois, 60611-3013, United States Less << | |
| NCT00098540 | Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << | Phase 2 | Completed | - | United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less << |
| NCT00096512 | Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << | Phase 2 | Completed | - | United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less << |
| NCT00621686 | Brain and Central Nervous Syst... More >>em Tumors Less << | Phase 2 | Completed | - | - |
| NCT00287495 | Kaposi's Sarcoma ... More >> HHV-8 KSHV Less << | Phase 1 | Terminated | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT00621686 | - | Completed | - | - | |
| NCT00217399 | Recurrent Breast Cancer ... More >> Stage IV Breast Cancer Less << | Phase 1 Phase 2 | Completed | - | United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 Less << |
| NCT00889343 | Colorectal Neoplasms | Phase 2 | Terminated | - | - |
| NCT00901901 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | - |
| NCT00217399 | - | Completed | - | - | |
| NCT00492297 | Melanoma | Phase 2 | Completed | - | France ... More >> Bordeaux, France, 33000 Lyon Cedex, France, 39373 Toulouse, France, 31052 Villejuif, France, 94805 United Kingdom Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Southampton, Hampshire, United Kingdom, SO16 6YD Northwood, Middlesex, United Kingdom, HA6 2RN Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, NW3 2QG London, United Kingdom, SE1 7EH London, United Kingdom, SW3 6JJ Manchester, United Kingdom, M20 4BX Less << |
| NCT01170104 | Hepatocellular Carcinoma | Phase 2 | Unknown | June 2013 | Korea, Republic of ... More >> Chung-Ang University Hospital Recruiting Dongjak, Seoul, Korea, Republic of, 156-755 Contact: Joung-Soon Jang, M.D. 82-2-6299-1427 alsaba@daum.net Contact: In Gyu Hwang, M.D. 82-2-748-9786 higyu72@yahoo.co.kr Principal Investigator: Joung-Soon Jang, M.D. Sub-Investigator: Hyung Joon Kim, M.D. Sub-Investigator: Hyun Woong Lee, M.D. Sub-Investigator: In Gyu Hwang, M.D. Less << |
| NCT00492297 | - | Completed | - | - | |
| NCT00526799 | Ovarian Cancer | Phase 1 Phase 2 | Terminated(Study closed to acc... More >>rual due unfavorable interim analysis) Less << | - | United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 St. Vincent Hospital Cynecologic Oncology Indianapolis, Indiana, United States, 46260 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 United States, New York Schwartz Gynecologic Oncology, PLLC Brightwaters, New York, United States, 11718 Less << |
| NCT01234337 | - | Completed | - | - | |
| NCT00901901 | - | Completed | - | - | |
| NCT00112671 | Metastatic Transitional Cell C... More >>ancer of the Renal Pelvis and Ureter Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Less << | Phase 2 | Completed | - | Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less << |
| NCT03140332 | Hepatocellular Carcinoma ... More >> Perfusion Scanner Less << | Not Applicable | Recruiting | February 27, 2020 | France ... More >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Vincent HAUTEFEUILLE, Dr +33322668206 hautefeuille.vincent@chu-amiens.fr Less << |
| NCT00131989 | Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << | Phase 1 | Completed | - | United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less << |
| NCT00526799 | - | Terminated(Study closed to acc... More >>rual due unfavorable interim analysis) Less << | - | - | |
| NCT00424385 | Prostate Cancer | Phase 1 | Completed | - | United States, Illinois ... More >> Oncology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less << |
| NCT00112671 | - | Completed | - | - | |
| NCT00424385 | - | Completed | - | - | |
| NCT00509613 | Advanced Solid Tumor ... More >> Refractory to Standard Therapies Less << | Phase 1 | Completed | - | Netherlands ... More >> UMC St Radboud Nijmegen, Netherlands Less << |
| NCT01761266 | Hepatocellular Carcinoma (HCC) | Phase 3 | Active, not recruiting | March 2019 | - |
| NCT00107432 | Epithelial Mesothelioma ... More >> Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Stage IA Malignant Mesothelioma Stage IB Malignant Mesothelioma Stage II Malignant Mesothelioma Stage III Malignant Mesothelioma Stage IV Malignant Mesothelioma Less << | Phase 2 | Completed | - | United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
| NCT00478374 | Hepatocellular Carcinoma | Phase 1 | Completed | - | Switzerland ... More >> Inselspital Bern, Switzerland, 3010 Less << |
| NCT01761266 | - | Active, not recruiting | - | - | |
| NCT03764293 | Locally Advanced or Metastatic... More >> and Unresectable HCC Less << | Phase 3 | Not yet recruiting | December 2021 | - |
| NCT01908322 | - | Completed | - | Germany ... More >> Many Locations, Germany Less << | |
| NCT00119249 | Stage III Melanoma ... More >> Stage IV Melanoma Less << | Phase 2 | Completed | - | United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less << |
| NCT00573755 | Breast Cancer | Phase 2 | Terminated(lack of participant... More >> accrual) Less << | - | United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 55259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT00095459 | Neoplasms | Phase 1 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT00573755 | - | Terminated(lack of participant... More >> accrual) Less << | - | - | |
| NCT01124669 | - | Completed | - | - | |
| NCT00467025 | Advanced Renal Cell Carcinoma | Phase 2 | Completed | - | - |
| NCT00672178 | - | Terminated(Slow accrual) | - | - | |
| NCT00672178 | Renal Cell Carcinoma | Phase 1 Phase 2 | Terminated(Slow accrual) | - | United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less << |
| NCT00110994 | Cancer Melano... More >>ma Less << | Phase 2 | Completed | - | United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, Colorado Aurora, Colorado, United States, 80045 United States, Florida Lakeland, Florida, United States, 33805 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02115-6084 Boston, Massachusetts, United States, 02215 United States, Missouri St. Louis, Missouri, United States, 63110-1093 United States, Nebraska Omaha, Nebraska, United States, 68114 United States, North Carolina Charlotte, North Carolina, United States, 28203 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hilton Head Island, South Carolina, United States, 29926-2739 United States, Tennessee Nashville, Tennessee, United States, 37232-6307 United States, Texas San Antonio, Texas, United States, 78229 Less << |
| NCT01664182 | Stage III Renal Cell Cancer AJ... More >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Less << | Phase 2 | Active, not recruiting | - | United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia VCU Massey Cancer Center at Hanover Medical Park Mechanicsville, Virginia, United States, 23116 Less << |
| NCT00771147 | - | Completed | - | Belgium ... More >> Many Locations, Belgium Less << | |
| NCT03468231 | Hepatocellular Carcinoma | Phase 3 | Recruiting | March 9, 2020 | China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD 13827285010 yuwusheng1998@126.com Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD 86-2087343115 shiming@mail.sysu.edu.cn Principal Investigator: Ming Shi, MD The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD 13725254145 tgs1976@163.com Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD 15521278919 13430288977@139.com Principal Investigator: Jinghua Chen, MD Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD 13717287622 Shijie_9262511@163.com China, Hunan First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD 13975486015 wxp19730806@sina.com China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD 13649265446 183421344@qq.com Less << |
| NCT00110994 | - | Completed | - | - | |
| NCT00430235 | Adenocarcinoma of the Prostate | Phase 2 | Completed | - | Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less << |
| NCT02847468 | Carcinoma, Hepatocellular | Not Applicable | Recruiting | March 27, 2021 | France ... More >> Emilie REDERSTORFF Recruiting Dijon, France, 21000 Contact: Emilie REDERSTORFF, PhD 0033 3 80 73 75 00 ext 3461 ERederstorff@cgfl.fr Contact: Sandrine TIAGO 0033 3 80 73 75 00 stiago@cgfl.fr Principal Investigator: Alexandre COCHET, MD Less << |
| NCT00538005 | Melanoma (Skin) | Phase 1 Phase 2 | Unknown | - | United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD 760-452-3340 emcclay@pacificoncology.com Less << |
| NCT00661180 | Chronic Myelogenous Leukemia | Phase 2 | Completed | - | United States, Oregon ... More >> Portland, Oregon, United States, 97239 France Lyon Cedex, France, 69437 Paris, France, 75010 Poitiers Cedex, France, 86021 Less << |
| NCT00906373 | Hepatocellular Carcinoma | Phase 2 | Completed | - | United States, Arizona ... More >> ImClone Investigational Site Scottsdale, Arizona, United States, 85259 United States, California ImClone Investigational Site Los Angeles, California, United States, 90095 United States, Illinois ImClone Investigational Site Chicago, Illinois, United States, 60611 United States, Louisiana ImClone Investigational Site Metairie, Louisiana, United States, 70006 United States, Massachusetts ImClone Investigational Site Burlington, Massachusetts, United States, 01805 United States, New York ImClone Investigational Site New York, New York, United States, 10032 United States, Pennsylvania ImClone Investigational Site Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT00979329 | - | Completed | - | Netherlands ... More >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH Less << | |
| NCT00906373 | - | Completed | - | - | |
| NCT01042041 | Hepatocellular Carcinoma ... More >> Liver Cancer Localized Unresectable Liver Cancer Less << | Phase 1 | Completed | - | United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT00895674 | - | Completed | - | - | |
| NCT00073307 | - | Completed | - | - | |
| NCT00499525 | Breast Cancer | Phase 2 | Active, not recruiting | December 2021 | - |
| NCT01108705 | Carcinoma, Hepatocellular | Phase 3 | Terminated | - | - |
| NCT01183663 | Advanced Cancers | Phase 1 | Completed | - | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00466752 | Adenocarcinoma of the Prostate... More >> Stage II Prostate Cancer Stage III Prostate Cancer Less << | Phase 2 | Completed | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
| NCT00825955 | Liver Cancer | Phase 3 | Terminated(Efficacy endpoint m... More >>et, however, overall experimental dosing regimen is not considered optimal to support further clinical development in this patient population) Less << | - | - |
| NCT01387555 | Hepatocellular Carcinoma ... More >> Liver Cancer HCC Less << | Phase 2 | Completed | - | - |
| NCT00096200 | Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << | Phase 2 | Completed | - | United States, Florida ... More >> Moffitt Cancer Center at Tampa General Hospital Tampa, Florida, United States, 33612 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Lake University Ireland Cancer Center Mentor, Ohio, United States, 44060 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less << |
| NCT00858871 | Hepato Cellular Carcinoma (HCC... More >>) Less << | Phase 3 | Completed | - | - |
| NCT02156297 | - | Recruiting | August 2019 | China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Jia Chen, M.D. +86 512 67781856 c_jerry_j@163.com Principal Investigator: Depei Wu, M.D., Ph.D. Sub-Investigator: Jia Chen, M.D. Less << | |
| NCT00466752 | - | Completed | - | - | |
| NCT00096200 | - | Completed | - | - | |
| NCT00492986 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
| NCT00565968 | Melanoma (Skin) | Phase 1 | Completed | - | United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less << |
| NCT00073307 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
| NCT00110019 | Mucosal Melanoma ... More >> Recurrent Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << | Phase 3 | Completed | - | - |
| NCT00661375 | Carcinoma, Renal Cell | Phase 2 | Completed | - | - |
| NCT00541021 | Pancreatic Cancer | Phase 3 | Unknown | - | France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Frederic Viret, MD 33-4-91-22-35-37 viretf@marseille.fnclcc.fr Less << |
| NCT01308723 | Carcinoma, Hepatocellular | Phase 1 | Completed | - | Singapore ... More >> Singapore, Singapore, 119228 Singapore, Singapore, 169610 Less << |
| NCT00732914 | Renal Cell Carcinoma | Phase 3 | Completed | - | Germany ... More >> Urologische Klinik Mannheim, Baden-Wuerttemberg, Germany, 68167 Less << |
| NCT00792350 | - | Completed | - | Austria ... More >> Many Locations, Austria Germany Many Locations, Germany Less << | |
| NCT00110019 | - | Completed | - | - | |
| NCT00623402 | Melanoma | Phase 2 | Completed | - | Germany ... More >> Dpt. of Dermatology, Humboldt University Berlin, Germany, 10117 Dept. of Dermatology, Elbe Klinikum Buxtehude, Germany, 21614 Dpt. of Dermatology, University of Hannover Hannover, Germany, 30449 Dpt. of Dermatology, University of Homburg/Saar Homburg/Saar, Germany, 66421 Dpt. of Dermatology; UK-SH Campus Kiel, Germany Kiel, Germany, D-24105 Dpt. of Dermatology, University of Cologne Koeln, Germany, D-50937 Dpt. of Dermatology, University of Mannheim Mannheim, Germany, 68163 Dpt. of Dermatology, Ludwig-Maximilian-University München, Germany, 80337 Dpt. of Dermatology, University of Tübingen Tübingen, Germany, 72076 Dpt. of Dermatology, University of Würzburg Würzburg, Germany, 97080 Less << |
| NCT00330421 | Metastatic Ewing Sarcoma/Perip... More >>heral Primitive Neuroectodermal Tumor Metastatic Osteosarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Osteosarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
| NCT00330421 | - | Completed | - | - | |
| NCT00417248 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << | - | United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Oncology Partners Network Cincinnati, Ohio, United States, 45247 Less << |
| NCT00378703 | Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v7 Less << | Phase 2 | Completed | - | - |
| NCT00589420 | Prostate Cancer | Phase 2 | Unknown | - | United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers 800-474-9892 Less << |
| NCT00483301 | Malignant Melanoma | Phase 2 | Completed | - | United States, California ... More >> Dr. Steven O'Day Los Angeles, California, United States, 90025 United States, Florida Mt. Sinai Medical Center Miami Beach, Florida, United States, 33140 Less << |
| NCT00417248 | - | Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << | - | - | |
| NCT02645981 | HCC | Phase 2 Phase 3 | Active, not recruiting | August 2019 | China, Jiangsu ... More >> The PLA 81 Hospital Nanjing, Jiangsu, China, 025 China, Sichuan West China Hospital Sichuan University Chengdu, Sichuan, China, 610042 Less << |
| NCT00492258 | Kidney Cancer | Phase 3 | Completed | - | United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, England, United Kingdom, BH7 7DW Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Queen's Hospital Burton-upon-Trent, England, United Kingdom, DE13 0RB Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Dorset County Hospital Dorchester, England, United Kingdom, DT1 2JY Gloucestershire Royal Hospital Gloucester, England, United Kingdom, GL1 3NN Diana Princess of Wales Hospital Grimsby, England, United Kingdom, DN33 2BA Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Ipswich Hospital Ipswich, England, United Kingdom, IP4 5PD Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Lincoln County Hospital Lincoln, England, United Kingdom, LN2 5QY Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Guy's Hospital London, England, United Kingdom, SE1 9RT Royal Marsden - London London, England, United Kingdom, SW3 6JJ Charing Cross Hospital London, England, United Kingdom, W6 8RF Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY James Cook University Hospital Middlesbrough, England, United Kingdom, TS4 3BW Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Dorset Cancer Centre Poole Dorset, England, United Kingdom, BH15 2JB Portsmouth Oncology Centre at Saint Mary's Hospital Portsmouth Hants, England, United Kingdom, PO3 6AD Whiston Hospital Prescot Merseyside, England, United Kingdom, L35 5DR Berkshire Cancer Centre at Royal Berkshire Hospital Reading, England, United Kingdom, RG1 5AN Scarborough General Hospital Scarborough, England, United Kingdom, YO12 6QL Scunthorpe General Hospital Scunthorpe, England, United Kingdom, DN15 7BH Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Wexham Park Hospital Slough, Berkshire, England, United Kingdom, SL2 4HL Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD University Hospital of North Staffordshire Stoke-On-Trent, England, United Kingdom, ST4 7LN Torbay Hospital Torquay, England, United Kingdom, TQ2 7AA Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less << |
| NCT00602576 | Melanoma (Skin) | Phase 2 | Unknown | - | United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less << |
| NCT00378703 | - | Completed | - | - | |
| NCT03236649 | Hepatocellular Carcinoma (HCC) | Phase 3 | Not yet recruiting | August 2019 | - |
| NCT01246843 | - | Completed | - | Netherlands ... More >> University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands, 6500 HB Less << | |
| NCT00474786 | Renal Cell Carcinoma | Phase 3 | Completed | - | - |
| NCT02728050 | Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Less << | Phase 1 Phase 2 | Recruiting | - | United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern 206-314-5944 halpern2@uw.edu Principal Investigator: Anna Halpern Less << |
| NCT01409499 | Hepatectomy H... More >>epatocellular Carcinoma Sorafenib Less << | Phase 4 | Completed | - | China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less << |
| NCT00474786 | - | Completed | - | - | |
| NCT02616692 | - | Completed | - | Japan ... More >> Many Locations, Japan Less << | |
| NCT00095693 | Anaplastic Thyroid Cancer ... More >> Insular Thyroid Cancer Recurrent Thyroid Cancer Stage III Follicular Thyroid Cancer Stage III Papillary Thyroid Cancer Stage IV Follicular Thyroid Cancer Stage IV Papillary Thyroid Cancer Less << | Phase 2 | Terminated | - | United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
| NCT01887717 | Hepatocellular Carcinoma | Phase 3 | Terminated(Poor Accrual.) | - | United States, Illinois ... More >> Northwestern Medical Faculty Foundation, Div of Hematology/Oncology Chicago, Illinois, United States, 60611 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 Belgium Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 France Paoli-Calmettes Institute Marseille, France, 13273 Italy UO Radiologia, Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy, 40138 ASO-Santa Croce e Carle di Cuneo Cuneo, Italy, 12100 Fondazione IRCCS Ca Grande Milano, Italy, 20122 S.C Radiologia Interventistica, A.O.Ospedale Niguarda Ca Granda Milano, Italy, 20162 Fondazione Istituto Nazionale Tumori di Milano Milano, Italy, I-20133 Azienda Ospedaliera Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy, 90147 University of Pisa Pisa, Italy, 56100 Policlinico A. Gemelli Rome, Italy, 8 - 00168 Spain Hospital Clínic Barcelona. IDIBAPS. CIBEREHD. Liver Unit Barcelona, Spain, 08036 Bulevar Sur s/n Madrid, Spain, 28041 Hospital Universitario Puerta de Hierro, Gastroenterology & Hepatology Dept Madrid, Spain, 28222 Hospital Universitari i Politecnic la Fe Valencia, Spain, 46026 United Kingdom University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Royal Free London NHS Foundation Trust London, United Kingdom, NW3 2QG Less << |
| NCT00496301 | Carcinoma, Renal Cell | Phase 2 | Completed | - | Spain ... More >> Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital de Basurto Bilbao, Spain, 48013 Hospital Santiago de Compostela Coruña, Spain, 15706 Hospital Josep Trueta Gerona, Spain, 17007 Hospital Juan Ramón Jiménez Huelva, Spain, 21005 Hospital Clínico Virgen de la Victoria Málaga, Spain, 29010 Clínica Universitaria de Navarra Pamplona, Spain, 31008 Hospital Virgen Macarena Sevilla, Spain, 41009 Hospital Xeral Cies Vigo, Spain, 36204 Less << |
| NCT00445588 | Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << | Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT01004978 | Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Less << | Phase 3 | Active, not recruiting | - | - |
| NCT00445588 | - | Completed | - | - | |
| NCT02101593 | Hepatocellular Carcinoma | Phase 1 | Completed | - | United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less << |
| NCT03340636 | - | Not yet recruiting | March 2019 | France ... More >> Caen University Hospital Not yet recruiting Caen, France Contact: Dupont Benoit, MD, PhD 02.31 06 45 40 ext +33 dupont-be@chu-caen.fr Principal Investigator: benoit Dupont, Md, PhD Less << | |
| NCT00490685 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less << |
| NCT00939627 | Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << | Phase 2 | Completed | - | United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Suburban Hospital Bethesda, Maryland, United States, 20814 United States, Montana Billings Clinic Billings, Montana, United States, 59107-7000 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less << |
| NCT00941967 | Liver Cancer | Phase 2 | Unknown | - | France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34295 Contact: Eric Assenat, MD 33-4-6761-2593 Less << |
| NCT00452387 | - | Terminated(Early stopping rule... More >>) Less << | - | - | |
| NCT00452387 | Metastatic Prostate Cancer | Phase 2 | Terminated(Early stopping rule... More >>) Less << | - | United States, California ... More >> Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Georgia Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, Ohio Mid-Ohio Oncology/Hematology, Inc. Columbus, Ohio, United States, 43213 United States, Pennsylvania Lancaster Cancer Center Lancaster, Pennsylvania, United States, 17605 Pennsylvania Oncology Hematmology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Less << |
| NCT00939627 | - | Completed | - | - | |
| NCT00606866 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 3 | Completed | - | United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less << |
| NCT00544167 | Breast Cancer | Not Applicable | Completed | - | United States, Florida ... More >> Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less << |
| NCT00352859 | Carcinoma, Renal Cell | Phase 4 | Terminated | - | United States, Missouri ... More >> Kansas City, Missouri, United States Less << |
| NCT00544167 | - | Completed | - | - | |
| NCT00607438 | Breast Cancer | Phase 2 | Terminated(Low accrual) | - | United States, Ohio ... More >> Veeda Oncology Columbus, Ohio, United States, 43215 Less << |
| NCT03212625 | Hepatocellular Carcinoma | Phase 4 | Active, not recruiting | January 31, 2019 | Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of, 08308 Less << |
| NCT00079612 | Carcinoma, Renal Cell | Phase 2 | Completed | - | United States, Illinois ... More >> Chicago, Illinois, United States, 60637 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Houston, Texas, United States, 77030 San Antonio, Texas, United States, 78229 United Kingdom London, Greater London, United Kingdom, SW3 6JJ Glasgow, Strathclyde, United Kingdom, G11 6NT Sutton, Surrey, United Kingdom, SM2 5PT Less << |
| NCT00687674 | - | Terminated(Due to study design... More >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) Less << | - | - | |
| NCT00454194 | Lung Cancer | Phase 2 | Completed | - | - |
| NCT00687674 | Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << | Phase 1 Phase 2 | Terminated(Due to study design... More >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) Less << | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT00454194 | - | Completed | - | - | |
| NCT00096434 | Male Breast Cancer ... More >> Recurrent Breast Cancer Stage IV Breast Cancer Less << | Phase 2 | Completed | - | United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less << |
| NCT03578874 | Hepatocellular Carcinoma | Phase 2 | Recruiting | December 31, 2021 | Hong Kong ... More >> Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Thomas Yau Principal Investigator: Thomas Yau, MD Less << |
| NCT01508364 | - | Completed | - | Germany ... More >> Many Locations, Germany Less << | |
| NCT03755791 | Hepatocellular Carcinoma | Phase 3 | Recruiting | December 1, 2021 | United States, California ... More >> Exelixis Clinical Site #2 Recruiting Rialto, California, United States, 92377 Contact: Exelixis 888-393-5494 druginfo@exelixis.com United States, Nevada Exelixis Clinical Site #1 Recruiting Las Vegas, Nevada, United States, 89169 Contact: Exelixis 888-393-5494 druginfo@exelixis.com Less << |
| NCT00335764 | Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << | Phase 1 Phase 2 | Completed | - | United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less << |
| NCT00875615 | - | Completed | - | - | |
| NCT00335764 | - | Completed | - | - | |
| NCT00696696 | - | Completed | - | - | |
| NCT00875615 | Liver Cancer | Phase 2 | Completed | - | United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less << |
| NCT00822848 | Sarcoma | Phase 1 | Completed | - | United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less << |
| NCT00449033 | - | Completed | - | - | |
| NCT00696696 | Pancreatic Cancer | Phase 2 | Completed | - | United States, California ... More >> Desert Regional Medical Center Palm Springs, California, United States, 92262 United States, New York Bellevue Hospital New York, New York, United States, 10016 New York University Cancer Center New York, New York, United States, 10016 Less << |
| NCT00876382 | - | Completed | - | United States, Arkansas ... More >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less << | |
| NCT00449033 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
| NCT01988493 | Carcinoma, Hepatocellular | Phase 1 Phase 2 | Active, not recruiting | October 18, 2018 | - |
| NCT00093457 | Prostate Cancer | Phase 2 | Completed | - | Canada, Alberta ... More >> Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less << |
| NCT01806740 | Hepatocellular Carcinoma | Phase 4 | Active, not recruiting | April 2018 | Korea, Republic of ... More >> Guerbet Korea Seoul, Gangnam Gu, Korea, Republic of, 135-920 Less << |
| NCT02349867 | Pancreatic Adenocarcinoma ... More >> Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Recurrent Pancreatic Carcinoma Less << | Phase 1 | Recruiting | May 31, 2022 | United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Andrew Poklepovic, MD 804-628-2321 andrew.poklepovic@vcuhealth.org Contact: Katherine Thompson, CRN 804-628-0960 masseysiit@vcu.edu Principal Investigator: Andrew Poklepovic, MD Less << |
| NCT00494299 | - | Completed | - | - | |
| NCT00238212 | Adenocarcinoma of the Extrahep... More >>atic Bile Duct Adenocarcinoma of the Gallbladder Adenocarcinoma With Squamous Metaplasia of the Gallbladder Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Squamous Cell Carcinoma of the Gallbladder Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << | Phase 2 | Completed | - | United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less << |
| NCT00494299 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | - |
| NCT00661830 | Adenocarcinoma | Phase 2 | Completed | - | Germany ... More >> Klinikum der Johannes Gutenberg-Universität Mainz, I. Med. Klinik Mainz, Rheinland-Pfalz, Germany, 55131 Universitätsklinikum Jena, Klinik für Innere Medizin, Innere Medizin II D-07740 Jena, Germany Universitätsklinikum Hamburg-Eppendorf, I. Med. Klinik, Zentrum für Innere Medizin, Martinistr. 3 D-20248 Hamburg, Germany Klinikum Fulda gAG, Tumorklinik, Pacelliallee 4 D-36043 Fulda, Germany Klinikum der Johann-Wolfgang Goethe-Universität, Innere Medizin I, Theodor-Stern-Kai 7 D-60590 Frankfurt, Germany Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II, Kirrberger Str., Gebäude 41 D-66421 Homburg/Saar, Germany Klinikum der Universität München, Medizinische Klinik II, Marchioninistr. 15 D-81377 München, Germany Klinikum rechts der Isar, TU München, II. Medizinische Klinik und Poliklinik, Ismaningerstr. 22 D-81675 München, Germany II. Med. Klinik, Leopoldina-Krankenhaus der Stadt Schweinfurt, Gustav-Adolf-Str. 8 D-97422 Schweinfurt, Germany Klinikum Esslingen Esslingen, Germany, 73730 Universitätsklinikum Halle, Innere Medizin I Halle, Germany, 06120 Less << |
| NCT00867321 | Liver Cancer | Phase 1 Phase 2 | Completed | - | - |
| NCT00449280 | Advanced Solid Tumor | Phase 1 | Completed | - | United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less << |
| NCT01353794 | - | Withdrawn | April 2018 | - | |
| NCT00661830 | - | Completed | - | - | |
| NCT00881751 | - | Completed | - | - | |
| NCT00867321 | - | Completed | - | - | |
| NCT00874874 | Sarcoma | Phase 2 | Unknown | - | France ... More >> Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Nicolas Penel, MD 33-3-20-295-920 Less << |
| NCT02786342 | - | Recruiting | January 2019 | Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, FC, Italy, 47014 Contact: Andrea Casadei-Gardini, MD Oncologia medica , PO FAENZA, Ausl della Romagna Recruiting Faenza, RA, Italy, 48018 Contact: Stefano Tamberi, MD Ospedale Civile degli Infermi Recruiting Rimini, RM, Italy, 47921 Contact: Emiliano Tamburini, MD Less << | |
| NCT00121251 | Recurrent Renal Cell Carcinoma... More >> Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7 Less << | Phase 1 Phase 2 | Completed | - | United States, New York ... More >> Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 Less << |
| NCT00547443 | Lung Cancer | Phase 1 Phase 2 | Terminated(Withdrawn as the sp... More >>onsor has stopped the drug for NSCLC population) Less << | - | United States, Texas ... More >> Arlington Cancer Center - Arlington Arlington, Texas, United States, 76012-2510 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less << |
| NCT00881751 | Liver Cancer | Phase 2 | Completed | - | United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 California Pacific Medical Center San Francisco, California, United States, 94115 United States, New York Columbia University/ New York Presbyterian Hospital New York, New York, United States, 10032 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Tennessee Oncology, PLLCat Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Virginia UVA Cancer Center Charlottesville, Virginia, United States, 22908 Less << |
| NCT00634751 | Pancreatic Neoplasms ... More >> Bile Duct Neoplasms Less << | Phase 1 Phase 2 | Completed | - | United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less << |
| NCT03406364 | Solid Tumor | Phase 1 Phase 2 | Recruiting | December 31, 2019 | Taiwan ... More >> Tri-Service General Hospital Recruiting Taipei, Nehu District, Taiwan, 114 Contact: Candace Liu +886-2-8792-3100 ext 19391 candaceliu@metagone.com.tw Less << |
| NCT01187199 | Advanced Cancer | Phase 1 | Active, not recruiting | August 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01182272 | Liver Cancer | Phase 2 | Unknown | - | France ... More >> Hopital Beaujon Recruiting Clichy, France, 92110 Contact: Contact Person 33-1-4087-5614 sandrine.faivre@bjn.aphp.fr Less << |
| NCT00121264 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | Phase 1 | Completed | - | United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less << |
| NCT00634751 | - | Completed | - | - | |
| NCT00117637 | Carcinoma, Renal Cell | Phase 2 | Completed | - | - |
| NCT00117637 | - | Completed | - | - | |
| NCT03516071 | Hepatocellular Carcinoma (HCC) | Phase 2 | Recruiting | May 10, 2019 | China, Anhui ... More >> Anhui Provincial Hospital Recruiting Hefei, Anhui, China Contact: Yueyin Pan China, Guangdong Nanfang Hospital Recruiting Guangzhou, Guangdong, China Contact: Jinlin Hou Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China Contact: Li Xu China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China Contact: Yuxian Bai China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Xinfang Hou China, Hunan Hunan Cancer Hospital Recruiting Changsha, Hunan, China Contact: Shanzhi Gu China, Jiangsu China PLA 81st hospital Recruiting Nanjing, Jiangsu, China Contact: Shukui Qin China, Jilin The first Hospital of Jilin University Recruiting Changchun, Jilin, China Contact: Wei Li China, Liaoning Army General Hospital of Shenyang military region Recruiting Shenyang, Liaoning, China Contact: Zhendong Zheng China, Shanghai Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China Contact: Zhiqiang Meng Zhongshan Hospital Recruiting Shanghai, Shanghai, China Contact: Zhenggang Ren China, Shanxi Tangdu Hospital Recruiting Xi'an, Shanxi, China Contact: Helong Zhang China, Sichuan West China Hospital West China School of Medicine Sichuan University Recruiting Chengdu, Sichuan, China Contact: Hong Zhu China, Tianjin Tianjin Medical University Cancer Institute & Hospital Recruiting Tianjin, Tianjin, China Contact: Tianqiang Song China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China Contact: Jieer Ying Less << |
| NCT02187302 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 2 | Completed | - | - |
| NCT01205828 | Hepatocellular Carcinoma | Phase 2 | Terminated(Lack of efficacy) | - | United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less << |
| NCT01180959 | Liver Cancer | Phase 2 | Active, not recruiting | April 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT00410124 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 3 | Completed | - | - |
| NCT01205828 | - | Terminated(Lack of efficacy) | - | - | |
| NCT03533582 | Childhood Hepatocellular Carci... More >>noma Childhood Malignant Liver Neoplasm Elevated Alpha-Fetoprotein Hepatoblastoma SMARCB1 Gene Mutation Less << | Phase 2 Phase 3 | Recruiting | March 31, 2025 | - |
| NCT00410124 | - | Completed | - | - | |
| NCT00495872 | Solid Tumors | Phase 1 | Completed | - | United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01620216 | Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << | Phase 2 | Recruiting | March 30, 2019 | United States, Maryland ... More >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan 301-803-8029 hourigan@nih.gov Principal Investigator: Christopher S. Hourigan United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux 503-494-9383 loriauxm@ohsu.edu Principal Investigator: Marc Loriaux United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins 214-648-4155 robert.collins@utsouthwestern.edu Principal Investigator: Robert H. Collins United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics 801-585-3229 tibor.kovacsovics@hci.utah.edu Principal Investigator: Tibor J. Kovacsovics Less << |
| NCT02013089 | Gastrointestinal Cancers | Not Applicable | Unknown | December 2017 | China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD 008613925106525 13925106525@163.com Principal Investigator: Yanhong Deng, PhD Less << |
| NCT01556490 | Unresectable Hepatocellular Ca... More >>rcinoma Less << | Phase 3 | Active, not recruiting | April 2019 | - |
| NCT03642236 | FLT3-ITD Mutation ... More >> Acute Myeloid Leukemia Brutons Tyrosine Kinase Less << | Phase 2 Phase 3 | Enrolling by invitation | September 2023 | China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less << |
| NCT02435433 | Hepatocellular Carcinoma | Phase 3 | Recruiting | June 2020 | - |
| NCT01441388 | Carcinoma, Renal Cell ... More >> Glioblastoma Carcinoma, Hepatocellular Less << | Phase 1 | Withdrawn(Business/Operational... More >> issues) Less << | November 2013 | - |
| NCT03298451 | Hepatocellular Carcinoma | Phase 3 | Recruiting | January 29, 2021 | - |
| NCT02184416 | - | Recruiting | July 20, 2019 | - | |
| NCT01964235 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 2 | Withdrawn(Study was cancelled ... More >>by Sponsor.) Less << | July 2019 | United States, Massachusetts ... More >> Massachusetts General Hospital Mass General Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Research Medical Center Onc Dept Kansas City, Missouri, United States, 64132 Australia, New South Wales Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 France Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site LILLE Cedex, France, 59037 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Nice Cedex 3, France, 06202 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Würzburg, Germany, 97080 Hong Kong Novartis Investigative Site Hong Kong SAR, Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Cordoba, Andalucia, Spain, 14004 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Genève, Switzerland, 1211 Less << |
| NCT02940496 | Malignant Neoplasms of Digesti... More >>ve Organs Advanced Liver Cancer Less << | Phase 1 Phase 2 | Active, not recruiting | December 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01248247 | Lung Cancer | Phase 2 | Active, not recruiting | June 2019 | United States, Connecticut ... More >> Yale Universtiy New Haven, Connecticut, United States, 06520 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01190241 | Advanced Solid Tumors ... More >> Inoperable Metastasis Less << | Not Applicable | Unknown | - | Netherlands ... More >> Medical Center Alkmaar Alkmaar, Netherlands, 1815 JD VU University Medical Center Amsterdam, Netherlands, 1081 HV Less << |
| NCT01035229 | - | Completed | - | - | |
| NCT01035229 | Carcinoma | Phase 3 | Completed | - | - |
| NCT01582009 | Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << | Phase 1 Phase 2 | Terminated(pts off study, PI l... More >>eft institute) Less << | - | United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 Less << |
| NCT03499626 | Advanced/ Metastatic Hepatocel... More >>lular Carcinoma Less << | Phase 1 Phase 2 | Recruiting | May 5, 2021 | Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Raghav Sundar (65) 6779 5555 raghav_sundar@nuhs.edu.sg Less << |
| NCT02089763 | Hepatocellular Carcinoma | Phase 2 | Terminated(Early termination f... More >>or futility) Less << | - | Hong Kong ... More >> Prince of Wales Hospital, the Chinese University of Hong Kong Hong Kong, Hong Kong Less << |
| NCT01582009 | - | Terminated(pts off study, PI l... More >>eft institute) Less << | - | - | |
| NCT01197170 | Solid Tumors ... More >>Advanced Cancer Less << | Phase 1 | Active, not recruiting | September 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT01449825 | - | Completed | - | - | |
| NCT02029157 | Liver Cancer | Phase 3 | Completed | - | Japan ... More >> Cancer Centers in Japan Tokyo, Japan Less << |
| NCT03163992 | Hepatocellular Carcinoma | Phase 2 | Recruiting | December 2019 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Sung Ju Park 234106820 Principal Investigator: Jeeyun Lee, M.D., Ph.D. Less << |
| NCT01953406 | Hepatocellular Carcinoma ... More >> Lung Metastasis Less << | Phase 2 | Withdrawn(No participants were... More >> enrolled. Therefore, we stop this study, prematurely.) Less << | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less << |
| NCT01209299 | - | Completed | - | - | |
| NCT00900536 | - | Completed | - | United Kingdom ... More >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Less << | |
| NCT01195649 | - | Completed | - | Taiwan ... More >> Many Locations, Taiwan Less << | |
| NCT03563170 | Hepatocellular Carcinoma Non-r... More >>esectable Hepatocellular Carcinoma Recurrent Less << | Phase 1 Phase 2 | Recruiting | December 30, 2022 | United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less << |
| NCT02015728 | Recurrent Childhood Brain Tumo... More >>r Less << | Not Applicable | Unknown | December 2017 | United States, Washington ... More >> Seattle Children's Seattle, Washington, United States, 98105 Less << |
| NCT01246986 | Carcinoma, Hepatocellular | Phase 2 | Active, not recruiting | December 3, 2018 | - |
| NCT00791544 | Liver Carcinoma | Phase 1 Phase 2 | Terminated(Company decision to... More >> discontinue the AVE1642 development program, not due to any safety or efficacy concerns) Less << | - | France ... More >> Sanofi-Aventis Administrative Office Paris, France Less << |
| NCT00829231 | Liver Disease | Phase 1 | Completed | - | United States, Florida ... More >> Miami, Florida, United States, 33014 Orlando, Florida, United States, 32809 United States, Tennessee Knoxville, Tennessee, United States, 37920 Less << |
| NCT02372162 | - | Active, not recruiting | July 2019 | Germany ... More >> University Hospital Tuebingen, BW, Germany, D-72076 Less << | |
| NCT02973204 | - | Recruiting | October 2020 | Denmark ... More >> Department of Hepatology and Gastroenterology Recruiting Aarhus, Aarhus C, Denmark, 8000 Contact: Stine Karlsen, MD, Phd Student +4522793193 stinkarl@rm.dk Contact: Jens Kelsen, Consultant, PhD +4530562682 jenskels@rm.dk Principal Investigator: Stine Karlsen, MD, Phd student Less << | |
| NCT02303444 | - | Active, not recruiting | July 31, 2020 | - | |
| NCT00110344 | Carcinoma, Renal Cell | Phase 2 | Terminated | - | United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115-6084 Less << |
| NCT01576185 | - | Completed | - | United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91006-3776 Less << | |
| NCT00920816 | Kidney Neoplasms | Phase 3 | Active, not recruiting | May 30, 2021 | - |
| NCT03630120 | Thyroid Cancer ... More >> Thyroid Cancer, Medullary Differentiated Thyroid Cancer Papillary Thyroid Cancer Follicular Thyroid Cancer Poorly Differentiated Thyroid Gland Carcinoma Less << | Phase 2 | Recruiting | December 2023 | United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Less << |
| NCT02794337 | Carcinoma, Hepatocellular | Phase 2 Phase 3 | Recruiting | January 2022 | India ... More >> Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Supriya Chopra, MD,DNB 022-27405000 ext 5510 schopra@actrec.gov.in Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Dr Supriya Chopra, MD 91-22-27405000 ext 5491 schopra@actrec.gov.in Principal Investigator: Supriya Chopra, MD Less << |
| NCT03132454 | Hematopoietic/Lymphoid Cancer ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Less << | Phase 1 | Recruiting | July 2021 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact tkadia@mdanderson.org Less << |
| NCT00920816 | - | Active, not recruiting | - | - | |
| NCT01752933 | Hepatocellular Carcinoma | Phase 2 | Completed | - | - |
| NCT03645980 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Recruiting | August 31, 2022 | Germany ... More >> Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik Recruiting Mainz, Germany, 55131 Contact: Jens U Marquardt, Dr.med. +49 6131 17 ext 6863 marquarj@uni-mainz.de Less << |
| NCT01655693 | Carcinoma, Hepatocellular | Phase 3 | Active, not recruiting | January 2019 | - |
| NCT01658878 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Active, not recruiting | December 26, 2019 | - |
| NCT01381614 | - | Completed | - | - | |
| NCT00979381 | - | Completed | - | Netherlands ... More >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH Less << | |
| NCT00543504 | Advanced Cancer | Phase 1 | Active, not recruiting | October 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02115373 | Carcinoma, Hepatocellular | Phase 1 Phase 2 | Completed | - | Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less << |
| NCT02406521 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 1 | Active, not recruiting | December 2018 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
| NCT00987935 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | Korea, Republic of ... More >> 1199.39.82001 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82002 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82003 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82004 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82005 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82006 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of Taiwan 1199.39.88606 Boehringer Ingelheim Investigational Site Changhua, Taiwan 1199.39.88609 Boehringer Ingelheim Investigational Site Kaohsiung, Taiwan 1199.39.88610 Boehringer Ingelheim Investigational Site Kaohsiung, Taiwan 1199.39.88605 Boehringer Ingelheim Investigational Site Taichung, Taiwan 1199.39.88608 Boehringer Ingelheim Investigational Site Tainan City, Taiwan 1199.39.88602 Boehringer Ingelheim Investigational Site Tainan, Taiwan 1199.39.88601 Boehringer Ingelheim Investigational Site Taipei, Taiwan 1199.39.88603 Boehringer Ingelheim Investigational Site Taipei, Taiwan 1199.39.88604 Boehringer Ingelheim Investigational Site Taoyuan County, Taiwan 1199.39.88607 Boehringer Ingelheim Investigational Site Yunlin County, Taiwan Less << |
| NCT01191385 | - | Withdrawn(Study is officially ... More >>cancelled bevore FPFV.) Less << | December 2013 | - | |
| NCT00199160 | Head and Neck Neoplasms | Phase 2 | Completed | - | Belgium ... More >> Jules Bordet Institute Brussels, Belgium, 1000 Less << |
| NCT01621906 | Metastatic Breast Cancer to th... More >>e Brain Less << | Not Applicable | Recruiting | June 2019 | United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Andrew Seidman, MD 646-888-5445 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andrew Seidman, MD 646-888-5445 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andrew Seidman, MD 646-888-5445 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andrew Seidman, MD 646-888-5445 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andrew Seidman, MD 646-888-5445 Contact: Heiko Schoder, MD 212-639-2079 Principal Investigator: Andrew Seidman, MD Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andrew Seidman, MD 646-888-5445 Less << |
| NCT00987935 | - | Completed | - | - | |
| NCT02220088 | Hepatocellular Carcinoma | Phase 2 Phase 3 | Completed | - | China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less << |
| NCT00678392 | Kidney Neoplasms | Phase 3 | Completed | - | - |
| NCT03605706 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 3 | Recruiting | December 2021 | China, Jiangsu ... More >> 81 Hospital Nanjing Recruiting Nanjing, Jiangsu, China, 210002 Contact: Shukui Qin, MD +862580864542 Less << |
| NCT02178358 | Hepatocellular Carcinoma | Phase 2 | Active, not recruiting | December 31, 2018 | China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China, 233004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 135 720 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gwei Shan Township, Taiwan, 333 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 11217 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan, Taiwan, 33378 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10330 Less << |
| NCT00974896 | Advanced Malignancy ... More >> Advanced Solid Tumors Cancer Solid Tumors Tumors Less << | Phase 1 | Completed | - | - |
| NCT01375569 | Hepatocellular Carcinoma ... More >> Hepatocellular Cancer Carcinoma, Hepatocellular Less << | Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT01897610 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 2 | Completed | - | Korea, Republic of ... More >> Inha University Hospital Incheon, Korea, Republic of, 400-711 Yonsei University Health System Seoul, Korea, Republic of, 120-752 Korea University Anam Hospital Seoul, Korea, Republic of, 136-750 The Catholic University of Korea, Seoul ST. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less << |
| NCT02867891 | - | Completed | - | - | |
| NCT01381601 | - | Completed | - | - | |
| NCT00678392 | - | Completed | - | - | |
| NCT02209441 | - | - | - | - | |
| NCT01324076 | Liver Cancer | Phase 3 | Unknown | - | United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Contact Person 44-121-472-1311 Bristol Royal Infirmary Recruiting Bristol, England, United Kingdom, BS2 8HW Contact: Contact Person 44-117-923-0000 Aintree University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: Contact Person 44-151-525-5980 Royal Free Hospital Recruiting London, England, United Kingdom, NW3 2QG Contact: Contact Person 44-20-7794-0500 King's College Hospital Recruiting London, England, United Kingdom, SE5 9RS Contact: Contact Person 44-20-3299-9000 Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: Contact Person 44-20-7352-8171 Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person 44-115-924-9924 Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person 44-23-8079-8751 Less << |
| NCT00673361 | Melanoma | Phase 2 | Terminated | - | - |
| NCT01375569 | - | Completed | - | - | |
| NCT03730675 | Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombosis Less << | Not Applicable | Not yet recruiting | November 2021 | - |
| NCT00673361 | - | Terminated | - | - | |
| NCT01222676 | Bladder Cancer | Phase 2 | Unknown | - | Italy ... More >> Fondazione Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Contact Person 39-2-2390-2359 roberto.salvioni@istitutotumori.mi.it Less << |
| NCT00687596 | Hepatocellular Carcinoma | Phase 2 | Terminated(Terminated due to s... More >>afety concerns) Less << | - | Italy ... More >> I.R.C.C.S. San Matteo University Hospital Golgi, Pavia, Italy, 27100 Less << |
| NCT02939807 | Carcinoma, Hepatocellular | Phase 2 | Recruiting | May 2021 | United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Lindsay Hunt 843-792-9321 hcc-clinical-trials@musc.edu Principal Investigator: Carolyn Britten, MD Less << |
| NCT01774344 | - | Active, not recruiting | - | - | |
| NCT01636284 | Hepatocellular Carinoma | Phase 2 | Completed | - | United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Spain University Clinic of Navarra Navarra, Spain Less << |
| NCT00108953 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
| NCT01908426 | Hepatocellular Carcinoma | Phase 3 | Active, not recruiting | October 2018 | - |
| NCT03275376 | Overall Survival ... More >> Tumor Responses Less << | Phase 2 | Recruiting | December 21, 2023 | Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Teng-Yu Lee, PhD 4-23592525 ext 3301 tylee@vghtc.gov.tw Less << |
| NCT02436902 | Hepatocellular Carcinoma | Phase 3 | Recruiting | August 2019 | China, Guangxi ... More >> Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Recruiting Nanning, Guangxi, China, 530021 Contact: Bang-De Xiang, MD,PhD 86-771-5330855 xiangbangde@163.com Less << |
| NCT01774344 | Carcinoma, Hepatocellular | Phase 3 | Active, not recruiting | February 28, 2019 | - |
| NCT01140347 | Hepatocellular Carcinoma | Phase 3 | Completed | - | - |
| NCT00811759 | Melanoma (Skin) | Phase 1 Phase 2 | Unknown | - | France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less << |
| NCT01140347 | - | Completed | - | - | |
| NCT01498952 | Unresectable or Metastatic Hep... More >>atocellular Carcinoma (HCC) Less << | Phase 1 | Completed | - | United States, California ... More >> Research Site Oxnard, California, United States United States, Colorado Research Site Golden Springs, Colorado, United States United States, Nevada Research Site Las Vegas, Nevada, United States Less << |
| NCT01357486 | Hepatocellular Carcinoma ... More >> CHILD B Less << | Phase 2 | Completed | - | France ... More >> CH d'Abbeville Abbeville, France, 80142 CH Pays d'Aix Aix-en-provence, France, 13616 CH d'Auxerre Auxerre, France, 89011 CH de la Côte Basque Bayonne, France, 64109 AP-HP- Hôpital Jean-Verdier Bondy, France, 93143 CHU de Bordeaux Bordeaux, France, 33075 CH Duchenne Boulogne Sur Mer, France, 62321 CH de Béziers Béziers, France, 34525 AP-HP Hôpital Henri Mondor Creteil, France, 94010 CHU Le Bocage Dijon, France, 21079 CH Départemental Vendée La Roche-sur-yon, France, 85925 CH Le Mans Le Mans, France, 72037 CH de Bretagne Sud Lorient, France, 56100 Hôpital privé Jean Mermoz Lyon, France, 69008 AP-HM Hôpital de la Timone Marseille, France, 13385 CH de Meaux Meaux, France, 77104 CH Mont de Marsan Mont-de-marsan, France, 40024 CHU de Nancy Hôpital Brabois Nancy, France, 54511 CHU de Nantes Hôpital de l'Hotel Dieu Nantes, France, 44093 CHU Nîmes Nimes, France, 30029 CHR d'Orléans - Hôpital La Source Orleans, France, 45067 Groupe Hospitalier Paris Saint Joseph Paris, France, 75014 CH Perpignan Perpignan, France, 66046 CHU de Bordeaux, Hôpital du Haut Lévèque Pessac, France, 33604 CH de la Région d'Annecy Pringy, France, 74374 Centre Eugène Marquis Rennes, France, 35042 Clinique Mathilde Rouen, France, 76000 Clinique Armoricaine de Radiologie Saint Brieuc, France, 22015 CH Saint-Malo Saint Malo, France, 35400 Centre René Gauducheau CLCC Nantes Atlantique Saint-herblain, France, 44805 CH Gaston Ramon Sens, France, 89100 Centre Régional de Lutte contre le Cancer Centre Paul Strauss Strasbourg, France, 67065 Hôpitaux Universitaires de Strasbourg Hôpital civil Strasbourg, France, 67091 Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre Strasbourg, France, 67098 CHRU de Tours Tours, France, 37044 Less << |
| NCT00406601 | Sarcoma, Soft Tissue | Phase 2 | Completed | - | Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less << |
| NCT00727233 | Neurofibromatosis Type I ... More >> Plexiform Neurofibroma Less << | Phase 1 | Completed | - | United States, Alabama ... More >> Children's Hospital of Alabama Birmingham, Alabama, United States, 35233 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT00108953 | - | Completed | - | - | |
| NCT03389126 | Carcinoma, Hepatocellular | Phase 2 | Recruiting | March 31, 2020 | Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Kyung-Hun Lee, MD, PhD 82-2-2072-7207 kyunghunlee@snu.ac.kr Less << |
| NCT00801385 | Lung Cancer | Phase 2 | Unknown | - | Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joo-Hang Kim, MD 82-2-2228-8131 kjhang@yuhs.ac Less << |
| NCT00532064 | - | Terminated(Terminated per PI's... More >> request) Less << | - | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << | |
| NCT01011010 | Liver Cancer | Phase 1 | Completed | - | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less << |
| NCT03008512 | Carcinoma, Hepatocellular | Phase 2 | Recruiting | October 2021 | Korea, Republic of ... More >> Gachon University Gil Medical Center Recruiting Incheon, Korea, Republic of Contact: Young Saing Kim, MD +82-32-460-3231 zoomboom@gilhospital.com Less << |
| NCT00667589 | Hand-foot Skin Reaction ... More >> Rash Less << | Phase 2 | Terminated(Study was halted du... More >>e to poor subject accrual.) Less << | - | United States, Illinois ... More >> Northwestern University Feinberg School of Medicine, Department of Dermatology Chicago, Illinois, United States, 60611 Less << |
| NCT00667589 | - | Terminated(Study was halted du... More >>e to poor subject accrual.) Less << | - | - | |
| NCT00111007 | Melanoma | Phase 3 | Completed | - | - |
| NCT01371981 | Acute Myeloid Leukemia ... More >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm Less << | Phase 3 | Active, not recruiting | - | - |
| NCT01777594 | Advanced Adult Hepatocellular ... More >>Carcinoma Less << | Phase 2 | Completed | - | United States, Texas ... More >> Mary Crowley Cancer Research Center Dallas, Texas, United States, 75230 Oncology Consultants, PA Houston, Texas, United States, 77030 University of Texas Health Sciences Center at Houston, Memorial Hermann Cancer Center Houston, Texas, United States, 77030 The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229-3900 Less << |
| NCT00111007 | - | Completed | - | - | |
| NCT01012011 | - | Completed | - | Korea, Republic of ... More >> Many Locations, Korea, Republic of Less << | |
| NCT00492505 | Melanoma (Skin) | Phase 2 | Unknown | - | United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD 760-452-3340 emcclay@pacificoncology.com Less << |
| NCT00493636 | - | Completed | - | - | |
| NCT01069328 | Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Less << | Phase 1 | Completed | - | United States, Minnesota ... More >> Rochester, Minnesota, United States, 55905 United States, Texas Houston, Texas, United States, 77030 Less << |
| NCT00861419 | Advanced Solid Tumors | Phase 1 | Completed | - | - |
| NCT00493636 | Breast Cancer | Phase 2 | Completed | - | - |
| NCT03511703 | Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | June 30, 2019 | - |
| NCT02665065 | Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << | Phase 3 | Recruiting | June 2020 | United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less << |
| NCT02135874 | Acute Bilineal Leukemia ... More >> Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Mixed Phenotype Acute Leukemia Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified Recurrent Mixed Phenotype Acute Leukemia Less << | Phase 2 | Recruiting | October 30, 2019 | United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour 713-792-4764 Principal Investigator: Elias Jabbour Less << |
| NCT03017326 | Hepatoblastoma ... More >> Carcinoma, Hepatocellular Less << | Phase 3 | Recruiting | December 2022 | United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Contact: Hugh Bishop, MBChB Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Amos Burke, MB ChB amos.burke@addenbrookes.nhs.uk Less << |
| NCT02788201 | Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Less << |
| NCT03318562 | Triple Negative Breast Cancer ... More >> Hepatocellular Carcinoma Less << | Phase 2 | Terminated(The study was termi... More >>nated due to change in focus of the development program) Less << | - | United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Missouri Kansas City Research Institute Kansas City, Missouri, United States, 64131 Less << |
| NCT00698659 | - | Terminated | - | Singapore ... More >> National University Hospital Singapore, Singapore Less << | |
| NCT03768375 | Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << | Phase 2 | Recruiting | December 30, 2021 | China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Yingbin Liu, PHD 13918803900 laoniulyb@163.com Principal Investigator: yingbin liu, PHD Less << |
| NCT03251612 | Colorectal Cancer Metastatic | Phase 2 | Recruiting | December 2020 | Denmark ... More >> Department of Oncology, Aalborg University Hospital Not yet recruiting Aalborg, Denmark Contact: Mette Yilmaz, MD m.yilmaz@rn.dk Department of Oncology, Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Lone N Petersen, MD Lone.Noergaard.Petersen@regionh.dk Departmen of Oncology, Vejle Hospital Recruiting Vejle, Denmark Contact: Lars H Jensen, MD lars.henrik.jensen@rsyd.dk Germany Universitätsklinikum Hamburg - Eppendorf, Universitäres Cancer Center Hamburg (UCCH) Not yet recruiting Hamburg, Germany Contact: Andreas Block, MD block@uke.de Less << |
| NCT03413176 | - | Completed | - | France ... More >> AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France, 75013 Less << | |
| NCT00498966 | Kidney Cancer | Phase 2 | Completed | - | United States, Kentucky ... More >> Investigative Site Louisville, Kentucky, United States, 40202 United States, New Jersey Investigative Site Morristown, New Jersey, United States, 07962 United States, New York Investigative Site Armonk, New York, United States, 10504 Less << |
| NCT03586973 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 2 | Recruiting | March 31, 2021 | Japan ... More >> Aichi Cancer Center Hospital Recruiting Nagoya, Aichi, Japan National Cancer Center Hospital East Not yet recruiting Kashiwa, Chiba, Japan Iizuka Hospital Recruiting Iizuka, Fukuoka, Japan Kurume University Hospital Not yet recruiting Kurume, Fukuoka, Japan Sapporo-Kosei General Hospital Recruiting Sapporo, Hokkaido, Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan Kanagawa Cancer Center Recruiting Yokohama, Kanagawa, Japan Yokohama City University Medical Center Not yet recruiting Yokohama, Kanagawa, Japan Kindai University Hospital Recruiting Osakasayama, Osaka, Japan National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan Japanese Red Cross Musashino Hospital Active, not recruiting Musashino, Tokyo, Japan Chiba University Hospital Recruiting Chiba, Japan Hiroshima University Hospital Active, not recruiting Hiroshima, Japan Okayama University Hospital Not yet recruiting Okayama, Japan Osaka City University Hospital Recruiting Osaka, Japan Osaka International Cancer Institute Not yet recruiting Osaka, Japan Less << |
| NCT02111889 | Disseminated Malignant Neoplas... More >>m Less << | Not Applicable | Completed | - | Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less << |
| NCT01507740 | - | Terminated(Study was stopped 0... More >>4.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of 10 patients planned) and CRC patients recruitment was stopped) Less << | - | Austria ... More >> University Hospital Innsbruck, Internal Medicine V, Hematology Oncology Innsbruck, Austria, A-6020 Less << | |
| NCT02086734 | - | Completed | - | Germany ... More >> Urologische Klinik und Poliklinik der Universität München München, Bavaria, Germany, 81377 Less << | |
| NCT01810744 | Metastatic Colorectal Cancer ... More >> Glioblastoma Bevacizumab Capillaroscopy Less << | Not Applicable | Active, not recruiting | June 2018 | France ... More >> Centre Georges François Leclerc Dijon, France, 21079 Less << |
| NCT00960167 | Hepatocellular Carcinoma | Phase 1 | Unknown | - | Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jason Chia-Hsien Cheng, Ph.D. 886-2-2312-3456 ext 66696 jasoncheng@ntu.edu.tw Less << |
| NCT02452853 | Hepatocellular Carcinoma | Phase 2 | Unknown | May 2018 | - |
| NCT01391962 | Sarcoma, Alveolar Soft Part | Phase 2 | Recruiting | December 15, 2019 | United States, California ... More >> Santa Monica Oncology Center Recruiting Santa Monica, California, United States, 90403 Contact: Shivaani Kummar, M.D. 301-435-5402 kummars@mail.nih.gov United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4096 Canada, Ontario Princess Margaret Cancer Center Recruiting Toronto, Ontario, Canada, M5G2M9 Less << |
| NCT01381211 | Hepatocellular Carcinoma | Phase 2 | Unknown | December 2016 | Belgium ... More >> University Hospital Ghent Recruiting Ghent, Belgium, 9000 Contact: L Defreyne, PhD, MD (0)9/332 2938 ext +32 luc.defreyne@ugent.be Principal Investigator: L Defreyne, PhD, MD Less << |
| NCT02428543 | Acute Myeloid Lukemia | Phase 1 Phase 2 | Recruiting | September 2020 | France ... More >> Dr Abdelaziz CHAIB Recruiting Aix-en-Provence, France, 13600 Contact: Abdelaziz CHAIB achaib@ch-aix.fr Principal Investigator: Abdelaziz CHAIB Chu Amiens Recruiting Amiens, France, 80054 Contact: MAROLLEAU Jean Pierre Principal Investigator: MAROLLEAU Jean Pierre CHU d'Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS Magardembas@chu-angers.fr Principal Investigator: Martine GARDEMBAS Hôpital VICTOR DUPOUY Recruiting Argenteuil, France, 95107 Contact: AL JIJAKLI Ahmad ahmad.aljijakli@ch-argenteuil.fr Principal Investigator: AL JIJAKLI Ahmad Dr Edouard RANDIAMALALA Recruiting Bayonne, France, 64100 Contact: Edouard RANDIAMALALA erandiamalala@ch-cotebasque.fr Principal Investigator: Edouard RANDIAMALALA CHU de Besançon Recruiting Besançon, France, 25030 Contact: Fabrice LAROSA flarosa@chu-besançon.fr Principal Investigator: Fabrice LAROSA Dr Thorsten BRAUN Recruiting Bobigny, France, 93000 Contact: Thorsten BRAUN thorsten.braun@aphp.fr Principal Investigator: Thorsten BRAUN CHU Boulogne Sur Mer Recruiting Boulogne Sur Mer cedex, France, 62321 Contact: CHOUFI Bachra b.choufi@ch-boulogne.fr Principal Investigator: CHOUFI Bachra Chr Clemenceau Recruiting Caen Cedex, France, 14033 Contact: REMAN Oumédaly reman-o@chu-caen.fr Principal Investigator: REMAN Oumédaly Hôpital d'Instruction des Armées PERCY Recruiting Clamart, France, 92141 Contact: Jean Valère MALFUSSON jvmalf@free.fr Principal Investigator: Jean Valère MALFUSSON Dr Stéphanie HAÏAT Recruiting Corbeil-essonnes, France, 91100 Contact: Stéphanie HAÏAT Principal Investigator: Stéphanie HAÏAT Hôpital Henri Mondor Recruiting Créteil, France, 94010 Contact: PAUTAS Cécile cecile.pautas@hmn.aphp.fr Principal Investigator: PAUTAS Cécile CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: CAILLOT Denis denis.caillot@chu-dijon.fr Principal Investigator: CAILLOT Denis Centre hospitalier de Versailles Recruiting Le Chesnay cedex, France, 78157 Contact: Rousselot Philippe 003339638622 phrousselot@ch-versailles.fr Principal Investigator: Rousselot Philippe Hôpital Claude Huriez Recruiting Lille cedex, France, 59037 Contact: QUESNEL Bruno bquesnel@chru-lille.fr Principal Investigator: QUESNEL Bruno CHRU Dupuytren Not yet recruiting Limoges cedex, France, 87042 Contact: TURLURE Pascal pascal.turlure@chu-limoges.fr Principal Investigator: TURLURE Pascal Hôpital Edouard Herriot Recruiting Lyon cedex 03, France, 69437 Contact: THOMAS Xavier xavier.thomas@chu-lyon.fr Principal Investigator: THOMAS Xavier Dr Regis COSTELLO Recruiting Marseille, France, 13000 Contact: Regis COSTELLO regis.costello@ap-hm.fr Principal Investigator: Regis COSTELLO Centre Hospitalier de Meaux Recruiting Meaux, France, 77104 Contact: FRAYFER Jamilé j-frayfer@ch-meaux.fr Principal Investigator: FRAYFER Jamilé Dr Mario OJEDA-URIBE Recruiting Mulhouse, France, 68000 Contact: Mario OJEDA-URIBE ojedam@ch-mulhouse.fr Principal Investigator: Mario OJEDA-URIBE Dr Jacques DELAUNAY Recruiting Nantes, France, 44000 Contact: Jacques DELAUNAY jacques.delaunay@chu-nantes.fr Principal Investigator: Jacques DELAUNAY CHU Nice, Hôpital Archet 1 Recruiting Nice cedex 3, France, 06202 Contact: MANNONE Lionel mannone.l@chu-nice.fr Principal Investigator: MANNONE Lionel CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Eric JOURDAN eric.jourdan@chu-nimes.fr Principal Investigator: Eric Jourdan Hôpital Saint Antoine Recruiting Paris cedex 12, France, 75751 Contact: ISNARD Françoise francoise.isnard@sat.aphp.fr Principal Investigator: ISNARD Françoise Hôpital Necker Enfants Malades Recruiting Paris cedex 15, France, 75743 Contact: SUAREZ Felipe felipe.suarez@nck.aphp.fr Principal Investigator: SUAREZ Felipe Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: RAFFOUX Emmanuel emmanuel.raffoux@sls.ap-hop-paris.fr Principal Investigator: RAFFOUX Emmanuel Hôpital La Pitié Salpêtrière Recruiting Paris, France, 75013 Contact: UZUNOV Madalina madalina.uzunov@psl.aphp.fr Principal Investigator: UZUNOV Madalina Dr Laurence SANHES Suspended Perpignan, France, 66000 Dr Arnaud PIGNEUX Recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX arnaud.pigneux@chu-bordeaux.fr Principal Investigator: Arnaud PIGNEUX Centre Hospitalier René Dubos Recruiting Pontoise Cedex, France, 95303 Contact: VAIDA Iona Dana ioana.vaida@ch-pontoise.fr Principal Investigator: VAIDA Iona Dana Marc BERNARD Recruiting Rennes, France, 35000 Contact: Marc BERNARD marc.bernard@chu-rennes.fr Principal Investigator: Marc BERNARD Dr Emilie LEMASLE Recruiting Rouen, France, 76000 Contact: Emilie LEMASLE emilie.lemasle@chb.unicancer.fr Principal Investigator: Emilie LEMASLE Centre Hospitalier René Huguenin Suspended Saint Cloud, France, 92210 Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY emmanuelle.tavernier@icloire.fr Principal Investigator: Emmanuelle TAVERNIER-TARDY Dr Réda GARIDI Recruiting Saint-Quentin, France, 02100 Contact: Réda GARIDI Principal Investigator: Réda GARIDI Dr Christian RECHER Recruiting Toulouse, France, 31000 Contact: Christian RECHER Principal Investigator: Christian RECHER Centre Hospitalier de Valenciennes Recruiting Valenciennes, France, 59322 Contact: FERNANDES José fernandes-j@ch-valenciennes.fr Principal Investigator: FERNANDES José Less << |
| NCT03091465 | - | Completed | - | - | |
| NCT01372813 | - | Terminated(Terminated for insu... More >>fficient accrual.) Less << | - | - | |
| NCT02426450 | Hepatocellular Carcinoma | Phase 2 | Unknown | April 2017 | China, Guangdong ... More >> Zhen-Wei Peng Guangzhou, Guangdong, China, 510080 Less << |
| NCT01322477 | - | Unknown | - | Israel ... More >> Hadassah Hebrew University Medical Center Not yet recruiting Jerusalem, Israel Contact: Marina Orevi, MD 0508946211 marinaor@hadassah.org.il Contact: Roland Chisin, MD chisin@hadassah.org.il Less << | |
| NCT01372813 | Advanced Clear Cell Renal Carc... More >>inoma Less << | Phase 2 | Terminated(Terminated for insu... More >>fficient accrual.) Less << | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
| NCT02847377 | Carcinoma, Non-Small-Cell Lung | Early Phase 1 | Recruiting | March 27, 2019 | France ... More >> CGFL Recruiting Dijon, France, 21079 Less << |
| NCT03097601 | - | Active, not recruiting | December 30, 2019 | France ... More >> Centre Antoine LACASSAGNE Nice, France, 06189 Less << | |
| NCT03630640 | Hepatocellular Carcinoma | Phase 2 | Recruiting | September 30, 2020 | France ... More >> Hôpital Jean Verdier Recruiting Bondy, France, 93140 Contact: Pierre NAHON, MD,PhD 01 48 02 62 99 ext 0033 pierre.nahon@aphp.fr Contact: Olivier SEROR, MD,PhD 01 48 02 58 68 ext 0033 olivier.seror@aphp.fr Less << |
| NCT01538238 | Locally Advanced or Metastatic... More >> Non-clear Cell Type Renal Cell Carcinoma Less << | Phase 2 | Completed | - | Korea, Republic of ... More >> Samsung medical Center Seoul, Korea, Republic of Less << |
| NCT03322280 | Hepatocellular Carcinoma ... More >> Portal Vein Occlusion Tumor Thrombus Less << | Not Applicable | Enrolling by invitation | June 30, 2022 | China, Guangdong ... More >> The 2nd Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510260 Less << |
| NCT02711007 | Osteosarcoma ... More >>Metastasis Less << | Phase 2 Phase 3 | Completed | - | China, Beijing ... More >> Peking University People's Hospital Beijing, Beijing, China, 100044 Less << |
| NCT01167374 | Hepatocellular Carcinoma | Not Applicable | Recruiting | August 2020 | Germany ... More >> University Hospital of Heidelberg, Radiation Oncology Recruiting Heidelberg, Germany, 69120 Principal Investigator: Jürrgen Debus, MD PHD Less << |
| NCT02056587 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 4 | Completed | - | Russian Federation ... More >> Tatarstan Regional Cancer Center Kazan, Tatarstan, Russian Federation, 420029 Altai Regional Cancer Center Barnaul, Russian Federation N.N. Blokhin Russian Cancer Research Center Moscow, Russian Federation, 115478 Less << |
| NCT02738697 | Carcinoma, Hepatocellular | Phase 3 | Recruiting | December 2021 | China, Guangdong ... More >> SUN YAT-SEN University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rong-Ping Guo, M.D. 00862087342266 guorp@sysucc.org.cn Contact: Wei Wei, Ph.D. M.D. 00862087343790 weiwei@sysucc.org.cn Less << |
| NCT02877368 | - | Completed | - | France ... More >> Chu de Reims Reims, France, 51092 Less << | |
| NCT02772029 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Unknown | September 2017 | - |
| NCT02857712 | Salivary Gland Cancers | Phase 2 | Active, not recruiting | June 2019 | Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy, 20133 Less << |
| NCT02448056 | - | Not yet recruiting | May 2025 | Taiwan ... More >> National Taiwn University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ja-Der Liang, Master 886-2-23123456 jdliangntu@ntu.edu.tw Less << | |
| NCT03229512 | Hand Foot Skin Reaction | Early Phase 1 | Recruiting | December 2018 | United States, Illinois ... More >> Department of Dermatology, Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD 312-695-8106 jennifer.choi@northwestern.edu Contact: Linda Serrano, MD 312-503-5903 linda.serrano@northwestern.edu Principal Investigator: Jennifer N Choi, MD Sub-Investigator: Linda Serrano, MD Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD 312-695-8106 jennifer.choi@northwestern.edu Contact: Linda Serrano, MD 312-503-5903 linda.serrano@northwestern.edu Principal Investigator: Jennifer N Choi, MD Sub-Investigator: Linda Serrano, MD Less << |
| NCT02290977 | Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombosis Less << | Phase 2 | Unknown | April 2016 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Yong Han Paik, MD, PhD yh.paik@samsung.com Principal Investigator: Yong-Han Paik, MD, PhD Sub-Investigator: Hee Chul Park, MD, PhD Sub-Investigator: Ju-Yeon Cho, MD Sub-Investigator: Jeong Il Yu, MD Less << |
| NCT00782275 | Renal Cell Carcinoma ... More >> Kidney Cancer Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee Vanderbilt Univeristy Medical Center Nashville, Tennessee, United States, 37232 Less << |
| NCT00715182 | Advanced/ Metastatic Renal Cel... More >>l Cancer Less << | Phase 1 | Completed | - | United States, California ... More >> Novartis Investigative Site San Francisco, California, United States United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98109-1023 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site München, Germany, 81675 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Less << |
| NCT01339962 | - | Completed | - | Denmark ... More >> University of Copenhagen Herlev Hospital Herlev, Denmark, 2730 Less << | |
| NCT03359018 | Progression-free Survival ... More >> Overall Survival Clinical Benefit Rate Toxicity Less << | Phase 2 | Active, not recruiting | March 1, 2020 | China ... More >> Musculoskeletal Tumor Center of Peking University People's Hospital Beijing, China, 100044 Peking University Shougang Hospital Beijing, China, 100144 Less << |
| NCT02571946 | Liver Neoplasm ... More >> Portal Vein Tumor Thrombosis Proton Therapy Less << | Not Applicable | Recruiting | September 2022 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hee Chul Park, M.D., Ph.D. 82-2-3410-2612 hee.ro.park@samsung.com Principal Investigator: Hee Chul Park, M.D., Ph.D. Sub-Investigator: Doo Ho Choi, M.D., Ph.D. Sub-Investigator: Jeong Il Yu, M.D. Sub-Investigator: Won Ki Kang, M.D., Ph.D. Sub-Investigator: Ho Yeong Lim, M.D., Ph.D. Sub-Investigator: Young Suk Park, M.D., Ph.D. Sub-Investigator: Joon Oh Park, M.D., Ph.D. Sub-Investigator: Se Hoon Park, M.D., Ph.D. Sub-Investigator: Jeeyun Lee, M.D., Ph.D. Less << |
| NCT00538772 | - | Withdrawn | - | Canada, British Columbia ... More >> BC Cancer Agency - Centre for Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 Less << | |
| NCT02632864 | Liver Neoplasm ... More >> Proton Therapy Less << | Phase 2 | Recruiting | November 2022 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Joon Hyeok Lee, MD, PhD 82-2-3410-3409 gijhlee.lee@samsung.com Contact: Hee Chul Park, MD, PhD 82-2-3410-2612 hee.ro.park@samsung.com Sub-Investigator: Jeong Il Yu, MD Less << |
| NCT00782275 | - | Completed | - | - | |
| NCT01911000 | Carcinoma. Hepatocellular | Phase 2 | Completed | - | Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less << |
| NCT03048877 | Differentiated Thyroid Cancer | Phase 3 | Recruiting | December 2019 | China, Jiangsu ... More >> Nanjing PLA 81 Hospital Recruiting Nanjing, Jiangsu, China Contact: Shukui Qin, Prof. M.D. +86-26-84453932 qinsk@csco.org.cn China Peking Union Medical College Hospital Recruiting Peking, China, 100730 Contact: Lin Yansong, MD +86-10-69155610 linys@pumch.cn Less << |
| NCT03066557 | Hepatocellular Carcinoma | Not Applicable | Not yet recruiting | December 31, 2018 | - |
| NCT03164057 | Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << | Phase 2 | Recruiting | June 2027 | United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD 800-826-4673 weilisun@coh.org Principal Investigator: Weili Sun, MD,PhD Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD 866-353-5437 frazzaqi@valleychildrens.org Principal Investigator: Faisal Razzaqi, MD Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD 714-509-4348 jfrediani@choc.org Principal Investigator: Jamie Frediani, MD Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD 650-497-8953 lacayon@stanford.edu Principal Investigator: Norman J. Lacayo, MD Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD 858-966-5983 dschiff@chsd.org Principal Investigator: Deborah Schiff, MD United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD 866-278-5833 tanja.gruber@stjude.org Contact: Referral Office 866-278-5833 referralinfo@stjude.org Principal Investigator: Tanja A. Gruber, MD, PhD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD 682-885-4007 kenneth.heym@cookchildrens.org Principal Investigator: Kenneth M. Heym, MD Less << |
| NCT00936858 | Thyroid Cancer | Phase 2 | Active, not recruiting | December 2019 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02716012 | Hepatocellular Carcinoma ... More >> Liver Cancer Less << | Phase 1 | Recruiting | December 2019 | Singapore ... More >> National Cancer Centre Not yet recruiting Singapore, Singapore Principal Investigator: Dr Han Chong Toh National University Hospital Not yet recruiting Singapore, Singapore Principal Investigator: Dr Cheng Ean Chee Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan Principal Investigator: Professor Kai-Wen Huang United Kingdom University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, United Kingdom Principal Investigator: Dr yuk-Ting Ma Cambridge University Hospitals NHS Trust Recruiting Cambridge, United Kingdom Principal Investigator: Dr Bristi Basu The Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Principal Investigator: Professor Jeff Evans Clatterbridge Cancer Centre NHS Foundation Trust Recruiting Liverpool, United Kingdom Principal Investigator: Professor Daniel Palmer Guy's and St. Thomas' NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Debashis Sarker Imperial College Healthcare NHS Trust Recruiting London, United Kingdom Principal Investigator: Professor Long R Jiao University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Professor Tim Meyer Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom Principal Investigator: Professor Ruth Plummer Less << |
| NCT01798446 | Renal Cell Carcinoma ... More >> Nonclear Cell Temsirolimus Resistance Less << | Phase 2 | Unknown | December 2016 | Korea, Republic of ... More >> Seou National University Hospital Recruiting Seoul, Korea, Republic of, 110744 Contact: Se-Hoon Lee, MD, PhD 82220722199 shlee119@snu.ac.kr Principal Investigator: Se-Hoon Lee, MD, PhD Sub-Investigator: Dae Seog Heo, MD, PhD Sub-Investigator: Dong-Wan Kim, MD, PhD Sub-Investigator: Tae Min Kim, MD, PhD Sub-Investigator: Bhumsuk Keam, MD Less << |
| NCT01105364 | Kidney Cancer ... More >> Metastatic Cancer Less << | Not Applicable | Unknown | - | France ... More >> Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Contact Person 33-2-4747-4776 Less << |
| NCT01771458 | Reccurent/Metastatic Solid Tum... More >>or Disease Less << | Phase 2 | Unknown | December 2016 | France ... More >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 Less << |
| NCT02702414 | Hepatocellular Carcinoma | Phase 2 | Recruiting | May 30, 2021 | - |
| NCT02558387 | Recurrent or Metastatic Saliva... More >>ry Gland Cancer of the Head and Neck Less << | Phase 2 | Unknown | January 2017 | Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less << |
| NCT02544737 | Esophageal Cancer ... More >> Metastatic Esophageal Cancer Apatinib Less << | Phase 2 | Unknown | December 2017 | China, Zhejiang ... More >> Hangzhou Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Shixiu Wu, MD +8657186826086 wushixiu@medmail.com.cn Contact: Tao Song, Dr +8657186826086 taosong01@hotmail.com Less << |
| NCT01545804 | Liver Cancer | Phase 2 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less << |
| NCT01390519 | - | Completed | - | Norway ... More >> Novartis Investigative Site Kristiansand, Norway, 4615 Novartis Investigative Site Tromsø, Norway, 9038 Novartis Investigative Site Trondheim, Norway, 7006 Less << | |
| NCT00923130 | Renal Cell Carcinoma | Phase 2 | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, South Carolina University of South Carolina Charleston, South Carolina, United States, 29425 Less << |
| NCT03732547 | Carcinoma, Hepatocellular | Phase 2 | Recruiting | October 22, 2023 | China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Liang Wen, MD PhD +8619967413613 11518214@zju.edu.cn Less << |
| NCT01949194 | Metastatic Colorectal Cancer | Phase 2 | Active, not recruiting | December 2018 | Canada, New Brunswick ... More >> The Moncton Hospital (Horizon Health Network) Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 St-Mary's Hospital Centre Montreal, Quebec, Canada, H3T 1M5 McGill University Health Centre Montréal, Quebec, Canada, H4A 3J1 Canada Hopital Maisonneuve-Rosemont Montreal, Canada, H1T 2M4 Less << |
| NCT03648073 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Not yet recruiting | December 3, 2019 | - |
| NCT01747642 | Quality of Life | Phase 2 Phase 3 | Unknown | June 2014 | Bangladesh ... More >> Farabi General Hospital Recruiting Dhaka, Bangladesh, 1215 Contact: Mamun A Mahtab, MD, FACG +8801711567275 shwapnil@agni.com Contact: Helal Uddin, BSc +880-1819251514 crobangladesh@gmail.com Principal Investigator: Mamun A Mahtab, MD, FACG Sub-Investigator: Lovely Begum, BPharm Less << |
| NCT02789137 | - | Recruiting | October 30, 2018 | Spain ... More >> Hospital Arquitecto Marcide de Ferrol Recruiting Ferrol, A Coruña, Spain, 15405 Hospital Asil de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Hospital Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Hospital Galdakano Recruiting Usansolo, Bizkaia, Spain, 48960 Complejo Hospitalario la Mancha Centro Recruiting Alcazar de San Juan, Ciudad REAL, Spain, 13600 Hospital Universitari Son Espases Recruiting Palma, Mallorca, Spain, 07120 H. Universitario Infanta Cristina Recruiting Badajoz, Spain, 06006 Hospital Vall de Hebrón Recruiting Barcelona, Spain, 08035 Hospital Universitario Ciudad Real Recruiting Ciudad Real, Spain, 13005 H. Reina Sofía de Cordoba Recruiting Córdoba, Spain, 14004 Hospital de Cabueñes Not yet recruiting Gijón, Spain, 33394 ICO Girona (Hospital Dr.Josep Trueta) Recruiting Girona, Spain, 17007 Hospital Universitario de Guadalajara Not yet recruiting Guadalajara, Spain, 19002 Complejo Hospitalario de Jaén Recruiting Jaén, Spain, 23007 Complejo Hospitalario de León Recruiting León, Spain, 24071 Complejo Hospitalario Ourense. Hospital Santa María Nai Recruiting Ourense, Spain, 32005 Hospital General de Asturias Not yet recruiting Oviedo, Spain, 33011 Complejo Hospitalario de Navarra Recruiting Pamplona, Spain, 31008 Hospital Universitario Canarias Not yet recruiting Santa Cruz de Tenerife, Spain, 38320 Hospital de Sant Pau i Santa Tecla Recruiting Tarragona, Spain, 43003 Hospital Virgen de la Salud Recruiting Toledo, Spain, 45071 Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46011 H Clínico Zaragoza Recruiting Zaragoza, Spain, 50009 Less << | |
| NCT01567930 | Unresectable or Metastatic Hep... More >>atocellular Carcinoma Less << | Phase 2 | Unknown | March 2013 | United States, Tennessee ... More >> Boston Baskin Cancer Foundation Recruiting Memphis, Tennessee, United States, 38120 Less << |
| NCT01498458 | Metastatic Breast Cancer | Phase 1 | Completed | - | Germany ... More >> GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less << |
| NCT00923130 | - | Completed | - | - | |
| NCT02942329 | Gastric Cancer ... More >> Hepatocellular Carcinoma Less << | Phase 1 Phase 2 | Recruiting | October 2018 | China, Beijing ... More >> The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Recruiting Beijing, Beijing, China, 100071 Contact: Jian-Ming Xu, M.D. +861066947176 jmxu2003@yahoo.com Principal Investigator: Jian-Ming Xu, M.D. Sub-Investigator: Yun Zhang, M.D. Less << |
| NCT00282048 | Kidney Neoplasms ... More >> Carcinoma, Renal Cell Less << | Phase 2 | Completed | - | United States, Illinois ... More >> Pfizer Investigational Site Chicago, Illinois, United States, 60637 United States, New York Pfizer Investigational Site Bronx, New York, United States, 10466 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111-2497 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less << |
| NCT02338570 | Renal Cell Carcinoma | Phase 4 | Terminated(Stopped on November... More >> 16th 2016, because of recruitment failure.) Less << | - | Italy ... More >> Spedali Civili Brescia, Italy Ospedale A Perrino Brindisi, Italy Istituto Europeo di Oncologia Milano, Italy Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale Napoli, Italy AOU Maggiore della Carità Novara, Italy Casa di Cura La Maddalena Palermo, Italy Unicampus Biomedico Roma, Italy AOU San Giovanni di Dio e Ruggi D'Aragona Salerno, Italy Less << |
| NCT02751827 | - | Recruiting | February 2019 | France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD Principal Investigator: Antoine ITALIANO, MD,PhD Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY, MD, PhD Principal Investigator: Jean-Yves BLAY, MD, PhD Less << | |
| NCT01265810 | Oral Complaints ... More >> Renal Cell Carcinoma Hepatocellular Carcinoma Gastrointestinal Stromal Tumors Less << | Phase 3 | Completed | - | Netherlands ... More >> The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Centre (LUMC) Leiden, Netherlands, 2300 RC Less << |
| NCT00282048 | - | Completed | - | - | |
| NCT00717756 | Liver Cancer | Phase 2 | Completed | - | United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467 United States, Rhode Island Memorial Hospital of Rhode island Pawtucket, Rhode Island, United States, 02860 Lifespan Hospitals Providence, Rhode Island, United States, 02903 Less << |
| NCT00448721 | Renal Cell Carcinoma | Phase 2 | Completed | - | United States, California ... More >> Investigative Site Duarte, California, United States, 91010 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Investigative Site Nashville, Tennessee, United States, 37232 Less << |
| NCT01498458 | - | Completed | - | - | |
| NCT01910909 | Localized Non-Resectable Adult... More >> Hepatocellular Carcinoma Less << | Not Applicable | Recruiting | October 2018 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hee Chul Park, M.D., Ph.D. 82-2-3410-2612 hee.ro.park@samsung.com Principal Investigator: Hee Chul Park, M.D., Ph.D. Less << |
| NCT02048371 | Liposarcoma O... More >>steogenic Sarcoma Ewing/Ewing-like Sarcoma Rhabdomyosarcoma Less << | Phase 2 | Recruiting | December 2020 | United States, California ... More >> City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Torie Fechner 626-256-4673 tfechner@coh.org Principal Investigator: Warren Chow, MD Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Magnolia Manzano 323-361-8156 mmanzano@chla.usc.edu Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua 310-552-9999 vchua@sarcomaoncology.com Principal Investigator: Sant Chawla, MD Stanford University Recruiting Stanford, California, United States, 94305 Contact: Maria Ahern 650-725-6413 mahern@stanford.edu Principal Investigator: Kristen Ganjoo, MD United States, Florida Mayo Clinic - Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO 904-953-7292 Attia.Steven@mayo.edu Principal Investigator: Steven Attia, DO H. Lee Moffitt Terminated Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Rasima Cehic 312-695-2082 rasima.cehic@northwestern.edu Principal Investigator: Mark Agulnik, MD United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Michele Niland 317-278-0778 mniland@iupui.edu Principal Investigator: Daniel Rushing, MD United States, Massachusetts Dana Farber/Partners Cancer Care Terminated Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Minnesota Recruiting Rochester, Minnesota, United States, 55905 Contact: Elizabeth Smith 507-293-3817 Smith.Elizabeth6@mayo.edu Principal Investigator: Scott Okuno, MD United States, North Carolina Carolinas Healthcare System Recruiting Charlotte, North Carolina, United States, 28203 Contact: Michelle Treadwell 980-442-2332 Michelle.Treadwell@carolinashealthcare.org Principal Investigator: Michael Livingston, MD Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Colleen Piechocki 919-681-1883 colleen.piechocki@duke.edu Principal Investigator: Richard Riedel, MD United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43202 Contact: Comprehensive Cancer Center 800-293-5066 Jamesline@osumc.edu Principal Investigator: David Liebner, MD United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: David Boody-Alter 503-418-9655 boodyalt@ohsu.edu Principal Investigator: Lara Davis, MD United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Melissa Sindler 615-875-0060 melissa.m.sindler@vanderbilt.edu Principal Investigator: Vicky Keedy, MD United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Justin Parker 801-587-4702 justin.parker@hci.utah.edu Principal Investigator: Jennifer Wright, MD United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore 206-288-6425 romoore@seattlecca.org Principal Investigator: Elizabeth Loggers, MD, PhD Less << |
| NCT03316872 | Hepatocellular Carcinoma | Phase 2 | Recruiting | April 2, 2022 | Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Jennifer J. Knox, M.D. 416-946-2399 Principal Investigator: Jennifer J. Knox, M.D. Less << |
| NCT02409524 | Advanced Adult Hepatocellular ... More >>Carcinoma Less << | Phase 2 | Unknown | August 2018 | Thailand ... More >> National Cancer Institute of Thailand Address: 268/1 Rama Rd. Ratchathewi Recruiting Bangkok, Thailand, 10400 Contact: Wirote Lausoontornsiri, MD 081-373-7690 wlausoon@gmail.com Contact: Nitiya Ritthidechratn 02-0260149 nitiya@immunovative.com Principal Investigator: Wirote Lausoontornsiri, MD Sub-Investigator: Somjin Chindavijak, MD Sub-Investigator: Jesada Suvikrom, MD Less << |
| NCT00717756 | - | Completed | - | - | |
| NCT02910843 | Rectal Cancer | Phase 1 | Recruiting | December 2022 | Switzerland ... More >> St. Claraspital Basel Recruiting Basel, Switzerland, 4016 Contact: Dieter Köberle, MD +41 61 685 85 85 dieter.koeberle@claraspital.ch Principal Investigator: Dieter Köberle, MD Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Viviane Hess, Prof +41 61 265 50 74 viviane.hess@usb.ch Principal Investigator: Viviane Hess, Prof Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Martin D. Berger, MD +41 31 632 41 14 martin.berger@insel.ch Principal Investigator: Martin D. Berger, MD Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ioannis Metaxas, MD +41 81 256 66 46 ioannis.metaxas@ksgr.ch Principal Investigator: Ioannis Metaxas, MD Kantonsspital Luzern Recruiting Luzern, Switzerland, 6000 Contact: Ralph Winterhalder, MD +41 41 205 58 75 ralph.winterhalder@ksl.ch Principal Investigator: Ralph Winterhalder, MD Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Markus Jörger, MD +41 71 494 29 22 markus.joerger@kssg.ch Principal Investigator: Markus Jörger, MD UniversitätsSpital Zürich Recruiting Zurich, Switzerland, 8091 Contact: Bernhard Pestalozzi, Prof +41 (0)44 255 34 40 bernhard.pestalozzi@usz.ch Principal Investigator: Bernhard Pestalozzi, Prof Less << |
| NCT00314119 | - | Completed | - | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << | |
| NCT01649180 | Renal Cell Carcinoma | Phase 2 | Terminated(Closed due to prolo... More >>nged enrollment timelines) Less << | - | United States, Nebraska ... More >> Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, Ohio Cleveland Clinic, Taussig Cancer Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT01700699 | - | Unknown | October 2013 | Italy ... More >> Department of Medicine and Surgery, Univeristy of Salerno Recruiting Baronissi, Salerno, Italy, 84081 Contact: Mario Vitale, MD +39 089672539 mavitale@unisa.it Principal Investigator: Mario Vitale, MD Less << | |
| NCT01649180 | - | Terminated(Closed due to prolo... More >>nged enrollment timelines) Less << | - | - | |
| NCT01871766 | Rhabdomyosarcoma | Phase 2 | Recruiting | June 2024 | United States, Florida ... More >> University of Florida Proton Therapy Institute Active, not recruiting Jacksonville, Florida, United States, 32206 Nemours Children's Clinic Active, not recruiting Jacksonville, Florida, United States, 32207 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Matthew J. Krasin, MD 866-278-5833 referralInfo@stjude.org Principal Investigator: Matthew J. Krasin, MD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Karen Albritton, MD 682-885-2103 karen.albritton@cookchildrens.org Principal Investigator: Karen Albritton, MD Less << |
| NCT02071719 | - | Terminated | October 2017 | Netherlands ... More >> VU Medical Center Amsterdam, Noord Holland, Netherlands, 1081 HV Less << | |
| NCT01946529 | Desmoplastic Small Round Cell ... More >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << | Phase 2 | Active, not recruiting | July 2026 | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
| NCT01946529 | - | Active, not recruiting | - | - | |
| NCT02779283 | Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << | Phase 1 | Recruiting | June 1, 2019 | United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon 503-494-8950 spurgeos@ohsu.edu Principal Investigator: Stephen E. Spurgeon Less << |
| NCT02423239 | Hepatocellular Carcinoma ... More >> Pancreatic Cancer Less << | Phase 1 | Unknown | December 2016 | Germany ... More >> University Hospital Bonn, Study Center Bonn (SZB) Clinical Study Core Unit Institute of Clinical Chemistry and Clinical Pharmacology University Hospital Bonn, Sigmund-Freud-Str. 25 Bonn, Germany, D-53127 Universitätsklinikum Hamburg-Eppendorf II. Medizinischen Klinik Martinistr. 52 Hamburg, Germany, 20246 Klinikum der Ruhr-Universitaet Bochum, Medizinische Klinik III - Hämatologie/Onkologie Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum Hölkeskampring 40 Herne, Germany, 44625 Klinikum der Universität München, Universitätsklinikum Großhadern Medizinische Klinik und Poliklinik III AG Onkologie Marchioninistr. 15 München, Germany, 81377 UNIFONTIS Praxis fur Integrative Onkologie, Hoppe-Seyler-Straße 6, Tübingen, Germany, 72076 Poland Osrodek Medyczny SAMARYTANIN, ul. Kazimierza Pużaka 11 Opole, Poland, 45-272 Wojewodzki Szpital Zespolony w Toruniu, ul. Św. Józefa 53-59 Toruń, Poland, 87-100 Spain Hospital Universitario Virgen de la Victoria, Servicio de Oncología Médica Campus de Teatinos, Málaga, Malaga, Spain, 29010 START MADRID-FJD, Hospital Fundación Jiménez Díaz, Av Reyes Católicos 2, Floor 1 28040 Madrid, Spain, 28040 Hospital Universitario Virgen del Rocio, Hospital Universitario Virgen del Rocío Oncología Médica Avda. Manuel Siurot, Sevilla, Spain, 41013 United Kingdom Beatson West of Scotland Cancer Centre, 1053 Great Western Rd, Glasgow, United Kingdom, G12 0YN St James's Hospital, Cancer Research UK Clinical Centre/Section of Oncology, Beckett St, Leeds, United Kingdom, LS9 7TF Freeman Hospital, Sir Bobby Robson Cancer Trials Research Centre, Freeman Road, High Heaton, Newcastle upon Tyne, United Kingdom, NE7 7DN Less << |
| NCT02638428 | Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << | Phase 2 | Recruiting | December 2023 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung 82-2-3410-3529 kwsped@skku.edu Principal Investigator: Ki Woong Sung Less << |
| NCT01911273 | Carcinoma, Hepatocellular | Phase 2 | Terminated(See termination rea... More >>son in detailed description.) Less << | - | United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Japan National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Kinki University Hospital, Department of Gastroenterology and Hepatology Osaka-Sayama, Osaka, Japan, 589-8511 National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 Less << |
| NCT01911273 | - | Terminated(See termination rea... More >>son in detailed description.) Less << | - | - | |
| NCT01446224 | - | Completed | - | - | |
| NCT02029001 | Malignant Solid Neoplasms | Phase 2 | Recruiting | October 2022 | France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO +335 56 33 33 33 a.italiano@bordeaux.unicancer.fr Principal Investigator: Antoine ITALIANO Sub-Investigator: Delphine GARBAY Sub-Investigator: Maud TOULMONDE Sub-Investigator: Sophie COUSIN Sub-Investigator: Sylvestre LE MOULEC Sub-Investigator: Mathilde CABART Sub-Investigator: Guilhem ROUBAUD Centre Jean Perrin Not yet recruiting Clermont-Ferrand, France, 63011 Contact: Xavier DURANDO 04 73 27 81 31 xavier.durando@cjp.fr Principal Investigator: Xavier DURANDO Sub-Investigator: Pierre DALLOZ Sub-Investigator: Anne-Françoise DILLIES-LEGRAIN Sub-Investigator: Pascale DUBRAY-LONGERAS Sub-Investigator: Hakim MAHAMMEDI Sub-Investigator: Marie-Ange MOURET-REYNIER Sub-Investigator: Isabelle VAN PRAAGH DOREAU Institut Daniel Hollard Not yet recruiting Grenoble, France, 38028 Contact: Cécile LEYRONNAS 04 76 70 73 33 c.leyronnas@ghm-grenoble.fr Principal Investigator: Cécile LEYRONNAS, MD Sub-Investigator: Claire GARNIER-TIXIDRE, MD Sub-Investigator: Laurence LANCRY-LECOMTE, MD Sub-Investigator: Jérôme LONG, MD Sub-Investigator: Christine REBISCHUNG, MD Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Jean-Yves BLAY +33478785126 jean-yves.blay@lyon.unicancer.fr Principal Investigator: Jean-Yves BLAY, MD Sub-Investigator: Virginie AVRILLON Sub-Investigator: Thomas BACHELOT Sub-Investigator: Christophe BERGERON Sub-Investigator: Pierre BIRON Sub-Investigator: Helen BOYLE Sub-Investigator: Philippe CASSIER Sub-Investigator: Patrick COMBEMALE Sub-Investigator: Maria CHELGHOUM Sub-Investigator: Françoise DESSEIGNE Sub-Investigator: Cécile FAURE-CONTER Sub-Investigator: Jérome FAYETTE Sub-Investigator: Aude FLECHON Sub-Investigator: Christelle DE LA FOUCHARDIERE Sub-Investigator: Didier FRAPPAZ Sub-Investigator: Pierre GUIBERT Sub-Investigator: Pierre-Etienne HEUDEL Sub-Investigator: Eve-Marie NEIDHARDT Sub-Investigator: Maurice PEROL Sub-Investigator: Isabelle RAY-COQUARD Sub-Investigator: Paul REBATTU Sub-Investigator: Pierre SAINTIGNY Sub-Investigator: Catherine TERRET Sub-Investigator: Olivier TREDAN Sub-Investigator: Olivia BALLY Sub-Investigator: Stéphane DEPIL Sub-Investigator: Olfa DERBEL Sub-Investigator: Nathalie MARQUES Sub-Investigator: Philippe TOUSSAINT Sub-Investigator: Mehdi BRAHMI Sub-Investigator: Matthieu SARABI Sub-Investigator: Alice BONNEVILLE-LEVARD Sub-Investigator: Nadège CORRADINI Sub-Investigator: Louis DOUBLET Sub-Investigator: Armelle DUFRESNE Sub-Investigator: Lauriane EBERST Sub-Investigator: Sylvie NEGRIER Sub-Investigator: Katell MICHAUX Sub-Investigator: Anne-Sophie MICHALLET Sub-Investigator: Guillaume MAURICEAU Sub-Investigator: Juliette REURE Sub-Investigator: Pauline ROCHEFORT Hopital Edouard Herriot Not yet recruiting Lyon, France, 69437 Contact: Julien FORESTIER, MD +33472119738 julien.forestier@chu-lyon.fr Principal Investigator: Julien FORESTIER Sub-Investigator: Catherine LOMBARD BOHAS Sub-Investigator: Thomas WALTER Sub-Investigator: Yann MOLIN Sub-Investigator: Noura BEN SLAMA Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: François BERTUCCI +334 91 22 35 37 bertuccif@ipc.unicancer.fr Principal Investigator: François BERTUCCI Sub-Investigator: Jean-Marc EXTRA Sub-Investigator: Anthony GONCALVES Sub-Investigator: Gwenaêlle GRAVIS-MESCAM Sub-Investigator: Anne MADROSZYK-FLANDIN Sub-Investigator: Jean-Luc RAOUL Sub-Investigator: Delphine PERROT Sub-Investigator: Magali PROVENSAL Sub-Investigator: Carole TARPIN Sub-Investigator: Frédéric VIRET Sub-Investigator: Louis TASSY Sub-Investigator: Maria Antonietta CAPPIELLO Sub-Investigator: Slimane DERMECHE Sub-Investigator: Simon LAUNAY Sub-Investigator: Frederique ROUSSEAU Sub-Investigator: Nicolas MEYER Sub-Investigator: Loïc MOUREY Sub-Investigator: Elisabeth MOYAL Sub-Investigator: Roxana Maria RADUT Sub-Investigator: Henri ROCHE Sub-Investigator: Thibaud VALENTIN Sub-Investigator: Sarah ZAHI Institut Curie Recruiting Paris, France, 75248 Contact: Christophe LE TOURNEAU, MD +33144324672 Christophe.letourneau@curie.fr Principal Investigator: Christophe LE TOURNEAU, MD Sub-Investigator: Philippe BEUZEBOC Sub-Investigator: François-Clément BIDARD Sub-Investigator: Bruno BUECHER Sub-Investigator: Paul-Henri COTTU Sub-Investigator: Catherine DANIEL Sub-Investigator: Véronique DIERAS Sub-Investigator: Valérie LAURENCE Sub-Investigator: Alain LIVARTOWSKI Sub-Investigator: Jean-Yves PIERGA Sub-Investigator: Marie ALT Sub-Investigator: Delphine LOIRAT Sub-Investigator: Marie-Paule SABLIN Sub-Investigator: Mustapha ZOUBIR Sub-Investigator: Francesco RICCI Sub-Investigator: Emanuela ROMANO Sub-Investigator: Olivier COLLARD Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69495 Contact: Benoit YOU, MD +33478864319 benoit.you@chu-lyon.fr Principal Investigator: Benoit YOU, MD Sub-Investigator: Nathalie BONNIN Sub-Investigator: Gilles FREYER Sub-Investigator: Salima HAMIZI Sub-Investigator: Sophie TARTAS Sub-Investigator: Véronique TRILLET-LENOIR Sub-Investigator: Marion CHAUVENET Sub-Investigator: Denis MAILLET Sub-Investigator: Julien PERON Sub-Investigator: Claire FALANDRY Sub-Investigator: Olivia LE SAUX Institut de cancérologie LUCIEN NEUWIRTH Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Olivier COLLARD, MD 04 77 91 70 34 olivier.collard@icloire.fr Principal Investigator: Olivier COLLARD, MD Sub-Investigator: Claire BOSACKI, MD Sub-Investigator: Pierre FOURNEL, MD Sub-Investigator: Aline GUILLOT, MD Sub-Investigator: Jean-Philippe JACQUIN, MD Sub-Investigator: Thierry MURON, MD Sub-Investigator: Léa SABAN-ROCHE, MD Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Carlos-Alberto GOMEZ-ROCA 05 31 15 51 01 Gomez-roca.carlos@iuct-oncopole.fr Principal Investigator: Carlos-Alberto GOMEZ-ROCA Sub-Investigator: Christine CHEVREAU Sub-Investigator: Ewa-Anna COTTURA Sub-Investigator: Florence DALENC Sub-Investigator: Jean-Pierre DELORD Sub-Investigator: Marion DESLANDRES Sub-Investigator: Cécile GANDY Sub-Investigator: Laurence GLADIEFF Sub-Investigator: Eleonora MAIO D'ESPOSITO Sub-Investigator: Nicolas MEYER Sub-Investigator: Loïc MOUREY Sub-Investigator: Elisabeth MOYAL Sub-Investigator: Henri ROCHE Sub-Investigator: Thibaud VALENTIN Sub-Investigator: Sarah ZAHI Sub-Investigator: Roxana Maria RADUT Less << |
| NCT02560012 | Carcinoma, Renal Cell | Phase 2 | Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << | - | United States, Texas ... More >> UTHealth Memorial Hermann Cancer Center Houston, Texas, United States, 77030 Less << |
| NCT02412475 | Leukemia, Acute Myeloid | Phase 1 | Active, not recruiting | February 2019 | United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less << |
| NCT01731158 | Metastatic Renal Cell Carcinom... More >>a Less << | Phase 2 | Unknown | May 2016 | Germany ... More >> Charité Berlin Berlin, Germany University Hospital Bonn Bonn, Germany University Hospital Dresden Dresden, Germany University Hospital Düsseldorf Düsseldorf, Germany Waldkrankenhaus St. Marien Erlangen, Germany University Hospital Essen Essen, Germany University Hospital Frankfurt Frankfurt, Germany University Hospital Freiburg Freiburg, Germany University Hospital Göttingen Göttingen, Germany Oncological Practice Hannover Hannover, Germany University Hospital Hannover Hannover, Germany University Hospital Magdeburg Magdeburg, Germany University Hospital Tübingen Tübingen, Germany Less << |
| NCT01224730 | Cancer | Phase 1 | Completed | - | United States, Texas ... More >> Dallas, Texas, United States, 75230 Houston, Texas, United States, 77030 Less << |
| NCT02560012 | - | Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << | - | - | |
| NCT02559778 | Neuroblastoma | Phase 2 | Recruiting | September 2026 | - |
| NCT01628640 | Advanced Malignant Solid Neopl... More >>asm Hepatocellular Carcinoma Less << | Phase 1 | Suspended(for evaluation of 3 ... More >>patients enrolled on DL3A) Less << | June 2025 | United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
| NCT01101906 | Advanced Hepatocellular Carcin... More >>oma (HCC) Less << | Phase 2 | Terminated(Company decided not... More >> to pursue the development of this drug in this patient population at this time) Less << | - | - |
| NCT01758575 | - | Terminated | - | Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less << | |
| NCT02551718 | Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << | Not Applicable | Recruiting | - | United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker Less << |
| NCT01246817 | Renal Cell Cancer | Phase 2 | Unknown | - | Netherlands ... More >> University Medical Centre Nijmegen Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Principal Investigator: C.M.L. van Herpen, Md PhD Less << |
| NCT00610012 | - | Active, not recruiting | August 2020 | Germany ... More >> iOMEDICO Freiburg, Germany Less << | |
| NCT01387503 | Carcinoma, Hepatocellular ... More >> Cirrhosis Less << | Phase 2 Phase 3 | Unknown | January 2014 | Italy ... More >> Ospedali Riuniti di Bergamo Recruiting Bergamo, Italy, 24125 Ospedale Maggiore di Milano Policlinico Recruiting Milano, Italy, 20122 Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Azienda Ospedaliera Ospedale Niguarda Ca' Granda Recruiting Milano, Italy, 20162 Azienda Ospedaliera Universitaria di Padova Recruiting Padova, Italy, 35128 Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT) Recruiting Palermo, Italy, 90133 Policlinico Tor Vergata Recruiting Roma, Italy, 00133 Ospedale "Lazzaro Spallanzani" Recruiting Roma, Italy, 00149 Ospedale Umberto Iº Policlinico di Roma Recruiting Roma, Italy, 00161 Ospedale Universitario Molinette S. Giovanni Battista di Torino Recruiting Torino, Italy, 10126 Less << |
| NCT03338166 | - | Not yet recruiting | December 2018 | - | |
| NCT02776644 | - | Completed | - | - | |
| NCT00986661 | Cancer Metastatic to the Liver... More >> Hepatocellular Carcinoma Less << | Phase 1 | Recruiting | February 2020 | United States, California ... More >> Sharp Memorial Hospital Recruiting San Diego, California, United States, 92123 Contact: Amy King 858-939-5052 Amy.King@sharp.com Principal Investigator: Kristin Rice, M.D. United States, Florida Florida Hospital Tampa Recruiting Tampa, Florida, United States, 33613 Contact: Heather Bingaman, BS 813-615-7068 heather.bingaman@ahss.org Principal Investigator: Alexander Rosemurgy, M.D. United States, Pennsylvania St Luke's University Health Network Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Alyse M LaLiberte, MPH 484-503-4151 Alyse.LaLiberte@sluhn.org Contact: Robyn Rex, RN, OCN, CCRP 484-503-4152 robyn.rex@sluhn.org Principal Investigator: Sanjiv Agarwala, MD United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Rhonda Combs, LPN 615-322-2260 rhonda.j.combs@vanderbilt.edu Contact: Melissa Ford, MSN, PhD, RN 615-875-7143 melissa.b.ford@vanderbilt.edu Principal Investigator: Daniel Brown, MD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Gener Balmes, RN, CCRP 713-794-4153 gcbalmes@mdanderson.org Principal Investigator: Sapna Patel, MD Less << |
| NCT01009801 | Liver Cancer | Phase 1 Phase 2 | Terminated(due to slow patient... More >> recruitement.) Less << | - | Switzerland ... More >> Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Graubuenden Chur, Switzerland, 7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Clinica Luganese di Moncucco Lugano, Switzerland, 6903 Institut Central des Hopitaux Valaisans / Hôpital de Sion Sion, Switzerland, CH-1951 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less << |
| NCT03419572 | - | Recruiting | January 5, 2021 | - | |
| NCT01827254 | - | Completed | - | - | |
| NCT02645149 | Melanoma | Phase 4 | Not yet recruiting | August 2021 | Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez 612 9911 7200 maria.gonzalez@melanoma.org.au Principal Investigator: John Thompson Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez +612 9911 7200 maria.gonzalez@melanoma.org.au Contact: Alex Menzies +612 9911 7200 info@melanoma.org.au Sub-Investigator: Georgina Long Principal Investigator: Alex Menzies Less << |
| NCT01827254 | - | Completed | - | France ... More >> CHU de la Timone Marseille, Cedex 5, France, 13335 Hopital albert Michalon Grenoble, Cedex 9, France, 38043 Centre Paul Papin Angers, France, 49100 Hôpital Saint-André Bordeaux Cedex, France, 33075 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre Oscar Lambret - Cancérologie Urologie Digestive Lille Cedex, France, 59020 clinique de la Louvière Lille Cedex, France, 59042 Hopital Dupuytren - Oncologie Medicale Limoges Cedex, France, 87042 Centre Leon Berard, Service d'Oncologie Medicale Lyon Cedex 08, France, 69373 Institut Paoli-Calmettes / Hôpital de jour Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Marseille Cedex, France, 13385 Hopital Europeen Georges Pompidou Paris Cedex 15, France, 75908 Centre Eugene Marquis Rennes, France, 35042 CHU Charles Nicolle ROUEN Cedex, France, 76031 Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint Priest en Jarez Cedex, France, 42271 Centre Rene Gauducheau - Service Oncologie Medicale St Herblain Cedex, France, 44805 Institut Claudius Regaud Toulouse, France, 31000 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Less << | |
| NCT02829840 | Leukemia FLT3... More >>-Mutated Acute Myeloid Leukemia FLT3-Mutated High-Risk Myelodysplastic Syndrome Less << | Phase 1 Phase 2 | Withdrawn | - | - |
| NCT01703910 | Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << | Phase 2 | Completed | - | Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less << |
| NCT00811993 | Neoplasms | Phase 1 | Terminated | - | United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, California San Francisco, California, United States, 94115 Santa Monica, California, United States, 90025 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Illinois Chicago, Illinois, United States, 60637 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Texas Houston, Texas, United States, 77030 Less << |
| NCT00601120 | Renal Cell Carcinoma | Not Applicable | Withdrawn(This protocol was ne... More >>ver officially opened and no patients were recruited.) Less << | - | United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less << |
| NCT02836847 | Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << | Phase 2 | Recruiting | December 2020 | China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: yingbin liu 13918803900 laoniulyb@163.com Less << |
| NCT01636908 | Cancer Advanc... More >>ed Solid Tumors Less << | Not Applicable | Active, not recruiting | - | Netherlands ... More >> VUMedical Center Amsterdam, Netherlands, 1081 HV Less << |
| NCT03520257 | Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | June 30, 2019 | - |
| NCT03680677 | Leukemia, Acute ... More >> MDS Less << | Not Applicable | Not yet recruiting | November 2025 | United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT05601895 | Acute Leukemia|Allogeneic Hema... More >>topoietic Stem Cell Transplantation Less << | UNKNOWN | 2024-12-31 | Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less << | |
| NCT04788420 | Acute Myeloid Leukemia|Acute M... More >>yeloid Leukemia With FLT3/ITD Mutation|Hematopoietic Stem Cell Transplantation Less << | COMPLETED | 2020-12-31 | Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less << | |
| NCT01091207 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE2 | COMPLETED | 2025-08-11 | Samsung Medical Center, Seoul,... More >> 135710, Korea, Republic of Less << |
| NCT00864032 | Soft Tissue Sarcoma | PHASE1|PHASE2 | COMPLETED | 2025-08-11 | University of california, Davi... More >>s Medical Center, Sacramento, California, 95817, United States Less << |
| NCT01159327 | Small Cell Lung Cancer | PHASE2 | TERMINATED | 2025-06-13 | National Cancer Center, Korea,... More >> Goyang-si, Gyeonggi-do, Korea, Republic of Less << |
| NCT00510289 | Myelodysplastic Syndromes|Leuk... More >>emia, Myelomonocytic, Chronic Less << | PHASE2 | TERMINATED | 2025-07-11 | Duke University Medical Center... More >>, Durham, North Carolina, 27710, United States Less << |
| NCT00532025 | Carcinoma, Non-Small-Cell Lung | PHASE2 | TERMINATED | 2025-09-08 | SIRN investigational trial sit... More >>e, Essen, Germany|SIRN investigational trial site, Halle (Saale), Germany|SIRN investigational trial site, Loewenstein, Germany|SIRN investigational trial site Johannes Gutenberg Universit?t, Mainz, Germany|SIRN investigational trial site Katholisches Klinikum, Mainz, Germany|SIRN investigational trial site, Rotenburg (Wuemme), Germany Less << |
| NCT00999843 | Hepatocellular Carcinoma | PHASE1|PHASE2 | UNKNOWN | 2025-10-12 | Fudan University Shanghai Canc... More >>er Center, Shanghai, Shanghai, 200032, China Less << |
| NCT01849588 | Hepatocellular Cancer | PHASE4 | TERMINATED | 2025-01-17 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02214, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less << |
| NCT00618384 | Hepatocellular Carcinoma | PHASE2 | TERMINATED | 2025-08-11 | Universit?tsklinikum Tübingen ... More >>Innere Medizin I, Tübingen, BW, 72076, Germany|Medizinische Universit?tsklinik Ulm Innere Medizin I, Ulm, BW, 89081, Germany|Klinikum der Universit?t Gro?hardern, Muenchen, BY, 81377, Germany|Klinikum der Johann-Goethe-Universit?t, Frankfurt, HE, 60590, Germany|Universit?tsklinikum Hamburg-Eppendorf Zentrum für Innere Medizin, Hamburg, HH, 20246, Germany|Johannes-Gutenberg-Universit?t Medizinische Klinik, Mainz, RP, 55131, Germany Less << |
| NCT00892424 | Liver Metastasis|Cancer | PHASE1|PHASE2 | COMPLETED | 2020-09-08 | University Health Network, Tor... More >>onto, Ontario, M5G 2M9, Canada Less << |
| NCT05117957 | Advanced Hepatocellular Carcin... More >>oma Less << | PHASE2 | ENROLLING_BY_INVITATION | 2025-12-31 | National Cancer Center, Korea,... More >> Seoul, Korea, Republic of Less << |
| NCT04674345 | Acute Leukemia|Relapse|Hematop... More >>oietic Stem Cell Transplantation Less << | PHASE2|PHASE3 | UNKNOWN | 2023-12-31 | Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less << |
| NCT05596968 | Acute Myeloid Leukemia With FL... More >>T3/ITD Mutation|Allogeneic Hematopoietic Stem Cell Transplantation Less << | UNKNOWN | 2024-12-31 | Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less << | |
| NCT00445042 | Carcinoma, Renal Cell | PHASE2 | COMPLETED | 2025-10-08 | Methodist Hospital - Baylor Co... More >>llege of Medicine, Houston, Texas, 77030, United States Less << |
| NCT00541840 | Soft Tissue Sarcoma | PHASE1|PHASE2 | UNKNOWN | 2025-04-10 | Grupo Geis, Madrid, 28001, Spa... More >>in Less << |
| NCT06527495 | HCC|Hepatocellular Carcinoma | PHASE1|PHASE2 | RECRUITING | 2024-12-01 | NLI, Shibīn Al Kawm, Menoufia,... More >> 32511, Egypt Less << |
| NCT05596981 | Acute Myeloid Leukemia With FL... More >>T3/ITD Mutation|Allogeneic Hematopoietic Stem Cell Transplantation Less << | UNKNOWN | 2024-12-31 | Department of Hematology,Nanfa... More >>ng Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China Less << | |
| NCT06532084 | Acute Myeloid Leukemia, in Rel... More >>apse|Myelodysplastic Syndromes|Chronic Myeloid Leukemia|Myeloproliferative Neoplasm Less << | PHASE2 | RECRUITING | 2025-05-28 | RM Gorbacheva Research Institu... More >>te, Saint Petersburg, 197022, Russian Federation Less << |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.15mL 0.43mL 0.22mL |
10.76mL 2.15mL 1.08mL |
21.51mL 4.30mL 2.15mL |
|